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Background
Over the last decades critique on the generalizability of scientific studies on the 
outcome of psychological interventions (e.g. Essock, Drake, Frank, & McGuire, 2003; 
Westen, 2005; Stirman, DeRubeis, Crits-Christoph, & Brody, 2003) has led to the 
emergence of practice-based research within the scientific community (Margison 
et al., 2000). At the same time, there was an increasing demand for practice-based 
research from therapists and mental health care providers. A combination of factors, 
such as expanding costs of mental health care and a deteriorating economic situation, 
has led to political measures, such as a restriction of the amount of refundable therapy 
sessions by insurance companies (e.g. Lambert, Huefner, & Nace, 1997). This state of 
affairs has made it necessary for providers to show that their interventions are effective. 
Measuring outcomes was also stimulated by the quality assurance perspective that 
has been adopted by the field (e.g. Edmunds et al., 1997; Valenstein et al., 2004).
Outcomes of psychological interventions depend on many factors, including 
patient and therapist characteristics and treatment variables. Results from randomized 
controlled trials tend to show positive results of treatment, but results measured in 
clinical practice are less favourable (Barkham et al., 2008; Hansen, Lambert, & Forman, 
2002; Hansen, Lambert, & Forman, 2003; Weisz, Donenberg, Han, & Weiss, 1995). There 
has been a growing awareness in research and practice that treatment effects should 
be evaluated for the individual patient in everyday practice and that the treatment has 
to be adjusted when patients do not progress according to expectation (Lambert et 
al., 2003). Measuring patient progress in clinical practice is often referred to as (routine) 
outcome monitoring or measuring. In outcome monitoring therapists are typically 
provided with feedback on their patients’ progress using a generic outcome measure. 
In some models, the progress of the patient is benchmarked against a prediction 
model (Lambert, 2007). Recently, outcome monitoring has burgeoned and there 
is a variety of feedback models available, that not only differ in design, but also in 
effectiveness. Recent review articles and meta-analyses show that feedback can have 
slightly negative to very large positive effects (Carlier et al., 2010; Knaup, Koesters, 
Schoefer, Becker, & Puschner, 2009; Shimokawa, Lambert, & Smart, 2010). In addition 
to therapists being able to adjust the treatment of individual patients, outcome 
monitoring enables research on patient, therapist and treatment factors that may be 
predictive of positive outcomes, which may inform decision making on an aggregated 
level (e.g. treatment unit, organization, national or international level).
At the start of this project, Michael Lambert was one of the few who had done 
controlled research in this area. His group still has performed the largest number of 
studies, but it was uncertain whether results of these studies could be generalized 
to Dutch outpatients, since his research was carried out in a very specific setting. The 




majority of the patients in his studies were students at a private mormon (Latter Day 
Saints; LDS) university, who were seeking counseling in the university counseling 
center, resulting in highly educated, young patients of relatively high social economic 
status (Shimokawa, et al., 2010). In addition, practically all of the therapists are 
LDS church members as well. This resulted in a very specific cultural subgroup of 
patients and therapists and the results of his studies might not translate well to other 
American cultural groups, let alone Dutch patients and therapists. Apart from cultural 
differences, the American mental health care system is different from the system in 
the Netherlands, where almost all mental health care is in the public sector and even 
service provided by private practitioners is reimbursed by public funds.
The central objective of this thesis is to develop an effective outcome monitoring 
feedback model that is fit for outpatient mental health treatment in the Netherlands 
and that may improve treatment outcomes for patients. The purpose of this chapter 
is to give an overview of the relevant literature. The chapter is organized as follows. 
First, an overview of relevant literature on outcome monitoring is given. Second, 
a definition of outcome, treatment success and treatment failure is provided. Third, 
relevant predictors of outcome will be discussed. Finally, the need for feedback to 
therapists is discussed. The chapter ends with an overview of this thesis.
Outcome monitoring
As has been stated above, outcome monitoring refers to the (frequent) measuring of 
results during therapy. The measures that are used depend on the treatment goals, 
which may differ distinctly across treatment settings. Worldwide, there are many large 
initiatives in which outcomes are monitored in clinical practice, including the COMPASS 
(Howard, Moras, Brill, Martinovich, & Lutz, 1996), the Partners for Change Outcome 
Management System (Miller, Duncan, Sorrell, & Brown, 2005), and the Treatment 
Outcome Package (Kraus, Seligman, & Jordan, 2005) in the United States; the Clinical 
Outcomes in Routine Evaluation – Outcome Measure (Evans et al., 2002) in the United 
Kingdom; and the Health of the Nation Outcome Scales (HoNOS) in the United Kingdom, 
Australia and New Zealand (Burgess, Pirkis, & Coombs, 2006; Wing et al., 1998).
In the Netherlands, a large national project on routine outcome monitoring started 
in 2009. The project is a collaboration between the branch organization of mental health 
care providers, the branch organization of health insurance companies, the national 
patient platform for mental health care, the Dutch institute for psychologists, the Dutch 
organization for psychiatrists and the national organization for patients in mental 
health care. It aims to promote routine outcome monitoring in clinical practice for all 
patient groups (Stuurgroep ROM ggz, 2010). What is unique about the project is that it 
is not centered around the use of one instrument or patient group, but a wide range 
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of instruments and patients. There are several task forces in the project that advice the 
field on topics such as the use of instruments, measurement frequency, comparability 
of outcome measured by different instruments, implementation and infrastructure. 
Outcome monitoring has been promoted by several professional organizations. The 
American Psychological Association (APA) Presidential Task Force on Evidence-Based 
Practice in Psychology (2006) states that “providing clinicians with real-time patient 
feedback to benchmark progress in treatment and clinical support tools to adjust 
treatment as needed” is one of “the most pressing current research needs” (p.278). 
The APA Interdivisional (Divisions 12 and 29) Task Force on Evidence-based Therapy 
Relationships (2011) reports that collecting client feedback is demonstrably effective and 
states in their recommendations for practice: “Practitioners are encouraged to routinely 
monitor patients’ responses to the therapy relationship and ongoing treatment. Such 
monitoring leads to increased opportunities to reestablish collaboration, improve the 
relationship, modify technical strategies, and avoid premature termination”. Similar 
advice is given by the American Group Psychotherapy Association (2007) in their 
Practice Guidelines for Group Psychotherapy.
Outcome monitoring can have several functions. The ROM ggz project mentions four 
functions of outcome monitoring: 1) to support clinicians in their treatment process; 2) to 
learn from aggregated outcomes within the organization and compare oneself with other 
organizations; 3) to demonstrate the effectiveness of treatments to third-party payers, such 
as insurance companies and the Ministry of Health; 4) to study predictors and mediators 
of outcome using large national databases (Stuurgroep ROM ggz, 2010). Kazdin (2008) 
states that the key argument for systematic evaluation is to provide high-quality care. 
Whether clinicians use evidence-based treatment or individualized treatment, they can 
never be sure that the treatment will be effective. In addition, monitoring treatment effects 
in an ongoing way is important to make decisions on continuing, altering or terminating 
treatment on the basis of how well the patient is doing (Kazdin, 2008). Sapyta, Riemer 
and Bickman (2005) use the metaphor of learning archery and indicate that without 
feedback on where the arrow lands, it is impossible to master archery, no matter how 
much natural talent someone has at archery. They state that: “Without direct feedback 
on how their clients are progressing, clinicians are essentially wearing a blindfold while 
shooting at a target”. Although the archery metaphor is certainly appealing, in real life the 
analogy does not hold. In archery feedback is straightforward: you hit the target or not. 
In clinical practice, the feedback will not always be that clear. When two measurements 
are administered to a patient, how does the clinician know if he or she is on target or not? 
How much does a patient need to improve to be considered a successful case? These 
questions will be addressed in the next paragraph. 







One of the main objectives of feedback models in clinical practice is to prevent 
treatment failure. Until recently, treatment failure was an issue that was not often 
addressed in literature, but a renewed interest in the matter has emerged, resulting in 
special issues in Cognitive Behavioral Practice (Dimidjian & Hollon, 2011) and the Journal 
of Clinical Psychology (Lampropoulos, 2011), as well as a series of articles in the American 
Psychologist (Barlow, 2010; Castonguay, Boswell, Constantino, Goldfried, & Hill, 2010; 
Dimidjian & Hollon, 2010). Treatment failure is a complex concept to define, as it may 
include dropout or premature termination, nonresponse (no change), partial change, 
slow change, deterioration (negative change) and relapse (failure to maintain gains). In 
addition, there might be challenges in defining failure in therapy depending on whose 
perspective is being used: patient, therapist or other observers (Lampropoulos, 2011). 
It seems that definition of treatment failure also differs between different treatment 
modalities. A recent special issue of the Journal of Clinical Psychology (November 2011) 
showed treatment failure from the perspective of five different theoretical orientations. 
In psychodynamic therapy gaining insight and character change are considered the 
most important goals and treatment could be perceived as failed by psychodynamic 
therapists if symptomatic relief would occur without structural changes in character 
(Gold & Stricker, 2011). The behavioral therapy approach focuses on nonresponse 
and deterioration, defined by symptom attenuation and uses self-report measures 
to assesses outcomes (Hopko, Magidson, & Lejuez, 2011). Watson (2011), who is an 
experiential psychotherapist, stresses that for patients who are nonresponders or 
who are slow to respond, the question of whether treatment has failed is not as easy 
to answer. In interpersonal therapy, failure includes partial response, nonresponse, 
worsening and premature termination (Ravitz, McBride, & Maunder, 2011). Common 
denominators that capture most perspectives on treatment failure across theoretical 
orientations include nonresponse and deterioration (Lambert, 2011), which is the 
definition we use in this thesis. 
Clinical significance
Nonresponse and deterioration are most often defined by the concept of clinical 
significant and reliable change (Jacobson & Truax, 1991). These authors define clinical 
significance as returning to normal functioning and this approach is nowadays the 
leading method in outcome research. The criterion is twofold: (a) the magnitude of 
change has to be statistically reliable and (b) by the end of treatment patients have 
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to end up in a (score) range that renders them either indistinguishable from well-
functioning people, or has them in the lower range of dysfunctioning (Jacobson, 
Roberts, Berns, & McGlinchey, 1999). A cut-off point for normal functioning and a 
reliable change index are calculated. The method works best when adequate norms 
are available for both the dysfunctional and the normal population. Three possible 
ways to calculate the cut-off point for normal functioning are given. The first method 
uses a score of two standard deviations above the patient population mean as cutoff. 
The second method is similar to the first and uses a score of two standard deviations 
below the normal population mean as a cut-off point. These two methods can only be 
used when the population curves of the normal population and patient population 
do not overlap. The third method is the most frequently used method and places the 
cut-off point at the intersection of the dysfunctional and normal population curves. It 
is estimated by using the mean and standard deviation of the normative samples for 
both populations. The reliable change index (RCI) is the minimum amount of change 
that has to occur to be statically reliable. It is usually expressed as the amount of points 
on a certain measurement instrument that a patient has to improve between pre- and 
post-treatment measurements. The RCI depends on the reliability of the measurement 
instrument and the variability of scores.
Within this system a patient is classified as ‘recovered’ if reliable change has occurred 
and the cutoff point for clinical significance is crossed. If the cutoff point is not crossed, 
but reliable change took place, a patient is classified as ‘improved’. If reliable change 
occurs in opposite direction, the patient is classified as ‘deteriorated’. Patients are 
considered nonresponders if they do not improve nor deteriorate (Jacobson, Follette, 
& Revenstorf, 1984; Jacobson, et al., 1999; Jacobson & Truax, 1991). 
There are some limitations to defining treatment success in this way. If the patients 
end up in the normal range at the end of treatment, but the magnitude of change is 
not reliable, patients are considered nonresponders, even though they are functioning 
comparable to non-patients. In addition, if a patient starts treatment in the normal 
range, no clinical significance can occur. This is especially problematic in naturalistic 
studies where selection on severity of problems is less common than in controlled 
trials. On the other end of the spectrum, there are patients who are not likely to ever 
return to normal functioning and for whom clinical significant change might not be 
the best criterion for treatment success. Nevertheless, for the majority of patients in 
outpatient mental health care it will be possible to classify the outcome of therapy 
according to this method. Despite its drawbacks, the method of clinical significance 
by Jacobson and colleagues remains the most frequently applied method and will be 
applied throughout this thesis. 




Outcome: rate of change and end state functioning
The method of determining clinical significance provides us with information on how 
to interpret the result of treatment when therapy has ended, but does not describe the 
way in which patients change between the beginning and end of therapy. Recently, 
there is a renewed interest among psychotherapy researchers in studying not only 
whether treatments work, but also for whom and under what conditions they work, 
how they work, and why they work (Laurenceau, Hayes, & Feldman, 2007). Outcome 
monitoring provides data on the course of therapy and it makes sense to analyse all 
available data rather than just begin and end state functioning. In fact, one of the 
major problems in measuring outcomes in psychotherapy research is that it can be 
a challenge to collect data on treatment outcomes at the end of treatment, due to 
reasons such as drop-out from therapy or research. This difficulty is especially relevant 
for practice-based studies, with large numbers of patients and reduced control over 
the measurements by the researchers. 
The availability of large naturalistic data sets that are the result of practice based 
studies has fired an interest in longitudinal models that are more flexible in handling 
unbalanced longitudinal data, including survival analysis and multilevel analysis 
(Singer & Willet, 2003). These models tend to describe change over time and predictor 
variables are modelled as interaction with time, meaning that they predict the speed 
of recovery – referred to as the rate of change – rather than end state functioning. To 
illustrate the difference between outcome defined as end state function and rate of 
change, consider the following example: two patients can have the exact same score 
at the start of therapy and at the end of therapy, so the absolute change they made is 
equal. However, Patient 1 received 10 sessions of therapy, whereas Patient 2 needed 30 
sessions. Both have the same end state functioning, but the rate of change is higher in 
Patient 1. Alternatively, two other patients could have the same starting point and the 
same rate of change but different treatment durations, resulting in differences in end 
state functioning. In this thesis, both end state functioning and rate of change will be 
used as outcome variables.
Predictors of outcome
A vast amount of literature exists on the subject of predicting treatment outcomes. 
It would be beyond the scope of this thesis to give a full review of all the research 
that is done in this area, since sufficient review literature is available (e.g. Beutler et al., 
2004; Clarkin & Levy, 2004; Lambert & Ogles, 2004; Orlinsky, Ronnestad, & Willutzki, 
2004). It is relevant to note that there are two lines of research that look into predictor 
variables: one focusing on treatment-specific effects and one focusing on common 
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or non-specific factors. Lutz (2002) states that identifying particular treatments 
for particular diagnoses could be seen as a bottom-up approach, whereas the top-
down approach assesses a class of treatments defined by overlapping techniques, 
mechanisms and proposed outcomes and could be seen as a first step for large-scale 
outcome monitoring. Both are relevant for the field of outcome research. For the 
current research we are interested in the full range of patients that are in outpatient 
mental health care and not in specific groups of patients. Therefore we take the top-
down approach and look for common factors that predict treatment outcomes. 
Predictor variables with a demonstrated relationship with treatment outcome can 
be classified into three categories: patient characteristics, therapist characteristics and 
treatment characteristics. The aim of the prediction model is to predict the treatment 
course and end state functioning of new patients; therefore, the focus is on pre- and 
early treatment predictors. that can be identified at the beginning of treatment, to 
make early prediction possible. Patient characteristics include both sociodemographic 
variables (e.g. sex, age, marital status) and clinical variables (e.g. diagnosis, prior 
treatment). The influence of demographic variables on outcome is mixed and 
inconsistent (Clarkin & Levy, 2004). Clinical variables have been studied intensively and 
frequently found predictors include initial severity of symptoms, having multiple Axis 
I or Axis II diagnoses, or a combination of Axis I and II disorders, prior treatment and 
duration of psychiatric complaints.
A second category of outcome predictors are characteristics of the treatment 
received by the patient. These characteristics include a wide range of variables 
associated with therapeutic techniques, the duration and frequency of therapy 
sessions, the treatment modality (e.g. individual, group, couples counselling, etc) and 
interactions between the patient and therapist. It is beyond the scope of this thesis 
to discuss the full range of treatment predictors. In naturalistic studies, treatment 
variables usually are outside the control of the researcher and treatments are often 
modified during the treatment process, making treatment characteristics complicated 
to use as predictors. Variables that are of interest to us are two early treatment factors 
that are consistently associated with outcomes: expectancies and the working 
alliance. Although expectancies could be considered patient characteristics, they 
usually emerge in the interaction with the therapist and can be modified within 
that interaction (Westra, Constantino, & Aviram, 2011). Expectancies have a small 
positive effect on outcome (Constantino, Arnkoff, Glass, Ametrano, & Smith, 2011). 
The relationship between therapist and patient, referred to as the working alliance 
or therapeutic alliance, has been the focus of many studies and appears to be a 
consistent albeit moderate predictor of treatment outcome (Hentschel, 2005; Horvath 
& Symonds, 1991; Martin, Garske, & Davis, 2000).
Numerous studies have demonstrated that therapist factors explain part of the 




variance in outcomes between patients (Crits-Christoph et al., 1991; Dinger, Strack, 
Leichsenring, Wilmers, & Schauenburg, 2008). Literature shows that therapist effects 
are usually small in randomized controlled trials and small to medium in naturalistic 
studies (Crits-Christoph & Gallop, 2006). Little is known about variables that predict 
therapist effects: demographic characteristics fail to emerge as predictors of outcome, 
but variables that are more closely related to personality traits for the therapist have 
been found as predictors, although more research is needed on the subject (Anderson, 
Ogles, Patterson, Lambert, & Vermeersch, 2009; Beutler, et al., 2004). In order to predict 
the treatment course and end state functioning for new patients, therapist variables 
may not be of much use, since it is still quite unclear how they affect outcomes. 
However, what is interesting for this thesis is how therapist variables may interact with 
the use of feedback by the therapist. Therefore, therapist variables that have found to 
be related to acceptance and use of feedback will be included in the study.
Feedback to therapists
The need for feedback
One could wonder why therapists need feedback on their patients’ progress. In fact, 
many therapists claim that they do not need feedback and are perfectly able to 
monitor progress in their patients themselves. However, meta-analysis comparing 67 
studies showed that statistical prediction had somewhat greater accuracy than clinical 
judgement (Ægisdóttir et al., 2006). In his review of the literature on clinical decision 
making, Garb (2005) concludes that psychologists should reduce their reliance 
on informal observation and clinical validation when making clinical judgements 
or interpret tests. None of these studies have been done on decisions on patient 
progress. In a study more specifically tailored to recognizing patients that deteriorate, 
Hannan and colleagues (Hannan et al., 2005) asked therapists to rate their entire 
caseload on the risk of deterioration for three consecutive sessions. Therapist were 
able to identify less than 1% of patients that deteriorated. The statistical model, using 
expected treatment recovery curves, was able to correctly identify 85% of all patients 
that deteriorated. More recently, Hatfield and colleagues showed that therapists 
had considerable trouble in identifying deteriorating clients when using their case 
files. Although therapists did seem to recognize the factors that might be related to 
deterioration, such as symptom increase and therapy indications such as ruptures in 
the working alliance or treatment goal failure, they still had trouble noticing these 
cues in their patients (Hatfield, McCullough, Frantz, & Krieger, 2010).
That clinicians may need feedback on their patients in order to prevent negative 
outcomes, does not mean that they like it. Some clinicians do not want to use outcome 
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monitoring feedback, even if it is beneficial to the patient (Aoun, Pennebaker, & Janca, 
2002; Walter, Cleary, & Rey, 1998). Feedback theory provides several factors that might 
be related to the attitude that therapists have towards feedback and whether they 
will use it. Clinicians will be more likely to use feedback effectively if they perceive 
the feedback as valid and reliable, pay attention to the feedback, have a preference 
for externally generated feedback and are committed to use the feedback in their 
treatment (Claiborn & Goodyear, 2005; Herold & Fedor, 2003; Riemer & Bickman, 2011).
Towards building an outcome monitoring feedback model
As was mentioned before, the main objective of this thesis was to develop an 
outcome monitoring feedback model for outpatients in the Netherlands and test 
whether providing feedback on patient progress to therapists can improve treatment 
outcomes. Therefore, the first step in the process of building a feedback model was 
to get an idea on how Dutch patients score on the outcome measure we wanted to 
use – the Outcome Questionnaire – 45 (OQ-45; Lambert et al., 2004) (see Chapter 2) 
and to obtain more insight in the progress in therapy that is made by these patients 
over time. In addition, we were interested in the pre and early treatment variables that 
predict outcomes and the differences among predictive variables in predicting the 
rate of change and end state functioning (Chapter 4). 
In designing a study to measure the effect of feedback, we needed to take into 
account that the feedback about the patient’s progress is provided to therapists (and 
sometimes the patients) and therapists might differ in how they handle the feedback, 
which in turn might influence the effectiveness of the feedback. In the study design, 
and more specially in estimating the amount of patients that needed to be included 
in the study to have sufficient statistical power, we needed to take into account that 
the data have a hierarchical structure with three levels: patients were nested within 
therapists and measurements were nested within patients. In Chapter 3 the factors 
that influence study design and study power in a situation with therapists accounting 
for some of the variance of the outcomes in patients is described.
Finally, two feedback studies were conducted. The first study was a multicenter 
study in an outpatient mental health care setting and followed patients in their 
treatment for one year. Feedback was provided to the therapist only and in addition to 
patient outcomes, and therapist characteristics on relevant traits that are hypothetically 
related to feedback effectiveness were studied (see Chapter 5). The second study was 
conducted in both public outpatient centers and in private practices and contained 
both short and longer term therapies, up until two years. This study had three 
treatment conditions, a control group, a group with feedback to therapists alone and 
a group in which both therapists and patients received feedback about the patient’s 




progress (see Chapter 6). Finally, in the general discussion, results of the studies will 
be summarized and discussed, study strengths and limitations will be reviewed and 
implications for future research and clinical practice will be presented (see Chapter 7).
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A
bstract
The cross-cultural validity of the Outcome Questionnaire (OQ-
45) in the Dutch population has been examined by comparing 
the psychometric properties and equivalence in factor structure 
and normative scores of the Dutch OQ-45 with the original 
American version. Data were collected from a university (n = 
268), in a community (n = 810) and from three mental health care 
organizations (n = 1920). Results show that the psychometric 
properties of the Dutch OQ-45 were adequate and similar to the 
original instrument. Some differences in equivalence were found 
though. In factor analysis, two additional factors were found: one 
consisting of social role items and another that reflected anxiety and 
somatic symptoms. Furthermore, normative scores were different 
for the Dutch and American samples, and this resulted in different 
cut-off scores for estimating a clinically significant change in the 
Dutch population. 
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2
Cross-cultural validation of the OQ
Introduction
Over the last years, the Outcome Questionnaire (OQ-45; Lambert et al., 1996) has 
become one of the 10 instruments most frequently used by practitioners in the USA to 
measure clinical outcomes (Hatfield & Ogles, 2004) and is often used in clinical outcome 
research. It is also gaining popularity in other countries and has been translated into 
several languages, including Japanese, Korean, Italian, French, Portuguese, German 
and Dutch. Even though the psychometric properties of the original version of the 
OQ-45 have been thoroughly investigated, few articles are available on the properties 
of translated versions of the OQ-45. This article addresses the cross-cultural validity of 
the Dutch OQ-45.
Reasons for the popularity of the OQ-45 lie in the fact that it has some advantages 
that most other instruments do not have. First, the OQ-45 aims to measure three 
domains of functioning: symptom distress (SD), interpersonal relations (IR) and social 
role (SR) performance. It has become accepted in outcome research to measure 
symptom reduction as well as an improvement in well-being (Gladis, Gosch, Dishuk, 
& Crits-Christoph, 1999). Other popular outcome instruments such as the Symptom 
Checklist-90 (SCL-90; Derogatis, 1977), the Brief Symptom Inventory (Derogatis, 1975) 
or the Social Adjustment Scale (SAS; Weissman & Bothwell, 1976) measure either 
symptoms or functioning. Additional instruments are required to measure the other 
domains. Moreover, the OQ-45, along with instruments such as the Clinical Outcomes 
in Routine Evaluation-Outcome Measure (Evans et al., 2000), is a general instrument 
that can be used for a large variety of disorders, so a comparison in functioning and 
outcome of a broad range of patients is possible, irrespective of psychiatric diagnosis. 
By contrast, specific instruments are designed for certain disorders and cannot 
compare symptoms and functioning of different types of patients.
Also, the OQ-45 is relatively short. An average patient can complete it in 
approximately 5 minutes. This is especially important in clinical practice, where there is 
neither time nor budget for the test batteries that are common in academic research. 
Probably the most important feature of the OQ-45 is that it is capable of tracking 
patient progress by repeated measurements. The OQ-45 is frequently used in outcome 
research that provides weekly feedback to the therapist about the patient’s progress. 
The patient’s treatment course is compared to a predicted course, and the therapist 
is alerted when the patient goes too far off the predicted track. This feedback results 
in more effective treatments, especially for those patients who have a higher risk for 
treatment failure (Lambert, Harmon, Slade, Whipple, & Hawkins, 2005; Lambert et al., 
2001, 2003).
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Psychometric Properties
The psychometric properties of the American version of the OQ-45 have been 
extensively investigated. Reliability and validity estimates are good for the SD subscale 
and total scale. Reliability is adequate for the IR and SR subscales, but concur rent validity 
estimates are less convincing. The OQ-45 has proper sensitivity and specificity, and the 
sensitivity to change is good on the scale as well as on the item level (Lambert et al., 
2004). Normative scores of the clinical and community samples differ significantly. The 
structure of the instrument, with three subscales, does not seem to have sufficient 
empirical support. Mueller, Lambert, and Burlingame (1998) found that the three-
factor model did not have a proper fit in a confirmatory factor analysis. Chapman 
(2003) could not find support for the three-factor structure either and performed an 
exploratory analysis, which resulted in nine factors. However, these factors have not 
been confirmed in a new sample.
Equivalence between Language Versions
During translation, many problems may occur that change the properties of an 
instrument.  First, there may be a difference in the meaning of the items of the instrument 
in a different language. Flaherty et al. (1988) refer to this as semantic equivalence and 
state that the key to obtain semantic equivalence is the back-translation method, 
which has been used in all OQ-45 translations. Still, a slight semantic difference is likely 
to occur, as the English language has considerably more words than the Dutch.
In order to assure the equivalence of two language versions of psychological 
tests, the constructs underlying the test need to be equivalent (Butcher, Derksen, 
Sloore, & Sirigatti, 2003). Cultural differences influence the conceptual equivalence 
of two language versions of an instrument. Hofstede (2006) introduced five cultural 
dimensions that can assist in differentiating between cultures. His research showed 
that American and Dutch cultures have similar levels of individualism, power distance 
and uncertainty avoidance, but differ in long-term orientation and masculinity.
One method of examining conceptual equivalence is to determine whether the 
items and scales maintain generally the same factors in the new language version. A 
well-known example of a difference in conceptual equivalence is the SCL-90: the Dutch 
version has a different factor structure than the original version (Arrindell & Ettema, 
1975). Differences in normative scores often exist between different cultures, even 
among Western countries. For example, in the European Psychiatric Services: Inputs 
Linked to Outcomes and Needs (EPSILON) study, van Wijngaarden et al. (2000) found 
differences in scoring and reliability estimates on the Involvement Evaluation Ques-
tionnaire: scores were usually high in Verona and low in Copenhagen. The Minnesota 
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Multiphasic Personality Inventory (MMPI) also has different norms for different 
countries (Butcher et al., 2003). More importantly, a difference in normative scores may 
result in different criterion validity, also changing the sensitivity and specificity of the 
instrument. Flaherty et al. (1988) refer to this as a lack of criterion equivalence.
In clinical outcome research, a common criterion is whether clinical significant 
change (Jacobson & Truax, 1991) has occurred between post and pretreatment 
measurements. Because the cut-off point for estimating clinical significant change is 
based on population curves, it is important to take proper samples of these populations 
in the new culture. If criterion equivalence is not reached, a calibration of scores should 
be performed, thus calculating new cut-off scores for the population (Flaherty et al., 
1988). Differences in cut-off scores are usually the result of significant differences in 
normative mean scores between two cultures, but may also occur when differences in 
mean scores are small (non-significant). Furthermore, differences in reliability estimates 
can lead to different reliable change indices (RCIs), because in the calculation of the 
RCI, the reliability of the instrument is used to estimate the measurement error.
The goal of the current research project was to find out if the factor structure 
and normative scores are equivalent with the original version and to determine the 
psychometric properties of the Dutch OQ-45. Preliminary studies showed that Dutch 
subjects seemed to have lower scores on the OQ-45 than American subjects (de Jong 
& Nugter, 2004). Also, some differences in psychometric properties were found. At 
that time, however, sample sizes were not large and representative enough to draw 
definite conclusions. Because the normative sample size was insufficient for individual 
use of the OQ-45 and more information was needed on the validity, more data were 
collected and additional studies were performed. For this paper, the data of initial and 
further studies of the OQ-45 are combined.
Method
Data
Subjects included a university sample, two community samples and two clinical 
samples. All data were collected for research purposes only. A student sample of 268 
undergraduates was collected from the psychology department of the University of 
Amsterdam as part of its educational program. Subjects completed an OQ-45, SCL-90 
and Groningse Vragenlijst Sociaal Gedrag-45 (GVSG-45) at the first session. A group 
of 264 students completed the OQ-45OQ-455 for the second time after 2 weeks. Data 
from the student sample were used only to calculate reliability and validity, as this 
group was not representative to function as a normative group.
A community sample of 446 individuals was collected by a random selection 
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of subjects in the phone directory of 13 phone regions, stratified by province, 
geographically distributed through the Netherlands and including major cities as well 
as suburban and rural regions. All adults in the household were asked to complete the 
question naire. If they consented to participate, ques tionnaires and consent forms were 
mailed. A selection of 1270 numbers was made of which 286 were never reached and 
487 households consented. A total of 818 questionnaires were sent (with an average 
of 1.7 per household), and 446 were returned completed (55%).
Another community sample of 362 individuals was collected from 14 commercial 
and non-profit business settings in a variety of business branches. The questionnaires 
were distributed by internal mail. A stamped addressed envelope was included. 
Completion of the test was on a voluntary basis and was anonymous. A total of 1097 
questionnaires was spread at the business settings, so the response rate was 33%, 
which is average for this type of sample. Subjects in the community sample who 
received treatment for psychological or psychiatric problems were deleted from the 
sample; 24 subjects were removed on this ground.
The first clinical outpatient sample of 1545 persons was collected at four sites 
of three mental health care institutions. Patients completed a paper-and-pencil 
version of the OQ-45 either before or after intake. To obtain test-retest stability data, 
a subsample of 43 patients who completed the OQ-45 after the intake completed 
the OQ-45 2-3 weeks later, before they received a treatment advice. During that 
time period, no treatment sessions took place. A different subsample of 117 patients 
completed the SCL-90 and Depression Anxiety and Stress Scale (DASS) together with 
the OQ-45 after intake to obtain concurrent validity estimates. By means of an internet 
screening tool, an additional sample of 375 patients completed the OQ-45 online prior 
Table 1  Characteristics of the samples




n (%) Range Mean (SD)
Community sample 810 513 (63) 297 (37) 18-94 44.3 (15)
- Phone directory sample 446 247 (55) 199 (45) 18-94 48.1 (16)
- Business sample 361 264 (73) 97  (27) 18-77 39.5 (12)
University sample 268 171 (64) 96 (36) 17-53 22.3  ( 6)
Clinical sample
- Outpatient sample paper-and-pencil 1545 896(58) 628(41) 18-65 37.3 (11)
     * test-retest  42   31 (74)   11 (26) 18-55 31.7 (10)
     *concurrent validity SCL-90/DASS 118   76 (64)   41 (35) 18-61 33.6 (11)
     * sensitivity to change  60 32 (53) 24 (40) 23-62 41.6 (10)
- Outpatient internet screening tool 375 - - - -
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to their intake session. Depending on a global screening procedure, additional specific 
questionnaires that matched the subject’s symptoms were completed by the subjects. 
An average number of 9.6 (SD = 3.3) questionnaires were completed by the patient.
An overview of sample characteristics is given in Table 1. There are some differences 
between the community and business samples with regard to gender and age, because 
one of the companies in the business sample, a private home care organization, had 
relatively many females among their employees. Data from this company were kept 
in the sample because scores on the OQ-45 did not differ significantly from the other 
business sites. For technical reasons, demographic characteristics of the internet 
screening sample were not available.
Subjects who left more than 20% of the questions of the questionnaire unanswered 
were removed from the sample; 8 students, 4 persons from the community sample 
and 49 outpatients were deleted. In case of missing values, a mean score for the 
remaining scale items was calculated, multiplied by the number of items on the scale 
and rounded to the nearest number. Mean subscale scores were only calculated if 
no more than 20% of the scale items were missing. Missing values were not replaced 




The OQ-45 consisted of 45 items that were scored on a five-point rating scale, ranging 
from never (0) to almost always (4). The SD subscale had 25 items that were associated 
with most common disorders in public mental health care; depression, anxiety and 
addiction to alcohol or drugs were well represented. The IR subscale consisted of 11 
items and measured the functioning of the patient in relationships with partner, family 
and friends. The SR subscale contained nine items and measured functioning in school, 
work and leisure. There were nine reversely scored items.
The American normative sample consisted of undergraduate, community and 
clinical subsam ples. The undergraduate samples were collected from universities in 
three states; the community sample was collected from various business locations 
and from the Utah phone directory, and the clinical samples were collected from a 
university counseling centre, an employee assistance program, a university-based 
outpatient clinic and a community mental health service centre (Lambert et al., 2004). 
Comparisons with the Dutch samples were made with the undergraduate, community 
and outpatient samples.
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Instruments Used for Validation of the OQ-45
A short description of the instruments used for validation of the OQ-45 is given in this 
section. All instruments are self-rating questionnaires and have proper psychometric 
properties. References for both the original and the Dutch versions are given. A 
distinction is made between general and specific instruments.
General Instruments
The SCL-90-item version (Arrindell & Ettema, 1975) and DASS (de Beurs, van Dyck, 
Marquenie, Lange, & Blonk, 2001; Lovibond & Lovibond, 1995) were used to validate 
the SD subscale. For the SCL-90, the Global Severity Index (GSI) was calculated. For the 
DASS, subscale scores were used to correlate with the OQ-45 subscales.
The GVSG-45-item version (de Jong & van der Lubbe, 2001) was used to validate 
the IR and SR domain scores of the OQ-45. It measures social behaviour on nine 
domains. For this research, two indices that were not in the original questionnaire 
were calculated: as an index of interpersonal problems, we used the mean score of 
the Parents, Partner, both Children domains and the Friends domain, further referred 
to as Functioning on Interpersonal Relationships. As an index of SR performance, we 
calculated the mean score of the School, Occupation, Housework and Leisure domains, 
further referred to as Functioning on Social Role.
Specific Instruments
The OQ-45 claims to be applicable for a variety of disorders. Therefore, a number of 
instruments that aim to measure symptoms of specific disorders were compared 
with the OQ-45. The specific instruments were part of an internet screening tool. 
Not all instruments that were in the internet screening tool were used in analysis. 
The instruments were selected using two criteria. First, the number of patients who 
completed the instru ment had to exceed 30. Second, the instruments had to measure 
symptoms that occur in a variety of patients, such as anxiety, depression, grief and 
reactions to overwhelming experiences. One would expect medium-high correlations 
between the specific instruments and the SD subscale of the OQ-45 and low-to-
medium correlations with the IR and SR subscales.
The Quick Inventory of Depressive Symptoms Self-Report (QIDS-SR16; Rush et al., 
2003) assesses all the criterion symptoms that the Diagnostic and Statistical Manual of 
Mental Disorders, 4th Edition indicates to diagnose a major depressive episode.
The Body Sensations Questionnaire (BSQ) and Agoraphobic Cognitions 
Questionnaire (ACQ) (Bouman, 1995; Bouman, 1998; Chambless, Caputo, Bright, & 
Gallager, 1984) both measure experienced anxiety during panic or anxiety attacks. The 
BSQ measures anxiety for physical sensations, while the ACQ measures catastrophic 
cognitions during the anxiety or panic attack.
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The Liebowitz Social Anxiety Scale-Self-Report (LSAS-SR; Liebowitz, 1987; van 
Balkom, de Beurs, Hovens, & van Vliet, 2004) measures the severity of social phobic 
symptoms and avoidance behaviour.
The Penn State Worry Questionnaire (PSWQ; Meyer, Miller, Metzger, & Borkovec, 
1990; van Rijsoort, Vervaeke, & Emmelkamp, 1999) measures the inclination to worry 
as well as the amount, intensity and uncontrollability of worrying.
The Padua Inventory-Revised (Sanavio, 1988; Van Oppen, Hoekstra, & Emmelkamp, 
1995) measures obsessive thoughts and compulsions on five domains: impulse, 
wash, control, ruminate and precision. The total score is used to assess the severity of 
obsessive-compulsive symptoms.
The Impact of Events Scale Revised (IESR; Weiss & Marmar, 1997) consists of 22 
items measuring reexperience of shocking events and avoidance of thoughts and 
feelings that are related to these events. It also measures increased arousal. There are 
three subscales: Intrusion, Avoidance and Hyperarousal. The Hyperarousal subscale 
was not yet normed for the Dutch population and is therefore not included in the total 
score. The Dutch translation of the IESR is known as the Schokverwerkingslijst (Brom & 
Kleber, 1985; van der Ploeg, Mooren, Kleber, van der Velden, & Brom, 2004).
The Inventory of Complicated Grief-revised (ICG-r; Prigerson, Kasl, & Jacobs, 1997) 
measures symptoms of normal and potentially complicated grief and mourning. The 
Dutch translation of the ICG-r is known as the Rouw Vragenlijst (Boelen, de Keijser, & 
van den Bout, 2001).
Analysis
The paper-and-pencil data were scanned by com puter and validated using the 
Teleform software from Verity, Inc.; Sunnydale, CA; USA, version 9.0. Data from the 
internet screening tool were collected with the screening tool developed specifically 
for one of the mental health care organizations by Interapy (2004).
All tests of difference were two-tailed against p < 0.05. The large sample sizes gave 
high statistical power; therefore, effect sizes were also reported. Effect sizes (Cohen’s 
d) were calculated with the effect size spreadsheet by Thalheimer and Cook (2002) 
in Microsoft Excel and were interpreted according to the criteria reported by Cohen 
(1992). Most analyses were conducted in SPSS for Windows, version 13.0 (2004) SPSS 
Inc. Chicago, IL: USA. The confirmatory factor analysis was performed in EQS 6.1 (2005), 
Multivariate Software Inc., Encino, CA: USA. Exploratory principal com ponent analysis 
on the residual matrix was performed in MATLAB, release 14 (2005) The Mathworks 
Inc., Natick, MA: USA.
The goodness-of-fit indices that were reported in the confirmatory factor analysis 
were the root mean square residual (RMR), the root mean square error of approximation 
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(RMSEA), the GFI, the Bentler-Bonnet normed fit index (NFI), the comparative fit 
index (CFI), the chi-square (χ2) and the chi-square divided by degrees of freedom in 
the model (χ2/df). General guidelines were that the RMR should be less than 0.10, the 
RMSEA less than 0.05, the GFI greater than 0.95, the CFI and NFI greater than 0.90, a χ2 
that is non-significant and χ2/df less than 2 (Kline, 1998). The goodness-of-fit indices 
that were reported in the original study by Mueller et al. (1998) are also reported in the 






As was stated earlier, the factor structure of an instrument may change in a differ-
ent cultural setting or language. The sample, consisting of the community and clinical 
sample, was randomly split in two so that if additional analyses would result in new 
factor structures, they could be fitted on the other split of the sample to test the 
stability of the factor solution. The first sample was used to test whether the OQ-45 had 
a three-factor structure. A confirmatory factor analysis was conducted, using general 
least squares estimation to make our solution comparable to the original analyses of 
Mueller et al. (1998).
As can be seen in Table 2, our solution meets three out of seven goodness-of-fit 
criteria. The indices that did not meet the criteria were the χ2, χ2/df, RMR and GFI. The 
χ2 and χ2/df are dependent on the sample size, and given our large sample size and 
consequently high power, a sig nificant χ2 is not necessarily a sign of a poor fit. The 
criteria for a good fit for the RMSEA, NFI and CFI criteria are met and the three-factor 
solution seems to have a reasonable fit. The fit of our solution is notably better than 
the solution that Mueller et al. (1998) obtained; their three-factor solution met none of 
the criteria that we applied.
Table 2  Confirmatory factor analysis Goodness of Fit Indices
Model χ2 df χ2/df RMR GFI AGFI NFI CFI
Three-factor solution 3678.2 942 3.90 .103 .880 .868* .933* .949*
Five-factor solution 3413.4 925 3.69 .075 .889 .875* .957* .964*
RMR = Root Mean square Residual; GFI = Goodness-of-Fit Index; AGFI = Adjusted Goodness-of-fit Index; 
NFI = Normed Fit Index; CFI = Comparative Fit Index; * Meets the recommended criteria
*
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9 .85 .82 .13







25 .76 .75 .14
27 .45 .36 .34
29 .61 .51 .44
31 .86 .88
33 .71 .61 .32
34 .37 .33 .39
35 .48 .38 .39
36 .73 .68 .29
40 .73 .71
41 .57 .56 .25
42 .84 .87
45 .45 .41 .34
1 .59 .60
7 .60 .60









4 .71 .51 .39
12 .63 .68




38 .81 .66 .50
39 .65 .44 .48
44 .66 .58
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Table 3 shows the standardized factor loadings on the three factors. Four items 
have factor loadings below 0.30: items 11, 14, 26 and 32. Items 11, 26 and 32 are known 
difficult items. They all measure problematic alcohol/drug use and have rather skewed 
scoring (a lot of ‘0’ scores). In exploratory factor analysis, they consequently end up in 
one factor, which consists only of these three items. Item 14 ‘I work/study too much’ is 
another special case. This item does not perform well in the original OQ-45 also and 
shows a negative correlation with several items in the covariance matrix. Moreover, it 
is the only item in the SR subscale wherein the functional sample (M = 1.87, SD = 1.1) 
actually scores slightly higher than the clinical sample (M = 1.68, SD = 1.2), t(1706) = 
3.54, p < 0.001, d = 0.14.
As the three-factor solution still was not satisfactory, we tried to explain more 
variance by using the residual matrix from the three-factor solution. A principal 
component analysis with varimax rotation produced two components with an 
eigenvalue greater than 1, which explained 34% of variance. Because of the varimax 
rotation, the two components are not correlated, and as the solution was based on 
the residuals of the three-factor solution, they are considered independent from the 
first three factors as well. For each component, the items that loaded above 0.15 were 
selected.
The two components were added to the original three-factor model and fitted on 
the second split sample. The chi-square value of the five-factor solution has dropped 
264.7 points, associated with a loss of 17 degrees of freedom, which leads to a χ2/df 
improvement ratio of 15.6. A ratio of 2 is usually considered a substantial improvement. 
The other goodness-of-fit values also show an improvement of fit. Especially important 
is the RMR value, which did not meet the criterion of 0.10 in the three-factor solution, 
but does so in the five-factor solution.
The first additional factor consists of items that all belong to the SR domain. The 
unexplained variance in the SR domain in the three-factor solution seems to be mainly 
caused by item 14, which has a low factor loading on this domain. In the five-factor 
solution, this item even has a negative factor loading on the SR domain. For clinical 
purposes, the extra social factor does not add much. It may be useful if one is merely 
interested in the social role functioning of an individual, but in that case, the OQ-45 
would probably not be used as the instru ment of choice.
In contrast, the second additional factor does seem to add something to the 
clinical utility of the instrument. Most of the items on this factor originate from the SD 
scale, which is a rather long scale. The items seem to be related to anxiety and somatic 
manifestations of anxiety. Some of the items represent cognitive representations 
of anxiety, such as item 10, ‘I feel fearful’, whereas others seem more physical 
manifestations of anxiety, such as item 29, ‘My heart pounds too much’, which is known 
to be a symptom of anxiety or panic attack. It may be a useful addition to the original 
 Jong de_PROEF (all).ps Back - 17     T1 -    Black
33
2
Cross-cultural validation of the OQ
three-factor structure. Therefore, we decided to evaluate the validity of this factor, 
along with the validity of the original three factors. The factor is further referred to as 
Anxiety and Somatic Distress (ASD).
Correlations between Subscales
The correlations between the subscales of an instrument give an indication of whether 
the structure of the instru ment is as it was intended. In the case of an instru ment that 
assesses several domains of functioning, multidimensionality should be reflected in 
the factor structure of the instrument. Also, each subscale should assess a concept 
that is not measured by the other subscales. Therefore, the correlations between the 
domains should not be too high. Table 4 shows that the correlation between the 
subscales of the OQ-45 is higher than is desirable, indicating a moderate construct 
validity. Especially high is the correlation between the SD and ASD subscales. This is 
not surprising, as the ASD subscale consists almost exclusively of items that are in the 
SD scale, but considering that, correlations would ideally be lower.
Criterion Equivalence
Differences in Scoring
Table 5 shows the mean scores of Dutch and American samples on the OQ-45 subscales 
and total scale. The mean scores for the Dutch community (t (1620) = 7.48, p < 0.001, 
d = 0.37) and clinical samples (t (2260) = 2.50, p = 0.01, d = 0.15) are somewhat below 
the American equivalents, even though the effect sizes are small. The mean scores of 
Dutch students are somewhat higher than the American student sample (t = -4.40, p 
< 0.001, d = 0.39). Figure 1 gives a visual representation of the sample differences for 
the OQ-45 total scale.
In the American samples, no differences were found between males and females. 
In the Dutch samples, some small differences were found. In Table 6, scores for the 
clinical and community samples are given for males and females. In the community 
Table 4  Correlations between the subscales and total scale
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sample, significant differences were found for gender, Wilks’ λ = 0.92, F(5, 792) = 13.3, 
p < 0.001. Women showed higher levels of SD, (F[1, 796] = 10.7, p = 0.001, d = 0.26) 
and ASD (F[1, 796] = 21.8, p < 0.001, d = 0.37), while men showed more problems in SR 
performance (F[1, 796] = 13.6, p < 0.001, d = 0.27).
Similar results were found in the clinical sample: Wilks’ λ = 0.92, F(5, 1446) = 23.7, p 
< 0.001. Here, women showed slightly higher levels of SD (F[1, 1450] = 5.83, p = 0.016, 
d = 0.13) and ASD (F[1, 1450) = 29.1, p < 0.001, d = 0.29), while men showed somewhat 
more problems in SR performance (F[1, 796] = 25.4, p < 0.001, d = 0.27).
Clinical Significance and Reliable Change
To measure individual change, the criterion of clinical significance by Jacobson and 
colleagues is often applied (Jacobson & Truax, 1991; Jacobson, Follette, & Revenstorf, 
1984; Jacobson, Roberts, Berns, & McGlinchey, 1999). Their criterion is twofold: (1) the 
magnitude of change has to be statistically reliable, and (2) by the end of treatment, 
patients have to end up in a (score) range that renders them indistinguishable from 
well functioning people. A cut-off point for clinically significant change and an RCI are 
calculated using formula c by Jacobson and Truax (1991).
For the American OQ-45, the cut-off score for clinical dysfunctioning is 63 for the 
total scale and 36, 15 and 12, respectively, for the SD, IR and SR subscales. The RCI is 14 
for the total scale and 10, 8 and 7 for the subscales, respectively (Lambert et al., 2004). 
For the Dutch OQ-45, the cut-off score for the SD subscale is 33; for the ASD subscale, it 
is 19; for the IR subscale, it is 12; for the SR subscale, it is 10, and for the total scale, the 
cut-off score is 55. A person that scores on or above the cut-off score belongs to the 
dysfunctional (clinical) range. Given the differences found between male and female 
respondents, separate cut-off scores for men and women were also calculated for the 
Table 5  Means and standard deviations of OQ-45 in the Dutch and American samples













M SD M SD M SD M SD M SD M SD
Symptom Distress 23.0 10 25.4 12 49.4 15 27.3 12 22.2 10 48.9 16
Anxiety and  
Somatic Distress
- - - - - - 15.6 7 13.3 6 25.9 9
Interpersonal 
Relations
8.8 5 10.2 6 19.7 6 11.4 5 8.4 5 16.8 7
Social Role 10.4 4 9.6 4 14.1 5 10.4 4 8.1 3 13.6 6
Total score 42.2 17 45.2 19 83.1 22 49.1 18 38.7 16 79.5 25
Notes: Means and standard deviations of the American samples were copied from the OQ-45 manual (Lambert et al, 2004); 
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subscales with gender differences. The cut-off score for the SD subscale was 31 for 
men and 33 for women; the cutoff for the ASD subscale was 17 for men and 19 for 
women, and the cut-off for the SR subscale was 12 for men and 10 for women.
Using the cut-off score of 55, sensitivity for the OQ-45 total scale is 0.84, which 
means that 84% of the community sample is correctly identified as belonging to the 
functional sample. The specificity of the OQ-45 is 0.85, which means that 85% of the 
clinical sample is correctly identified as dysfunctional. Using the cut-off score of 63 from 
the original OQ-45 leads to a higher sensitivity (0.93), but lower specificity (0.74). This 
means that fewer patients are correctly identified as belonging to the dysfunctional 
sample.
The RCI is usually expressed as the amount of points on a certain measurement 
instrument that a patient has to improve between preand posttreatment 
measurements. The RCI depends on the reliability of the measurement instrument 
and the variability of scores. As reliability index, the pooled internal consistency of the 
Figure 1  OQ-45 total score for the American and Dutch samples
Table 6  Means and standard deviations by gender in the clinical and non-clinical sample
Community sample Clinical sample
Male Female Male Female
n M SD n M SD n M SD n M SD
Symptom Distress 296 20.6 10 511 23.2 10 628 47.4 15 896 49.3 16
Anxiety and Somatic Distress 296 11.9 6 511 14.1 6 628 24.3 9 896 26.8 9
Interpersonal Relations 296   8.3 5 511 8.4 5 627 16.6 7 894 16.6 7
Social Role 292   8.6 4 506 7.7 3 598 14.3 5 857 12.8 5
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clinical and community sample was used (see Table 7). Using either subgroup would 
lead to less variability in the answers, which leads to lower values of Cronbach’s alpha. 
In literature, this phenomenon is referred to as range restriction (Cronbach, 1990). The 
RCIs for the SD, ASD, IR and SR subscales are 10, 8, 8 and 9, respectively. The RCI for the 
OQ-45 total scale is 14, so a patient has to improve a minimum of 14 points on the OQ-
45 to obtain reliable change.
Psychometric Properties
Reliability
Internal consistency estimates are sufficient for subscales and the total scale in most 
of the samples (see Table 7), except for the SR subscale, for which disappointing 
values for Cronbach’s alpha were found in the university, community and clinical 
samples. Combining the clinical and community samples improves the results, which 
indicates that restriction of range may occur here. Another explanation may be that an 
increased sample size improves internal consistency values. In reliability analysis, cases 
are rapidly lost: if one item of the scale is missing, the case cannot be used entirely.
We tried replacing missing values with the mean score of the remaining scale 
items. This resulted in slightly better a values for the clinical sample, but not for the 
community and the university samples. Beside restriction of range, the SR subscale 
has the lowest number of items, and two of the items that were awkward in the three-
factor factor analysis belong to this scale. These two items, items 14 and 32, have 
relatively low item-total correlations (rit = 0.11-0.15).
Most values are similar to values that were found in the American sample. No reports 
of internal consistency in the American community sample exist, so comparison is not 
Table 7  Internal consistency (Cronbach’s α) and test-retest reliability (Pearson’s product-
moment correlation coefficient)
Internal consistency Test-retest






Domain n α n α n α n α r r
Symptom Distress 257 0.90 768 0.89 1247 .91 2390 0.95 0.81 0.76
Anxiety and 
Somatic Distress
261 0.79 786 0.82 1743 0.84 2529 0.89 0.74 0.70
Interpersonal 
Relations
264 0.74 770 0.77 1607 0.80 2377 0.84 0.71 0.83
Social Role 258 0.61 773 0.53 1620 0.69 2393 0.72 0.73 0.74
OQ-45 Total score 247 0.92 726 0.91 1309 0.93 2035 0.96 0.82 0.79
Note: a 262 cases
a
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possible, but in a German community sample, Cronbach’s alpha for the SR subscale 
has been found to be 0.59, which is close to our value of 0.53 (Lambert, Hannöver, 
Nisslmüller, Richard, & Kordy, 2002).
Test-retest reliability is an indication for the stability of scoring over time. Very 
marked score changes over a short period of time would be problematic. The 
correlation between the first and second completion of the OQ-45 is sufficient for both 
clinical (rtt = 0.70-0.83) and student (rtt = 0.71-0.81) samples.
Validity
Criterion Validity. An important validity requirement of an outcome measure is that 
it should discriminate between the clinical population for which it is designed and 
the functional (community) population. Table 8 shows that the difference between 
community and clinical means were large.
The community sample has a highly significantly better level of functioning on all 
subscales and the total scale, Wilks’ λ = 0.58, F(5, 2637) = 388.1, p < 0.001. Effect sizes 
for the difference between the clinical and community samples are very large for the 
IR (F[1, 2643] = 960.5, p < 0.001, d = 1.32) and SR (F[1, 2643] = 674.1, p < 0.001, d = 1.10) 
subscales, and huge for the SD (F[1, 2643] = 1873.2, p < 0.001, d = 1.83) and ASD (F[1, 
2643] = 1280.7, p < 0.001, d = 1.52) subscales and total scale (F[1, 2643] = 1804.5, p < 
0.001, d = 1.80).
Concurrent Validity
To assess the concurrent validity, three subsamples completed additional ques-
tionnaires together with the OQ-45. Results are presented in Table 8. The SCL-90 and 
DASS were used to validate the SD and ASD subscales. The concurrent validity of the 
SD subscale with the GSI of the SCL-90 was slightly below the American value in the 
Table 8  Concurrent validity estimates for the OQ-45 with SCL-90, DASS and GVSG-45
Clinical (n = 118) University (n = 268)
gsi dass-d dass-a dass-sa gsi fir fsr
Symptom distress 0.80 0.78 0.74 0.72 0.78 0.42 0.54
Anxiety and  
Somatic Distress
0.75 0.63 0.74 0.60 0.66 0.34 0.42
Interpersonal relations 0.62 0.54 0.38 0.54 0.59 0.51 0.51
Social role 0.51 0.51 0.46 0.48 0.57 0.38 0.55
OQ-45 Total score 0.80 0.77 0.68 0.72 0.77 0.49 0.60
Note: GSI = Global Severity Index of the Symptom Checklist 90 – Revised (scl-90-R); DASS-D = Depression Anxiety Stress – Depression 
subscale; DASS-A = Depression Anxiety Stress – Anxiety subscale; DASS-S = Depression Anxiety Stress – Stress subscale; FIR = Functioning on 
interpersonal relationship, based on the Groningse Vragenlijst Sociaal Gedrag 45-item version (GVSG-45) subscales Parents, Partner, Children and 
Friends; FSR= Functioning on social role, based on the GVSG-45 (Groningen Questionnaire of Social Behaviour) subscales Study, Work, Housework 
and Leisure. All correlations are significant at the .01 level. a 117 cases
 Jong de_PROEF (all).ps Front - 20     T1 -    Black
38
clinical sample (r = 0.80 versus r = 0.84), but better in the university sample (0.78 versus 
0.61). The correlations between the SD and DASS subscales were adequate: neither 
too high, nor too low. The ASD subscale also showed proper concurrent validity with 
the SCL-90 and the Anxiety subscale of the DASS (r = 0.74). Correlations between the 
Depression (r = 0.63) and Stress (r = 0.60) subscales and the ASD subscale were lower, 
as was to be expected.
It was difficult to find a Dutch instrument to validate the IR and SR subscales, and we 
had to calculate our own indices with the instrument we finally used. Nonetheless, the 
convergent validity of the GVSG-45 with the IR (r = 0.51) and SR subscale (r = 0.55) falls 
in the range of correlations of the OQ-45 subscales with the Inventory of Interpersonal 
Problems (r = 0.49-0.64) and Social Adjustment Scale (r = 0.44-0.73), respectively in the 
American samples.
Correlations with other Psychological Constructs. In the internet screening tool 
sample, several instru ments that measure specific disorders were administered 
together with the OQ-45 (see Table 9). On almost all specific questionnaires validity 
estimates are good, showing high correlations with the SD subscale (and subsequently, 
the OQ-45 total scale) and lower correlations with the IR and SR subscales. Exceptions 
are the PSWQ and the Quick Inventory of Depressive Symptoms-Self-Report 16 (QIDS-
SR16). The correlation between the PSWQ and the SD subscale is not high (r = 0.38), 
even though it is lower for the ASD, IR and SR subscales, as expected. The concept of 
worrying may not be uniquely linked to a certain pattern in symptoms.
The QIDS-SR16 shows a good concurrent validity with the SD subscale (r = 0.78), 
but correlations with the ASD (r = 0.65), IR (r = 0.47) and SR subscales (r = 0.44) seem 
higher than desirable. The ASD subscale shows good concurrent validity on the ACQ 












ACQ 119 0.58 0.62 0.27 0.38 0.56
BSQ 119 0.50 0.57 0.22 0.24 0.46
ICG-r 56 0.60 0.62 0.33 0.38 0.60
IESR 110 0.44 0.47 0.11 0.13 0.35
LSAS-SR 54 0.62 0.50 0.48 0.34 0.63
PI-R 137 0.57 0.52 0.31 0.35 0.55
PSWQ 122 0.38 0.26 0.15 0.18 0.33
QIDS-SR16 164 0.78 0.65 0.47 0.44 0.77
Note: ACQ = Agoraphobic Cognitions Questionnaire; BSQ = Body Sensations Questionnaire; GL= Gewaarwordingenlijst; ICG-r = Inventory of 
Complicated Grief (ICG-r); IESR = Impact of Events Scale; LSAS-SR= Liebowitz Social Anxiety Scale- Self Report; PI-R = Padua Inventory-Revised; 
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(r = 0.62) and BSQ (r = 0.57) and the LSASSR (r = 0.50). Unexpected is the relatively 
high correlation of the ASD subscale with the ICG-r (r = 0.62). Of further interest is 
the correlation between the IR subscale and the LSAS-SR (r = 0.48). Having symptoms 
of social anxiety will probably influence interpersonal functioning, which shows a 
subsequently somewhat higher correlation.
In summary, the concurrent validity of the SD, ASD subscales and the total scale 
seems good, but validity estimates of the IR and especially SR subscales are less 
convincing (Table 9).
Sensitivity to Change
Another important criterion for instruments that are used for outcome and progress 
research is that they are capable of measuring changes in functioning that occur as 
a result of treatment. A subsample of 60 patients received a short treatment, with a 
maximum of five sessions. The OQ-45 was administered before and after treatment. 
The OQ-45 showed high sensitivity to change on all subscales (SD: t(55) = 6.8, p < 
0.001, d = 1.29; ASD: t(56) = 7.7, p < 0.001, d = 1.43; IR: t(51) = 4.3, p < 0.001, d = 0.84; 
SR: t(55) = 4.1, p < 0.001, d = 0.77) and the total scale, t(56) = 7.1, p < 0.001, d = 1.33.
Discussion
This study investigated the cross-cultural validity of the OQ-45 in the Dutch population 
by evaluating the psychometric properties of the Dutch version and its equivalence 
with the original version of the OQ-45. The results show that the language versions 
are similar when it comes to reliability and validity estimates, but differences in factor 
structure and normative scores have been found.
The three-domain structure of the instrument, for which there was no strong 
evidence in the original version, had a reasonable fit in the Dutch population. Further 
analyses resulted in two additional factors that overlap mainly with the SR and SD 
subscales. The first one, which consisted of four items that are in the SR domain, was 
unexpected but not unexplainable considering the bad perfor mance of item 14 
(‘I work/study too much’). This item has low item-total correlation and also came to 
notice in the reliability analysis. It is problematic in the original OQ-45 as well (see 
Mueller et al., 1998) and probably does not represent problematic behaviour. In fact, 
in contemporary society, some people may consider working too hard a good quality. 
The second factor, named ASD, was considered a useful addition to the existing scales 
and was therefore used in further analyses. Reliability and validity estimates for the 
ASD factor are promising. This factor may be especially interesting for use by care 
providers that specialize in anxiety or psychosomatic disorders.
Finding additional factors to the original structure does not seem to indicate 
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conceptual equivalence between the two versions of the OQ-45. And the fit of our 
solution is notably better than the fit of the original three-factor solution. However, 
this does not necessarily imply that they are not equivalent. Some of the GFIs that we 
found for the three-factor solution were similar to the ones reported in the American 
sample (Mueller et al., 1998). Running the same statistical analyses as we did may result 
in a similar structure in the American OQ-45.
The correlations between the subscales were too high. This suggests inadequate 
conceptual equivalence. Another possible explanation for the high correlations 
between the subscales may be that there really is a mutual interdependence between 
the concepts and that distress in one area influences functioning in other areas.
Comparison of normative scores between the American and Dutch populations 
showed that the Dutch community and clinical samples scored somewhat below 
their American equivalents. As was mentioned earlier, differences in scoring between 
culturally different populations are common in psychological testing. For instance, 
differences were found in the EPSILON study and on instruments such as the MMPI. The 
Dutch students showed higher scores than the American students. This may be due 
to a difference in sampling. In the Netherlands, the sample consisted of psychology 
students, whereas the American sample included other disciplines as well. Even 
though the differences between the populations were relatively small, calibration 
of cut-off scores and RCIs was necessary, for a lack of criterion equivalence occurred. 
Calibration resulted in a cut-off score for the Dutch population of eight points below 
the American cut-off point. After calibration, sensitivity and specificity values were 
very similar to those of the original version. The specificity of the American and Dutch 
OQ-45 is 0.83 and 0.85, respectively, and the sensitivity is 0.84 for both versions. The 
RCIs were equal as well.
A marked difference between the American and Dutch normative scores is that 
in the Dutch population, gender differences were found in both the clinical and the 
community sample. Men had more problems in the SR domain, whereas women 
showed higher levels of SD as well as ASD. Gender differences in normative scores are 
quite common in testing, and it is surprising that they were not found in the original 
OQ-45. The OQ-45 manual reports that in one study, some statistically different mean 
scores were found in the patient sample, but they were not considered to be of clinical 
relevance. In the OQ-45 manual, gender scores are only reported on a relatively small 
subsample, so a lack of power may be causing the insignificant findings.
When developing normative scores for any test, the quality of the population 
samples is very important. By combining phone book and business setting sampling, 
we strived for a representative sample of the Dutch functional population. This was 
more complicated for the clinical sample, as we could only address patients who 
received treatment in the participating mental health care centres. Given that the 
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sample size is large and multiple mental health care organizations participated, we 
believe our sample to be representative for the Dutch outpatient population.
Besides examining the equivalence, the psychometric properties of the Dutch 
version were investigated. The reliability of the subscales and the total scale was 
adequate in most of the samples. An exception was the internal consistency of the SR 
domain, which was too low in all three samples, but was substantially better when the 
clinical and community samples were combined. Sensitivity to change is very good, 
and the OQ-45 can effectively discriminate between functional and dysfunctional 
populations. The concurrent validity showed proper values for the SD and ASD 
subscales, but less support for the IR and SR subscales.
This study did not address the OQ-45 as a measure for tracking patient progress. 
More research should be conducted with the Dutch OQ-45 on this subject to 
obtain a better comparison of progress curves between the Dutch and American 
population. Given the differences in normative scores that were found in the current 
study, differences in treatment progress are to be expected. In connection with that, 
the sensitivity to change on a session to session basis should be investigated. Also, 
further research should be conducted on the SR domain and the additional factor that 
was identified in the present study. We are currently performing a pilot study with a 
different formulation of item 14 (‘My work/study is too much for me’) that may better 
reflect problematic functioning in the SR domain. The Dutch OQ-45 has moderate 
to good psychometric properties and is ready for use in clinical practice. However, 
separate norms for patient progress should be developed for the Dutch population.
Summarized, the Dutch OQ-45 has similar psychometric properties as the original 
instrument, but the two versions are not equivalent on all aspects. There may be a 
difference in conceptual equivalence, although further analyses with the original 
instrument can prove otherwise. Criterion validity of the Dutch OQ-45 was similar to the 
original values, but only after calibration of cut-off scores, indicating a lack of criterion 
equivalence. These results imply that a similarity in psychometric properties does 
not guarantee equivalence. The fact that calibration of cut-off scores was necessary, 
even though differences in population scores were small, shows the importance of 
proper normative scores for translated instruments. This is especially true for clinical 
outcome measures such as the OQ-45, where use of the ‘wrong’ norms may lead to 
faulty treatment decisions.
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A priori power analysis in longitudinal 
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an example with therapist effects
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bstract
Multilevel analysis (or hierarchical linear modeling) has become 
increasingly popular for the analysis of longitudinal data in 
psychotherapy research. Over the last few years, three-level 
longitudinal models have become more common in psychotherapy 
research, particularly in therapist-effect or group-effect studies. 
Thus far, limited attention has been paid to power analysis in these 
models. This article demonstrates the effects of intraclass correlation, 
level of randomization, sample size, covariates and drop-out on 
power, using data from a routine outcome monitoring study. Results 
indicate that randomization at the patient level is the most efficient, 
and that increasing the number of measurements does not increase 
power much. Adding a covariate or having a 25% drop-out rate had 
limited effects on study power in our data. In addition, the results 
demonstrate that sufficient power can be reached with small sample 
sizes, but that larger sample sizes are needed to prevent estimation 
bias for the model parameters and standard errors.
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Introduction
Multilevel analysis (Goldstein, 2003; Hox, 2002; Raudenbusch & Bryk, 2002; Snijders & 
Bosker, 1999) has gained significant popularity as a statistical technique for the analysis 
of longitudinal data in psychotherapy research over the last decade. It has been used 
to analyze growth models of phenomenon such as patient progress and expected 
treatment response (e.g. Finch, Lambert, & Schaalje, 2001; Haas, Hill, Lambert, & Morrell, 
2002; Lueger et al., 2001; Lutz, 2002; Lutz, Martinovich, & Howard, 1999; Lutz, Rafaeli, 
Howard, & Martinovich, 2002; Slee, Garnefski, Van der Leeden, Arensman, & Spinhoven, 
2008), the dose-response relationship (Lutz, Lowry, Kopta, Einstein, & Howard, 2001) 
and group therapy (e.g. Haringsma, Engels, Van der Leeden, & Spinhoven, 2006; Tasca, 
Balfour, Ritchie, & Bissada, 2007). Multilevel analysis describes the class of methods 
employing hierarchical regression models, and is also referred to as hierarchical linear 
modeling, linear mixed modeling, random effects regression modeling and random 
coefficient modeling. These models explicitly take into account the hierarchical 
structure of the data (the fact that repeated measurements are nested within patients). 
The popularity of multilevel analysis in analyzing longitudinal psychotherapy data lies 
in its flexibility to handle missing data and unbalanced designs, its capacity to model 
individual growth trajectories (Van der Leeden, 1998), the within-subject covariance 
structure (Hedeker & Gibbons, 2006), as well as models with three or more levels.
In higher level models, an additional level at which the subjects are clustered (e.g. 
‘therapist’ or ‘organization’), is added to account for between-therapist or between-site 
variance. Three level models are becoming more common in psychotherapy research, 
especially in studies on group therapy and therapist effects (e.g. Elkin, Falconnier, 
Martinovich, & Mahoney, 2006; Lutz, Leon, Martinovich, Lyons, & Stiles, 2007; Okiishi, 
Lambert, Nielsen, & Ogles, 2003).
For a special section on therapist effects in Psychotherapy Research, data from the 
National Institute of Mental Health Treatment of Depression Collaborative Research 
Program (TRDCP, Elkin et al., 1989) were re-analyzed using two multilevel approaches. 
Employing a two-level (non-longitudinal) model with functioning at termination as 
the dependent variable,  Kim, Wampold & Bolt (2006) showed significant differences 
between therapists in treatment results. In contrast, a three-level longitudinal model 
by Elkin, Falconnier, Martinovich & Mahoney (2006) did not find significant therapist 
variance. These contrasting results initiated an exploration of whether three-level 
longitudinal models are appropriate for psychotherapy research. Wampold & Bolt (2006) 
posit that, in psychotherapy research, the level of functioning at treatment termination 
is important; not the change pattern, arguing a move away from longitudinal models. 
However, there are serious drawbacks to both the completers sample analysis they 
suggest and the missing data imputation methods used in intent-to-treat analysis that 
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longitudinal analysis does not have (Crits-Christoph & Gallop, 2006). 
One of the problems in the re-analyses of the TRDCP data was that the sample size 
was smaller than is generally recommended for multilevel analysis (Kim, Wampold, 
& Bolt, 2006; Soldz, 2006). Given that therapist-effects have been found in analyses 
with larger datasets (Lutz, Leon, Martinovich, Lyons and Stiles, 2007) it is possible 
that power might have been an issue in the TRDCP analyses. Therapist effects have 
usually been small in randomized controlled trials and small to medium in naturalistic 
studies (Crits-Christoph & Gallop, 2006). It seems that therapist effects are harder to 
detect in randomized controlled trials using treatment manuals (Crits-Christoph et al., 
1991) and that therapist variance declines when therapists are trained (David M. Clark, 
personal correspondence). Yet, even a small amount of variance at the therapist level, 
can have a significant influence. It has been shown that ignoring a level of nesting 
in the data can have considerable effects on the estimated variances and power to 
detect treatment or covariate effects (Moerbeek, 2004) and can seriously inflate the 
Type I error rate and size of the treatment effect (Wampold & Serlin, 2000). Numerous 
researchers have shown that ignoring clustering can also lead to serious errors in 
interpreting the results of statistical significance tests (e.g. Nich & Carroll, 1997). As a 
result, in many cases, adding a third level that models between-therapist variance is 
necessary, regardless of whether therapist effects are the main topic of interest in the 
study. 
Having nested data can strongly influence the power to detect a treatment effect. 
Unfortunately, many researchers still use power analyses that ignore the effect of 
nesting, even if they plan to do a multilevel analysis. The reason for this is that in 
multilevel analysis (a priori) estimation of power is complex, as it depends on a number 
of variables, including study duration, number of measurements, number of patients, 
number of therapists, the level of randomization and the intraclass correlation between 
the levels. Determining the sample size that is needed for sufficient power to detect 
a treatment effect is more complicated than in other approaches, because there are 
different sample sizes at the different levels: the number of measurements per patient 
(level 1), the number of patients per therapist (level 2) and the number of therapists 
(level 3). Moreover, it is necessary to use plausible values of the variance components 
in the model to get a proper estimation of power, and these are usually unknown. 
Although some literature (e.g. Raudenbusch, 1997; Snijders & Bosker, 1993) and 
software solutions (Bosker, Snijders, & Guldemond, 1996) are available to estimate the 
power for two-level models, there is little information about power analysis for three-
level longitudinal models. The Optimal Design software developed by Raudenbush 
and colleagues (Spybrook, Raudenbush, Liu, Congdon, & Martínez, 2008) is the only 
program we are aware of with an option to compute power for three-level models, 
 Jong de_PROEF (all).ps Back - 24     T1 -    Black
47
3
Power in 3-level longitudinal models
and this functionality exists only for limited designs. In this paper we will demonstrate 
a method to compute power for three-level longitudinal models. With limited financial 
resources it is very valuable to know whether it is more efficient to collect more 
measurements per patient, a larger number of patients with fewer measurements or a 
larger number of therapists, with a smaller number of patients per therapist. First, we 
will discuss factors that influence power in more detail. Then, the influence of these 
factors on power will be illustrated using naturalistic data from an outpatient setting.
Factors influencing power
Intraclass-correlation
Ignoring a significant intraclass correlation (ICC) by using traditional regression 
models can result in substantial estimation bias for parameters and standard errors 
(Goldstein, 2003). The ICC is defined as the degree of resemblance between micro-
units belonging to the same macro-level unit and can also be interpreted as the 
fraction of total variability that is due to nesting (Snijders & Bosker, 1999). In multilevel 
modeling,  although nesting is taken into account by the model, the size of the ICC 
strongly influences the power to detect treatment and covariate effects. For three-
level models intraclass correlations are calculated for levels two and three. There are 
multiple ways to compute the level-two intraclass correlations (see Hox, 2002; Snijders 
& Bosker, 1999).
The effect of clustering can be clearly demonstrated by the design effect. The 
design effect is the ratio of patients required for modeling nested data, relative to 
non-nested data and is defined as 1+(k-1)ICC, with k being the number of patients per 
therapist, and the ICC defined as the proportion of the total variance accounted for 
by the therapist level (Donner & Klar, 2000). For example, with an ICC of 0.1 and four 
patients per therapist the design effect would equal 1.3, meaning that approximately 
30% more patients are needed for sufficient power than in non-nested data. The 
higher the ICC, the larger the design effect and the lower is the power to detect a 
treatment effect. In this example a higher ICC means that there is a larger difference 
between therapists, and that the therapist variance explains part of the variance of the 
treatment effect, thus reducing the power to detect that effect.
One of the major challenges in a priori power analysis for multilevel models is the 
need for plausible values of the variance components, and these are usually unknown.. 
Using ICC values from the literature will provide an idea of the extent to which the 
design-effect will decrease power. As the ICC depends on the outcome measure, it is 
necessary to base the ICC estimates on studies using the same outcome measures. 
In educational and medical research, there is an increasing amount of literature 
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reporting intraclass correlations for different outcome measures and covariates (e.g. 
Adams et al., 2004; Campbell, Mollison, & Grimshaw, 2001; Hedges & Hedberg, 2007). 
In psychotherapy research, such papers are desperately needed in order to perform 
sensible a priori power analyses. 
Level of randomization
Three-level longitudinal models offer a choice of which level should be used to 
randomize to treatment conditions. In terms of statistical precision and power it is 
usually best to randomize at the lowest level possible (Moerbeek, 2005). In the case of 
three-level longitudinal models in psychotherapy research this is the patient level (level 
two), since the first level consists of the repeated measurements. A common design in 
randomized controlled trials in psychotherapy research is that patients are randomly 
assigned to treatment conditions, and therapists are recruited to either provide the 
experimental or control treatment. Although patients are randomly assigned to 
treatment conditions, statistically the randomization is at the therapist level, since 
within a therapist all patients receive the same treatment. The reason that this design 
is so common, is that it prevents contamination of the treatment effect. Contamination 
occurs when members of the experimental treatment condition influence members of 
the control condition. If therapists provide both the control (for instance treatment as 
usual) and the experimental treatment, they might unconsciously use techniques from 
the experimental treatment for their patients in the control group, thus contaminating 
the treatment effect. In case of contamination, randomization at the therapist level, 
actually might lead to higher power to detect an effect (Moerbeek, 2005). Alternative 
designs like pseudo-cluster randomization (Borm, Melis, Teerenstra, & Peer, 2005) and 
the split-plot design (Reise & Duan, 2003) have been developed to help to handle 
contamination, but have not been widely used so far. 
Sample size
In three-level longitudinal models there are different sample sizes at different levels: 
the number of measurements per patient (m), the number of patients per therapist 
(k) and the number of therapists (J). Several combinations of m, k and J can result 
in an identical power to detect an effect, but a minimum sample size at each level 
is necessary for accurate estimation of the estimates and standard errors. The most 
significant limitation on accurate estimation is usually the sample size at the highest 
level (Maas & Hox, 2005). For instance, when a relatively large portion of the variance is 
situated at the therapist level, and  randomization takes place at this level, power does 
not increase much when more patients are included per therapist. Similarly, without 
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prolonging the duration of the study, the effect of additional measurements on power 
is limited (Moerbeek, 2008; Raudenbusch, 1988). However, having a larger number 
of measurements does provide more information about the progress of individual 
patients and makes it possible to fit models with a more complicated random part at 
the patient level (Snijders & Bosker, 1999).
Covariates
The effect of covariates on power is not always straightforward in multilevel models. 
The optimal sample size for each level can change when covariates are used, 
particularly when covariates are used at multiple levels. Determining the precise 
impact of a covariate on power a priori is complicated because it depends on a number 
of factors, including how much within and between variance a covariate accounts for 
(Reise & Duan, 2003). For example, should  a covariate have a low correlation with the 
dependent variable, but a moderate to high correlation with other variables in the 
model (such as time or treatment condition) power is usually decreased by including 
the covariate in the model. However, if the covariate explains part of the variance that 
is unexplained by time or treatment condition, power is increased by its inclusion 
(Moerbeek, 2006). 
Missing data and drop-out
One of the challenges of longitudinal research is the, almost inevitable, loss of data 
due to missingness or drop-out. Multilevel analysis is capable of handling most cases 
of missing data very well1. Missing data will, nonetheless, affect study power simply 
by the fact that fewer data points are available as a result. Moerbeek (2008) presented 
power plots for several drop-out patterns and showed that in studies with dropout, 
power especially decreases when the drop-outs are concentrated in the beginning 
of the study. Increasing the study duration can also have a negative effect on power, 
especially if the dropout is concentrated at the end of the study. 
Data used as example
For a new study on the effect of providing feedback to therapists about their patients’ 
progress, we sought to estimate how many therapists and patients would need to be 
included in order to obtain sufficient power to detect an effect. In the planned study, 
patients will be randomly assigned to either a feedback or control condition. In the 
feedback condition, therapists will receive charts by e-mail that indicate the patients 
progress on the Outcome Questionnaire (OQ-45; Lambert et al., 2003). Because the 
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variance components in the planned study are unknown, data from a routine outcome 
monitoring study were used to estimate the variance in the control group. The 
routine outcome monitoring (ROM) data consists of 1966 measurements of patient 
functioning (average of 3.22 measurements per patient), within 610 patients (average 
of 5.60 patients per therapist), who were treated by 109 therapists. Collection of the 
ROM data is an ongoing process and a portion of the patients in this dataset are still 
in treatment. Patients completed the OQ-45 at several moments during treatment. 
We used the log of the number of sessions as our time variable, a common choice 
in psychotherapy research that has been shown to linearize treatment progress. 
The intraclass correlation at the patient level2 and therapist level were 0.75 and 0.18 
respectively in the (empty) unconditional model. Several three-level multilevel models 
were fitted to the data and compared on the deviance values and Wald test for fixed 
effects. For explanatory purposes we used relatively simple models, even though 
there are numerous modeling options that might be relevant for this kind of data 
(e.g. anchoring, centering, transformations, additional covariates). Table 1 shows the 
results for a model with a random effect of (log) time at the patient level (Model A) and 
the effect of adding a covariate (gender) to the model (Model B). Adding a  random 
effect of (log)time at level-two and three simultaneously demonstrated no significant 
improvement compared to Model A. Adding a random slope at the therapist level, 
Table 1  Parameter estimates and standard errors for two multilevel models fitted to the 
routine outome monitoring data
Parameter Model A Model B
Estimate SE Estimate SE
Fixed effects
Initial status, β0jk Intercept δ000 78.37 1.26 78.38 1.27
Rate of change, β1jk Slope δ100 -13.30 0.99 -10.56 1.64
Gender δ110 -4.16 1.99
Variance components
Level 1 Within-person 71.77 3.27 71.67 3.26
Level 2 Initial status 454.09 23.97 448.93 30.69
Rate of change 187.80 29.57 183.72 29.25
Level 3 Initial status 48.61 19.40 49.53 19.61
Rate of change
Goodness of fit Deviance 16123.5 16119.24
Pseudo R2
SE = Standard error
Model A: random slope at the patient level
Model B: random slope at the patient level, gender as covariate
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but not at the patient level, produced a significant improvement compared to a fixed 
effect of time, however, the model with a random slope at the patient level had a 
better goodness-of-fit.
Once we derived our best-fit model, we used the values from Model A as estimates 
for the variance and covariance components in the control condition of the planned 
study. The equations used to compute the power curves are described in Appendix A. 
A medium effect of 0.5 was expected for the interaction between time and treatment 
condition. For the power plots, the study duration was set at 21 weeks3, with patients 
receiving one therapy session per week. The maximum number of therapists was set 
at 100. To demonstrate the effect of adding a covariate, we used the values from Model 
B. To show the effect of drop-out on power, we performed a simulation study using 
Splus. For each combination of number of therapists and drop-out pattern, 5000 data 
sets were simulated in which model parameters and standard errors were estimated. 
The observed power is reflected by the percentage of data sets in which the null 
hypothesis was not rejected; in other words, in percentage of data sets in which the 
effect of the feedback condition on the slope was not significant.
A priori power analysis using the example data
Figure 1 shows the estimated power curve for five measurements per patient, and two, 
four and eight patients per therapist. Since the slope variance at the therapist level 
did not significantly deviate from 0 in Model A, the therapist variance has no influence 
on the power to detect an effect (also see Appendix A), and consequently the figure 
applies to both randomization on the patient and the therapist level.
General guidelines state that a power level of 0.80 is considered adequate to 
detect treatment effects (Cohen, 2002). According to Figure 1, to obtain a power of 
0.80 one should have either 22 therapists with eight patients each (176 patients in 
total), 43 therapists with four patients each (172 patients in total) or 85 therapists with 
two patients each (170 patients in total). In order to get unbiased estimations of the 
parameters and standard errors, a sufficient number of therapists is needed. In the 
simulation study by Maas & Hox (2005) for two levels, it was shown that with 30 groups 
the standard errors for the highest level were estimated about 15% too small; only with 
50 groups were the chances of reliable estimation acceptable.
Optimal level of randomization
In the ROM data, the slope at the therapist level was relatively small and not significant. 
However, in some cases there might be a significant difference between therapists in 
how their patients progress over time. In that case, the level of randomization could 
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5 measurements per patient
8 patients per therapist
4 patients per therapist
2 patients per therapist
Figure 2a  Estimated power, significant therapist slope variance, randomization at the patient 
level (level 2)
 

















11 measurements per patient
8 patients per therapist
4 patients per therapist
2 patients per therapist
Figure 1 Estimated power for the planned study, no significant slope variance at the therapist 
level
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have a substantial impact on power. For this reason, we performed an additional power 
analysis with a significant slope at the therapist level. Based on the results from Lutz, 
Leon, Martinovich, Lyons & Stiles (2007), we assumed that beside the slope variance of 
187.80 at the patient level that was found in Model A an additional variance of 35.77 
(16% of the total slope variance) was situated at the therapist level. Figure 2a shows 
the power curve for this simulation, with randomization at the patient level, and Figure 
2b shows the power curve for randomization at the therapist level, both for eight, four 
and two patients per therapist and 11 measurements per patient. When randomization 
takes place at the patient level (patients are randomly assigned to conditions, therapists 
are in both conditions) the samples required are 17 therapists with eight patients 
each,  33 therapists with four patients each, or 66 therapists with two patients each 
to reach a power level of 0.80. When randomization takes place at the therapist level 
(therapists are randomly assigned to conditions, all patients within a therapist are in 
the same condition) sample requirements are 37 therapists with eight patients each, 
53 therapists with four patients each, or 86 therapists with two patients each.
Comparing Figures 2a and 2b also shows that adding patients per therapist has 
less effect on power when randomization takes place at the therapist level than 
at the patient level. Suppose we have 15 therapists with four patients each. When 
randomization occurs at the patient level, the power is 0.47. When the number of 
Figure 2b  Estimated power, significant therapist slope variance, randomization at the therapist 
level (level 3)
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patients per therapist is doubled, the resulting power is 0.77. When randomization 
takes place at the therapist level doubling the amount of patients per therapist 
increases the power from 0.32 to 0.44. However, doubling the amount of therapists in 
the study, rather than the amount of patients, results in a power of 0.56 and is, thus, far 
more effective.
Figures 2a and 2b demonstrate how randomization at the therapist level is less 
effective in terms of power than randomization at the patient level. Randomizing 
at the therapist level is only advised in case of contamination. In the planned study, 
contamination is not likely, as the studies performed by Lambert and colleagues 
(Harmon, Hawkins, Lambert, Slade, & Whipple, 2005; Hawkins, Lambert, Vermeersch, 
Slade, & Tuttle, 2004; Lambert et al., 2002; Lambert et al., 2001; Whipple et al., 2003) 
show, therapists do not perform better with patients in a control condition over time. If 
contamination was an issue, effect sizes would have shrunk in each consecutive study 
as a result of the learning effect. In other words, if the feedback had taught therapists 
to treat all their patients more effectively, the effect of the feedback would have 
decreased with each consecutive  study. Randomization at the patient level seems the 
best option for the study design in this case and, therefore, further power plots will 
only be presented for this situation.
Figure 3 Estimated power for a varying number of measurements per patient, randomization 
at the patient level
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Number of measurement occasions
Earlier it was stated that the number of measurement occasions within the same time-
period has little influence on power. To demonstrate this, power plots were produced 
for 5, 11 and 21 measurements. As can be seen in Figure 3 increasing the number of 
measurements per patient hardly has an effect on study power; respectively 36, 33 or 
31 therapists are needed to obtain a power level of 0.80. 
Adding a covariate
To demonstrate the effect of a covariate on power, gender was added as a slope 
predictor (see Figure 4). Although gender is a significant slope predictor, adding it to 
the model has little effect on power because it decreases the slope variance by only 
2%. Stronger covariates might have a larger effect on power, provided that they don’t 
increase variance on other levels. As is shown in Table 1, Model B, adding a covariate 
can increase the variance at other levels, in this case the initial status variance at level 3. 
Figure 4 Estimated power with and without gender as a covariate, randomization at the 
patient level
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Figure 5a  Simulated patterns of dropout (25% drop-out)
Figure 5b Estimated power for the simulated drop-out patterns, randomization at the patient 
level
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The effect of study drop-out on power
Figure 5a shows the simulated patterns of drop-out for therapists with eleven 
measurements per patient and four patients per therapist. All patterns have a total 
drop-out of 25%. Pattern 1 has most of the drop-out at the end of the study; Pattern 2 
has an equal drop-out throughout the study and Pattern 3 has most of the drop-out 
at the beginning of the study. Figure 5b shows the observed power for the simulated 
drop-out patterns. The effect of drop-out on the number of therapists needed for 
drop-out is limited. Having most of the drop-out at the beginning of the study seems 
to have the most substantial impact on power. Drop-out at the end of the study has 
the least impact on power.  In a sample with no dropout, 31 therapists are needed. 
Drop-out at the end of the study results in a need for two additional therapists (33), 
equal drop-out throughout the study requires three additional therapists (34) and 
drop-out at the beginning in 6 additional therapists (37). 
Discussion
The aim of this article was to perform an a priori power analysis for three-level 
longitudinal multilevel models and to demonstrate the effect of the level of 
randomization, samples size, covariates and drop-out on the power to detect a 
treatment effect. Results demonstrated that randomization at the patient level was 
more effective, in terms of power, than randomization at the therapist level. Increasing 
the number of patients was shown to be the best way to improve power when 
randomization takes place at the patient level. In the case of randomization at the 
therapist level, including more therapists in the study was more effective. The sample 
size at level one, the repeated measurements, did not have a strong effect on power. 
Furthermore, in our example adding gender as a covariate did not improve the power 
much. However, our covariate did not have a strong effect and other, more significant, 
covariates might have different effects on power. Drop-out also did not affect power 
substantially, although it did reduce power to some extent, especially when drop-out 
was concentrated at the beginning of the study. Besides power, it is necessary to have 
appropriate sample sizes at each level to ensure accurate estimation of parameters 
and standard errors. In some cases this may result in larger sample sizes than are 
necessary for sufficient power. In addition, in order to effectively distinguish between 
the slope variances at the patient and therapist level, there needs to be a sufficient 
level of patients per therapist. 
Results indicate that, in three-level models, larger sample sizes are required 
than are common in general linear model approaches. It should be noted, however, 
that the intraclass correlation at level three in our example data was rather high. 
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This is consistent with naturalistic data, and one is less likely to find such values in a 
randomized controlled trial. Moreover, it is likely that the feedback condition in our 
planned study will reduce therapist variance and, by consequence, the level three 
intraclass correlation. In other naturalistic data we have found lower ICC values and, as a 
result, sufficient power with lower numbers. In such a case, power is no longer the main 
concern, and is secondary to estimation bias. For example, in our simulation, we found 
sufficient power using 17 therapists with eight patients each. However, by choosing 
that size sample, the model parameters and standard errors could be seriously biased, 
thus inflating the Type I error. This is specifically the case for the estimation of random 
effects; in fixed effects the standard errors are more robust. Maas and Hox (2005) found 
evidence for this in a simulated two-level model and although there are no simulations 
available for longitudinal three-level models, the problem of estimation bias likely 
applies to the highest level of the model and, thus, similar results can be expected for 
three-level models. Estimation bias in multilevel modeling is partly resolved by using 
non-parametric tests such as the likelihood ratio test instead of parametric tests, but 
this doesn’t solve the problem completely.
The analyses that were performed in this article have some limitations. First, the 
modeling on which the analyses were based was kept deliberately simple. A random 
intercept, random slope model was selected, but fixed intercept or slope models could 
also have been used. For the time variable, a log-linear model was chosen, as this is 
the most frequently reported time variable in psychotherapy research, but other time 
variables are plausible as well (e.g. a combined linear and quadratic time variable). 
Another issue with the time variable is that calculating the dosage in sessions 
attended, rather than length of treatment,  ignores frequency effects that would be 
found in, for example, twice weekly versus once-weekly psychotherapy. In addition, 
psychotherapy studies usually have several relevant predictor variables, rather than 
just one, and there would be predictors for both the slopes and the intercepts at the 
patient and therapist level. Since intercept predictors do not influence the power to 
detect a treatment effect, they were not included in the model. An additional limitation 
of this article is that it only describes power for situations with two conditions. Many 
clinical trials have three conditions, comparing two experimental conditions and one 
control condition. In such a case, the model becomes more complex quickly, because 
an additional (dummy) variable has to be added. One has to know in advance how the 
three conditions will affect slope and intercept variances. Lastly, although this article 
has provided examples how several relevant factors such as covariates and drop-out 
influence power, it has only addressed these phenomenon one at a time, whereas 
in practice multiple such factors frequently apply at the same time. However, these 
results offer a good indication of how each factor influences power in these models 
and could help in making decisions about study designs in the future.
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Although a priori power analysis for multilevel models is a complex undertaking, 
these results indicate that such modeling is not only possible, but practical. Traditional 
power analyses for linear models does not distinguish between sample sizes at 
different levels and can lead to an underestimation of the number of cases that are 
needed. Therefore, although a growing literature on multi-level power analysis exists, 
further exploration is warranted. In particular, in order to be able to perform a priori 
power analyses for clinical trials, there is a strong need for more articles on variance 
components and intraclass correlations in different types of patients, treatments and 
outcome measures.
Since the special section in this journal on therapist effects, the discussion about 
whether therapist effects exist has become mixed up with the discussion on what 
models should be used to investigate them. Wampold & Bolt (2006) have stated that 
longitudinal models may increase patient variability and thereby reduce therapist 
effects. While this is true, patient variance in treatment progress is an integral part to 
the kind of data we collect in psychotherapy studies, as patients differ in their treatment 
course. By ignoring that variance one might be able to better detect therapist effects, 
but does that mean it is better? We do not claim to have the answer to that question, 
and would like to state that, in our opinion, it is more a matter of what the focus of the 
study is, than one method being better than the other. Longitudinal models do have 
some disadvantages, for instance, in the case of differential treatment length, longer 
treatments will have more impact on the model as they have more measurements than 
shorter treatments. Another issue is that longitudinal models do not assess whether 
treatment is successful or not, but neither do end-of-functioning models. 
Irrespective of the method or model used, the evidence for therapist effects is 
limited so far (Crits-Christoph & Gallop, 2006). The lack of evidence for therapist 
effects in clinical trials seems to have two main causes: the number of trials that take 
the therapist level into account is small and the trials that do include therapist effects 
often have small sample sizes that are too small for unbiased estimation or sufficient 
power. In order to get more information on the existence of therapist effects in clinical 
trials, the therapist level should, at least, be registered and reported, regardless of 
significance. In addition, predictor variables at the third level should be included in 
more studies, to explain what factors may contribute to therapist effects. 
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I  Multilevel analysis can handle data that is Missing Completely At Random (MCAR) or Missing At Random 
(MAR), but not data that is Missing Not At Random (MNAR).
II The patient level variance has been calculated according to Davis & Scott, 1995 cited in Hox, 2002 (p.32)
III A study duration of 21 weeks results in equally spaced, round session numbers for the measurement 
occasions, as well as pre and post test. For 5 measurements the occasions are set at session 1, 6, 11, 16 and 
21; for 11 measurements at sessions 1, 3, 5,…21; and for 21 measurements at each session.
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bstract
Objective. Risk models that aimed to identify consistent 
predictors for negative outcomes have encountered several 
challenges. This study uses state of the art statistical techniques to 
handle these problems, by using multilevel analysis combined with 
multiple imputation to predict the rate of change and classification 
and regression tree (CART) analysis to predict end state functioning. 
Method. A naturalistic sample of 1540 outpatients (63% female; 
age range 17-67 years, M = 37.5, SD = 11.7) was collected in three 
mental health care organizations in the Netherlands. Patients 
completed the Outcome Questionnaire (OQ-45; Lambert et al., 2004) 
regularly during treatment. In addition, several potential predictor 
variables were collected. 
Results. Initial severity, educational level, expectancies, Global 
Assessment of Functioning (GAF) and the working alliance were 
significant predictors for end state functioning. In predicting rate 
of change, the same predictors were found, except for educational 
level and expectancies. In addition, previous treatment, comorbidity 
and having a personality disorder as main diagnosis were significant 
predictors for rate of change as well. 
Conclusions. Although there was overlap in predictors of 
negative outcomes with regard to end state functioning and rate 
of change as outcome variables, both analyses provide different 
information. By combining the prediction models, patients that 
may need to be monitored more closely during treatment can be 
identified so that negative outcomes may be prevented. By using 
CART and multilevel analysis combined with multiple imputation 
substantially more data could be used in analysis than would 
otherwise have been the case, thus reducing the selection bias and 
improving generalization.
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Risk models for negative treatment outcomes
Introduction
Risk models that aim to predict the future course and outcome of disease processes 
are common in medical and health research. Good risk models are valuable for a 
wide variety of purposes, including policy making, adjusting for differences in patient 
case-mix between institutions, and assisting patients and clinicians to make informed 
decisions about treatment (Ambler, Omar & Royston, 2007). In medical situations, 
knowing the risk factors for negative treatment outcomes might mean the difference 
between life and death. Although psychotherapy is usually not involved in life and 
death situations, negative treatment outcomes can have a large impact on patients’ 
quality of life and potentially constitute an increased risk of long-term psychiatric 
complaints and higher costs for mental health care. Hansen, Lambert and Forman 
(2002) have shown that in naturalistic settings a lack of treatment success is common: 
3-14% of patients deteriorate and 45-60% show no clinically significant change during 
treatment. By comparison, in clinical trials results are much better: 67% of patients 
improve significantly. Similar results were found by Barkham et al. (2008), who showed 
that approximately 18% more patients were clinically significantly improved and 
effect sizes were more than twice as large in randomized trials than in practice-based 
studies. This suggests that there is much room for improvement in clinical practice. 
Although not all patients are likely to achieve treatment success and some might 
be on a progressive decline that cannot be stopped, evidence suggests that at least 
some patients might worsen as a result of therapy (Lambert & Ogles, 2004). Therefore, 
knowing risk factors for negative treatment outcomes in psychotherapy can be very 
valuable for treatment selection.
In psychotherapy research, risk models are best known from the line of research that 
is referred to as patient-focused research and health services research such as quality 
assurance programs. Such research aims to prevent negative treatment outcomes by 
making predictions about the patient’s progress using variables that have previously 
been associated with positive or negative treatment outcomes (e.g. Howard, Moras, 
Brill, Martinovich, & Lutz, 1996; Lueger et al., 2001; Lutz, 2003). These models usually 
attempt to forecast the course of treatment or rate of change, rather than end state 
functioning, and are often referred to as expected treatment recovery (ETR) curves. 
Most models use multilevel modeling or similar techniques to make these predictions. 
Although these models are very valuable, it has been a challenge to identify reliable 
predictors of change beyond initial severity.  Some authors have found additional 
predictors, including patients’ expectancies of outcome and the Global Assessment 
of Functioning score, but in these studies initial severity still explained the highest 
proportion of outcome variance, compared with all other predictors (Lutz et al., 2005; 
Lutz, Lowry, Kopta, Einstein, & Howard, 2001; Lutz, Martinovich, & Howard, 1999). 
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Moreover, most factors have not been consistently replicated by others. For outcome 
in terms of functioning at the end of treatment, initial severity is an important 
predictor too. In the review by Clarkin & Levy (2004), a high initial severity of symptoms 
was related with poor treatment outcomes, especially in depression and addiction 
populations. The results on other client variables were less consistent: comorbid 
personality disorders for instance could have a positive or negative effect on outcome 
and client demographics were usually not consistently found as relevant predictors 
(Clarkin & Levy, 2004). 
One reason for not finding many predictors for end state functioning and rate of 
change might be that we oversimplify the relationship between the predictor variable 
and outcome. Most prediction models suppose a linear relationship between the 
predictor and outcome, whereas the true relation might be much more complex. 
Kendler (2008) states that we need to start looking at more complex interactions in 
explanatory models for psychiatric illness – models that consider predictors at different 
levels: micro and macro, within and outside the individual – to better understand 
what risk factors are relevant in psychiatry. Assuming simple linear relationships 
between a predictor and outcome may be misleading. Take for example a predictor 
like the working alliance. The working alliance is one of the more robust predictors 
of outcome that has been identified (e.g. Horvath & Symonds, 1991; Klein et al., 2003; 
Martin, Garske, & Davis, 2000).  It is often assumed that a strong alliance leads to better 
outcomes, yet not all patients with a high working alliance have good outcomes. 
Suppose that the true relationship would only hold for those patients with average to 
low severity of symptoms and not for patients with a high level of symptom distress. 
Standard regression models, would only find working alliance to be a predictor and 
might miss the interaction.
 Another challenge for developing accurate risk models is ensuring sufficiently 
complete data. Most risk models for health outcomes are estimated using data 
routinely collected in clinical practice. The advantage of that approach is that there is 
usually a large dataset available, with high external validity. The disadvantage is that 
those datasets typically have many missing values. A review of more than 800 articles 
published in three leading personality journals showed that almost half of the articles 
reported missing data problems (Van Ginkel, Sijtsma, van der Ark, & Vermunt, 2010). 
It is not unusual for some important predictors to be missing for over 50% of patients 
(e.g. Ambler et al., 2005). Moreover, in many studies patients have missing data on 
several variables simultaneously. Combinations of missing data on different predictor 
variables may result in percentages of complete data as low as 32% (Ambler, Omar, & 
Royston, 2007). Although missing values are common, information on the percentage 
of missing data and how missing data are handled statistically is often not reported. 
A survey of 46 papers in a counseling psychology journal showed that only a little 
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over one third of the papers reported missing data percentages (Schlomer, Bauman, & 
Card, 2010). A review of 100 articles using longitudinal data in three leading journals 
in developmental psychology showed that 82% of the studies that did report having 
missing data, used missing data techniques that are problematic (Jelicic, Phelps, & 
Lerner, 2009). In addition, anecdotes from other psychotherapy researchers tell us that 
it is not uncommon for more than half of the data to be “cleaned up” prior to final 
analysis (see Hatfield, McCullough, Frantz, & Krieger, 2010 for an example) although 
this is seldom reported in the published articles. Complete case analysis can result 
in substantially smaller sample sizes, biased regression coefficients and reduced 
reliability for predicting future observations as a result (Ambler, Omar & Royston, 
2007). Moreover, researchers have demonstrated that serious violations of statistical 
assumptions occur when missing data are ignored (e.g. Allison, 2003; Graham & Hofer, 
2000; Wothke, 2000).
Several statistical techniques have been developed that handle missing data 
problems well, including repeated measures multilevel analysis (Hedeker & Gibbons, 
2006; Raudenbush & Bryk, 2002; Singer & Willet, 2003) and classification and 
regression trees (CART; Breiman, 1984). Multilevel analysis handles missing data on 
the dependent variable by estimating an individual change trajectory that depends 
on the observed variables for each person and as a result can handle missing data 
on the dependent variable very well, but it does need complete values on predictor 
variables. CART is a regression based datadriven technique that automatically searches 
for moderators in the data and calculates optimal splits for predictor variables. The 
missing data are handled by the use of surrogate splits. These type of split points are 
created as backup for the main split, meaning that if the split variable being evaluated 
is missing, a surrogate predictor is used (Breiman, 1984). Contrary to most techniques 
it can handle missings on the predictor variables very well, but needs complete cases 
on the dependent variable. CART has the additional advantage of being able to 
select important predictors automatically, especially when there are many variables 
(categorical and/or interval), and has the ability to uncover complex interaction effects 
between them. Furthermore, the method is robust for non-normally distributed data 
(Briand, Ducharme, Parache, & Mercat-Rommens, 2009). The resulting trees are easy 
interpretable by lay persons and can be used to create decision rules, which can be 
generalized to a non-research setting (Lewis, 2000). CART and multilevel analysis 
address different aspects of outcome: multilevel analysis assesses factors that are 
related to the rate of change, whereas CART assesses factors related to end of treatment 
functioning.
Another approach to handling missing data is multiple imputation. Multiple 
imputation can be used to address missing data in both independent and dependent 
variables and restores the dataset to the full size. Many authors have illustrated that 
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multiple imputation gives better results in statistical analyses than listwise deletion 
(e.g. Ambler, et al., 2007; Little & Rubin, 2002; Rubin, 1987; Schafer, 1997; Schlomer, et 
al., 2010). It decreases estimation bias in both the parameters and the standard errors 
and when the imputation model is correct and the data are missing at random, the 
precision of the parameter estimates will approach the precision that would have 
been achieved with complete data (Huang et al., 2009). However, clinical researchers 
seem to be reluctant to use it (Jelicic, et al., 2009). Although multiple imputation is 
a very useful method to deal with missing data and has been rapidly developed for 
many types of data, it still has trouble handling unbalanced designs like those that are 
common in naturalistic settings in clinical psychology. For example, patients’ progress 
is often measured multiple times during the course of treatment, yet the frequency of 
sessions and assessments may differ considerately among patients - one patient might 
have 5 sessions of treatment with one measurement missing whereas another patient 
has 15 sessions with 3 measurements missing. Even with complete data the number 
of measurements would differ between patients. In the currently available software 
packages, the full data matrix is filled up, rather than just the true missing values. In 
this situation, multiple imputation can be used to impute the predictor variables, but 
not the outcome variable.
In summary, developing prediction model for negative treatment outcomes is 
important, since many patients in clinical practice do not experience sufficient change. 
Yet, handling the missing data that are typical in the naturalistic data used for these 
models poses a challenge. Applying techniques that are more flexible in handling 
missing data seem a good solution, but these methods have their limitations as well. 
In the current article, we will use a naturalistic dataset collected in three community 
outpatient facilities in the Netherlands to predict patients at risk for negative 
treatment outcomes. Data on the predictor variables will be multiply imputed and 
multilevel analysis will be used to predict factors related to the rate of change. Factors 
directly related to negative outcomes will be assessed using CART on the original data. 
The predictor variables in the multilevel analysis and CART analysis will be identical 
and include clinical variables (e.g. initial severity, diagnosis, duration of complaints), 
demographic variables (e.g. sex, age, educational level) and process variables 
(expectancies, working alliance). Differences in the results and the performance of 
both models will be compared.
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Method
Participants
Data were collected between June 2006 and June 2009 in eight treatment departments 
of three mental health care organizations in the Netherlands. Subjects were outpatients 
who were seen for psychological or psychiatric treatment. Data were collected as part of 
routine care, but patients were offered the option to refuse participation. The research 
proposal was evaluated by the local ethical committees of the participating institutions. 
There were 4447 patients in the original sample, including 1689 males (38%) , 2752 
females (62%) and 6 persons with unknown gender. The age of the patients ranged from 
17 to 71, with a mean of 37.7 years (SD = 11.8). Patients with psychotic disorders, mental 
retardation or in a current crisis at the time of referral (n = 92), patients who received non-
verbal treatments (n = 151), patients who did not have a sufficient level of understanding 
of Dutch (n = 121) and patients who did not receive more than one treatment session (n 
= 148) or were unable to participate in the study for other reasons (n = 91) were excluded 
from the study. A total of 503 patients actively refused to participate in the study, and 
an additional 1801 patients completed less than two questionnaires during treatment 
- 773 of which never completed a single questionnaire. The remaining sample of 1540 
consisted of 561 men (36%) and 976 women (63%) and 3 people of unknown gender. 
The age of the subjects ranged from 17 to 67 with a mean age of 37.5 (SD = 11.7) (see 
Table 1).
 A subset of 541 patients was used for the complete case analysis in the multilevel 
model, to demonstrate the effect of the multiple imputation on the analysis. Since only 
19% of patients (n = 295) had complete values on all predictor variables, an optimal set of 
predictor variables was selected in such a way that the most relevant predictor variables 
could be included, without losing too many other cases (see Table 2).
Table 1 shows the baseline characteristics of the sample that met inclusion criteria, the 
final selection and the complete case sample. There were no significant differences found 
between the  samples in sex, age, main diagnosis for treatment following the Diagnostic 
and Statistical Manual of Mental Disorders IV (DSM-IV) and Outcome Questionnaire – 45 
(OQ-45; Lambert et al., 2004) scores at intake. The most common main diagnosis in our 
sample was mood disorder, followed by anxiety disorder and adjustment disorder.
Instruments
Outcome Questionnaire-45 item version (OQ-45)
The Dutch translation of the Outcome Questionnaire-45 item version (OQ-45; Lambert 
et al., 2004) was used to measure patient progress during treatment. The OQ-45 is 
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Table 1  Patient characteristics of the sample meeting inclusion criteria, the sample selected 





















Age M =  37.6
SD =  11.8








- Disorders usually first diagnosed 
in childhood
- Personality disorder (Axis II)
- Cognitive disorder
- Substance related disorders
- Other
- No DSM-IV Axis I or II diagnosis 





































Note. DSM-IV = Diagnostic and Statistical Manual of Mental Disorders, 4th Edition; OQ-45 = Outcome Questionnaire-45 item version
a n = 2452, b n = 1419
a self-report instrument and has 45 items, 9 of which are reversed, asking how the 
respondent has felt over the last week on a 5 point rating scale, ranging from 0 (never) to 
4 (almost always). The OQ-45 consists of three subscales that assess different domains 
of client functioning: Symptom Distress, Interpersonal Relations and Social Role. The 
Symptom Distress domain consists of 25 items relating to psychological symptoms 
that are common in highly prevalent mental disorders. The Interpersonal Relations 
domain consists of 9 items that assess the functioning of the patient in interpersonal 
relationships, and the Social Role domain assesses the patients functioning in social 
roles, such as work and school. The Dutch OQ-45 has satisfactory psychometric 
properties. The internal consistency for the Total score ranges between 0.92 and 0.96 
in university, community, patients and community and patients combined samples. 
For the subscales the international consistency is 0.90-0.95 for the Symptom Distress 
(SD) scale, 0.74-0.84 for the Interpersonal Relations (IR) subscale and 0.53-0.72 for the 
Social Role (SR) subscale (De Jong, Nugter, Lambert, & Burlingame, 2009).
a b
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Working Alliance Inventory (WAI)
The therapeutic relationship between therapist and patient was assessed using the 
Working Alliance Inventory Client’s Form (WAI; Horvath & Greenberg, 1989). The Dutch 
version of the WAI is called the Werkalliantie Vragenlijst (WAV; Vervaeke & Vertommen, 
1996) and consists of 36 items that are scored on a 5-point rating scale, ranging from 1 
(never) to 5 (always). An example of an item from the WAI is ‘I believe ____ (therapist’s 
name) likes me’. The WAI has three subscales that consist of 12 items each: The Bond, 
Task and Goal subscales. The Bond subscale assesses the therapeutic bond between 
the patient and therapist, the Goal subscale measures the level of agreement in 
therapy goals between patient and therapist, and the Task subscale assesses the level 
of agreement between therapist and patient on who has to do what in the treatment. 
The Dutch version of the WAI had internal consistencies for the Bond, Task and Goal 
subscales of 0.85, 0.88 and 0.88 respectively (Vervaeke & Vertommen, 1993).
Treatment Credibility Questionnaire (TCQ)
The patient’s expectations of the treatment results were measured with a questionnaire 
derived from the Treatment Credibility Questionnaire (TCQ; Borkovec & Nau, 1972). 
Our version was based on the adaptation by Addis et al. (2004), with one additional 
item (“How much improvement in your symptoms do you think will occur”) from the 
new version of the TCQ, the Credibility Expectancy Questionnaire (Devilly & Borkovec, 
2000). The TCQ version that was used in this study consisted of 7 items that are scored 
on a 7-point rating scale, ranging from 1 (not at all) to 7 (extremely).  The TCQ consists 
of two factors, Expectancies and Credibility. The Expectancies subscale consists of 4 
items and assesses patients’ expectations of therapy outcome. The Credibility subscale 
consists of 3 items and measures the degree to which the patient thinks the therapy 
is credible. The version that was used in this study has an internal consistency of 0.89 
for the Expectancies subscale and 0.84 for the Credibility subscale (Hüpscher, 2007).
Patient characteristics
A variety of patient characteristics were extracted from the electronic registration 
systems of the participating mental health care institutions. Patient characteristics 
included demographic variables such as age, gender, education, and clinical variables 
such as DSM-IV diagnosis and prior treatment (see Table 2 for the full list). The 
information that was retrievable differed between the participating institutions. In 
addition, information from intake forms and electronic patient files was used in order 
to complete missing data when possible. 
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Procedure
Patients were informed about the study through a letter, before the intake. Participation 
in the study was on a voluntary basis and patients could object to participate by 
filling out the enclosed rejection form, but were automatically included if they did 
not reject. Patients were asked to report to the reception desk fifteen minutes before 
their treatment session started. The receptionist provided them with an OQ-45. The 
therapist handed out the TCQ and WAI to the patient after session 2. The patient 
could hand in the completed forms the next session at the reception desk. Patients 
were asked to complete the OQ-45 at intake, the first five sessions of treatment and 
subsequently every fifth session of treatment (the tenth, fifteenth, etc.), for a maximum 
period of one year. If patients were still in treatment after one year, the final measure 
was administered at that time; this applied to 445 patients (n = 1494; 30%).
Analysis
Missing Data
In the final sample, only 295 (19%) of the 1540 patients had completely observed 
responses on all the relevant predictor variables. The amount of missing values ranged 
between 0 and 20, with a mean of 5.3 (SD = 3.8). Missing data on the predictor variables 
were handled using Multiple Imputation using Chained Equations (MICE; Van Buuren, 
Brand, Groothuis-Oudshoorn, & Rubin, 2006). In general, multiple imputation works 
as follows: Missing data are estimated multiple times using one or more statistical 
models. The procedure then generates plausible random values for the missing data 
that resemble the observed data as much as possible. By estimating the missing data 
multiple times several complete versions of the incomplete dataset are created, which 
are analyzed by standard statistical procedures. The results of these analyses are then 
pooled into one final analysis. Multiple imputation was carried out using PASW 17.0 
(SPSS, 2009).
The MICE procedure uses linear regression to estimate the missing values on 
continuous variables, using the other variables as predictors, and logistic regression to 
estimate the missing values on categorical variables. Van Buuren, Boshuizen & Knook 
(1999) recommend using a maximum of 25 variables. Thus, a selection of variables 
was used which were necessary for carrying out the statistical analyses of interest. The 
variables that were used in the imputation procedure are given in Table 2. Based on 
recommendations by Graham (Graham, 2009; Graham, Olchowski, & Gilreath, 2007) data 
were imputed 20 times and the results of the 20 imputed databases were combined 
using Rubin’s (1987) rules for multiple imputation. PASW 17.0 (SPSS, 2008) automatically 
combines the results of multiply imputed datasets into one pooled analysis. 
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Definition of negative outcome
The OQ-45 was used to define treatment outcome, based on the score at the end 
of treatment, or, if that score was missing, the last available score for that patient. 
Negative treatment outcome was defined as  a patient scoring in the clinical range (55 
or higher on the OQ-45) at the end of treatment and having experienced no change 
(less than 14 points decrease in score on the OQ-45) or deterioration (more than 14 
points increase in score) according to the criteria for reliable change within the concept 
of clinical significance by Jacobson & Truax (1991). This definition is slightly different 
from that used by others. Usually negative outcomes are defined as deterioration or 
no change, regardless of the level of functioning at the end of treatment. We think 
that people who are functioning in the normal range at the end of treatment should 
not be considered as having experienced a negative outcome, so we excluded this 
group from the negative outcomes group. Based on the definition that we used, 727 
(49%) patients in our sample had negative treatment outcomes, of which 130 patients 
deteriorated and 597 showed no (reliable) change. 
Classification And Regression Trees (CART)
The Classification And Regression Trees (CART) method to acquire a valid model can be 
broken down in a couple of steps. The CART algorithm searches through the predictor 
values for a split point. This way the data are split up in subsets, also called nodes, and 
the homogeneity of the outcome variable in the new subgroups has increased. The 
best split is selected, based on the criterion that there is an optimal division of the 
outcome variable. This partitioning of data is then repeated for the new (sub)sets. In 
other words, we start with the full dataset, which is split up based on an optimal cut 
point value on a particular predictor and then the same procedure is applied to the 
new sets, also called child nodes. Repeating this process many times will lead to a 
situation where the number of subjects in a child node becomes one or they all have 
the same outcome. In case of the latter, the partitioning process can be stopped. It can 
be reasoned that the large model constructed may be poorly generalizable, in other 
words an overfitted model, because it is tailored for a particular dataset. To overcome 
this problem Breiman (1984) proposed a regularization method, which aims to find 
the optimal trade-off between the size of a tree and its predictive power. We start with 
a very large tree, which has overfitted the data. Each branch causes some amount 
of homogeneity gain in their end nodes. But this reduction needs to be viewed in 
relation to the size of the branch, for example a branch early in the tree probable leads 
to a larger reduction than one almost at the end. This ratio, often referred to as the 
cost-complexity ratio, is used to select the branch which benefits the model the least 
and pruned (removed) out of the tree. This pruning procedure is then sequentially 
repeated and the optimal size of the final tree is determined based on cross-validation.
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Table 2 Predictor variables prior to multiple imputation (n = 1540) and correlations with 
change and the last available OQ-45 score (end).
r (change) r (end) % missing In complete 
case analysis
Values
Sex -0.03 0.06 0% Yes See Table 1
Age -0.04 0.04 0% Yes See Table 1


























2% Yes See Table 1
Educational level -0.06 -0.03 36% No
31% Low, 32% middle, 
33% high,  4% other
Having a paid job -0.02 -0.15 32% No 64% Yes
Previous treatment 0.04 0.12 31% No 55% Yes
Using psychiatric 
medication at intake*
-0.03 0.23 34% No 49% Yes
Duration of complaints 0.05 0.01 34% No
52% Longer than 
one year
Diagnosis on Axis I -0.05 0.07 2% Yes 98% Yes
Comorbidity on Axis I 0.01 0.18 2% Yes 34% Yes
Diagnosis on Axis II 0.03 0.10 2% Yes 17% Yes
Comorbidity Axis I and II 0.02 0.12 2% Yes 16% Yes
Problems with primary 
support group 
-0.05 0.11 13% No 46% Yes
Problems related to 
social environment 
0.01 0.06 13% No 18% Yes
Occupational problems  -0.05 0.10 13% No 33% Yes
Legal problems / crime  0.00 -0.09 13% No 1% Yes
GAF score (Axis V) 0.01 -0.22 6% Yes M=59.6, SD=8.6
OQ-45 SD subscale -0.33 0.89 8% Yes M=48.3, SD=15.3
OQ-45 IR subscale -0.22 0.71 8% Yes M=16.1, SD=6.5
OQ-45 SR subscale -0.26 0.64 10% Yes M=13.0, SD=5.2
TCQ Expectancies subscale -0.05 -0.13 47% Yes M=21.2, SD=4.2
TCQ Credibility subscale -0.03 -0.11 47% Yes M=15.1, SD=3.2
WAI Bond subscale -0.03 -0.15 56% Yes M=49.6, SD=6.4
WAI Task subscale -0.02 -0.24 56% Yes M=48.7, SD=6.8
WAI Goal subscale -0.02 -0.23 56% Yes M=48.1, SD=6.7
Note. Correlations between the predictor variables and change and the last available measurement of the OQ-45 (end) are pooled estimates, 
based on the imputed dataset. * Psychiatric medication had already been prescribed by the general practitioner for these patients
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For the building of the initial models based on the CART method, the R package 
Rpart (Therneau & Atkinson, 1997) was chosen, because it closely follows the work and 
propositions of Breiman (1984). To acquire a large tree, which could later on be pruned 
back, the following model parameters were used. The maximum depth possible for 
a tree was 30 layers. The minimum number of cases in a terminal node was set to 10 
cases. The complexity parameter was set to 0.001. The Gini splitting criterion was used 
because it in general is more favorable (Breiman, 1984). The optimal classification 
threshold was set at 0.50, based on ROC curve analyses for the two final models.
Multilevel Analysis
Two multilevel analyses were performed, on the complete case sample and on 
the multiply imputed datasets. Both models were two-level random intercept 
random slope multilevel models, using maximum likelihood estimation and with an 
unstructured covariance structure. The analyses were performed in PASW 17.0 (SPSS, 
2009). Time was set as the logarithm of the session number. A backwards procedure 
was applied, starting with a full model and removing non-significant predictors (based 
on the Wald test for fixed effects) one by one until a parsimonious model was reached 
that was not significantly worse than the full model.  























Inf 0.0095 0.0072 0.0048 0.0036 0.0032 0.0025 0.0017 0.001
1 3 10 11 13 15 16 20 31 59 67 74 88 93 144
size of tree
 Jong de_PROEF (all).ps Front - 38     T1 -    Black
74
Results
Predicting negative outcomes at end of treatment
A classification and regression tree was modelled to predict negative treatment outcomes. 
First, a tree that is too large was constructed. The pruning step followed by using the 
cross-validated error rates for different cost-complexities (see Figure 1). Even though a 
cross validation of 10-fold is a generally accepted as a satisfactory amount, we applied 
250-fold to attain a more stabilized model. Having acquired our estimations, we selected 
the complexity value that was within the 1 SE range of the lowest error rate (three nodes). 
With this parameter set, the tree was pruned upward and the final model was acquired. 
In addition to the three nodes model, a second tree with ten nodes that also fitted the 
cost-complexity criterion and had a similar fit was selected (the second tree under the 
dotted line in Figure 1). The second model should be considered an exploratory model 
and was used to study more complex interactions between predictors. Figure 2 shows 
both models, nested within each other (the three node model in bold). As can be seen in 
Figure 2, the first model shows that patients who have low pre-treatment scores on the 
SD subscale of the OQ-45 have favorable outcomes, as do patients who have a high level 
of education (bachelor degree or higher). Patients with a high score on the SD subscale 
and a low or medium level of education are most at risk for negative treatment outcomes. 
It also shows that patients with low expectations of treatment outcomes – given higher 
initial symptom severity and lower education – have an increased risk for negative 
outcomes. Model 2 further explores the risk factors for negative outcomes. Patients with 
higher expectancies, but with more problems on social role functioning on the other 
hand have more favorable outcomes. From here on the model becomes more complex: 
Given low social role problems, high expectancies, low to medium educational level, a 
medium to high symptom severity, in patients with a initial GAF score below 57 (poor 
overall functioning), but a score on the initial SD subscale between 27 and 78 negative 
outcomes are more likely. Those patients who have an initial GAF above 57 and a good 
working alliance (WAI above 53) are predicted to have favorable outcomes, whereas a 
low working alliance, combined with an initial severity on the SD scale of 27-55 and high 
initial problems on interpersonal relationships are predicted to have negative outcomes. 
That is also true for patients with an initial severity on the SD scale between 44 and 55 
and low initial problems on interpersonal relationships.
Predicting rate of change
Variables predicting the rate of change were investigated by using a two level multilevel 
analysis, with the repeated measures within patients at level 1 and differences 
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Figure 2  Nested CART models for negative treatment outcomes
Note: The two classification trees are nested. The smallest model is in bold, the extended model consists of all the branches that are shown. 
Negative outcomes are dark grey and square, positive outcomes light grey and square with rounded corners.
Full sample
(n = 1490)
Initial SD ≥ 27
(n = 1353)
Education Low/




< 22 (n = 949)





≥ 22 (n = 34)
Initial SD ≥ 56
(n = 100) 
Initial SD ≤ 44
(n = 50) 
WAI Task ≥ 53
(n = 37) 
GAF score ≥ 57
(n = 516) 
Initial SD < 56
(n = 326)
Initial IR < 12
(n = 76) 
WAI Task < 53
(n = 426)
GAF score < 57
(n = 433)
Initial SD ≥ 78
(n = 17)
Expectancies < 17
(n = 85) 
Initial IR ≥ 12
(n = 250)
Initial SD > 44
(n = 26) 
Initial SD < 78
(n = 416) 
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Table 3  The unconditional growth model and final model predicting the rate of change for the 











































WAI Task scale -0.71
(0.13)
  
WAI Goal scale -0.41
(0.12)
0.492 0.92










































Goodness of fit Deviance 20900 49929
AIC 20926 49956
Note: Time is modeled as the 10log of the session number. *p<0.05 *** p<0.001
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between patients at level 2. First, the complete case sample was analyzed, followed 
by the imputed data set. The final models for both analyses are presented in Table 3. 
As can been seen in Table 3, some predictor variables were significant in both models, 
but some differences could be observed as well.  For pre-treatment scores on the SD, 
IR and SR subscales of the OQ-45 higher scores slow down the rate of change. A higher 
GAF score, indicating better functioning, is positively related to the rate of change. The 
working alliance Task scale has a positive relationship with the rate of change in the 
complete case sample, whereas the Goal scale is positively related to the rate of change 
in the imputed data set. The complete case sample emphazises the relationship with 
Axis I disorders, showing a more positive rate of change for patients that have mood 
disorders or adjustment disorders as their main diagnosis. The imputed dataset shows 
a stronger emphasis on the complexity of the presented problems, demonstrating that 
having comorbid Axis I disorders, having had previous treatment for psychological 
complaints and having a personality disorder as main diagnosis slow down the rate 
of change. Since the imputed data set most likely provides the most valid base for 
prediction, further analyses and interpretations were only performed for this model. 
Model performance
To test model performance, the sensitivity, specificity and the positive and negative 
predicted values were computed for both CART models (see Table 4). Model 1 had 
better performance in sensitivity (0.82), which means that most cases with negative 
outcomes are picked up, but had poor specificity (0.39), so many people that would 
be detected by the model as having a high risk of negative outcomes do not actually 





































































Note: CART= Classification and Regression Tree; FB = Failure bound; ML = Multilevel analysis. 
The 95% confidence intervals for the values are reported between brackets.
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have negative outcomes. Model 2 has a better balance between sensitivity (0.68) and 
specificity (0.63), although both values were lower than ideally would be the case.
For the multilevel model based on the multiply imputed data sets, two confidence 
interval based failure bounds were computed in order to determine if deviation from 
the predicted treatment course (based on the multilevel model), would result in a 
higher risk for negative outcomes. If the failure bound was crossed the patient was 
considered to be at risk for negative outcomes (see Figure 3). As can be seen in Table 4, 
both the 68% and 75% failure bound had reasonably good specificity values (0.78 and 
0.82 respectively), meaning that patients who do not cross the interval have a good 
chance of having positive treatment outcomes. However, specificity is poor (0.40 and 
0.34), so patients at risk for negative outcomes are not picked up very well. Since we 
defined negative outcomes as still scoring in the clinical range and either no change 
or deterioration, secondary analyses were performed to test how well the multilevel 
model performs in identifying patients at risk for deterioration. After all, for some 
patients, (reliable) change may not be feasible. The multilevel model does predict 
deterioration well. The 68% failure bound has somewhat better sensitivity (0.89) 
but the 75% failure band had better specificity (0.80) while maintaining satisfying 
sensitivity (0.85).
Discussion
In this article, we aimed to predict risk factors for negative treatment outcomes at 
the end of treatment using CART and for rate of change using multilevel modeling 
(combined with multiple imputation). Fifty-one per cent of the patients in our 
Figure 3  Example of the multilevel model for an individual patient
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sample improved and had scores on the OQ-45 outside the clinical range at the end 
of treatment. In the CART analyses we found that patients with relatively low pre-
treatment scores for symptom distress, and patients with high education and positive 
expectancies have a better chance of favorable outcomes. The extended model 
showed the complexity of the relation between predictors and outcome and showed 
how pre-treatment expectancies, social role problems and GAF scores and the working 
alliance at the beginning of treatment (Task subscale) interacted in different ways to 
predict negative outcomes at the end of treatment. The multilevel analyses showed 
that initial severity, the working alliance (Task or Goal subscale) and GAF score were 
significant predictors for the rate of change in patients. In the complete case sample, 
having a mood or adjustment disorder as main diagnosis had a positive relationship 
with the rate of change, whereas in the imputed sample previous treatment, having 
comorbid Axis I disorders and having a personality disorder as main diagnosis had 
a negative relationship with the rate of change. The model based on the multiply 
imputed data was considered the most reliable model, and further analyses were 
computed only for this model. The CART models and multilevel models differed in their 
sensitivity to detect negative outcomes. The first CART model had high sensitivity, but 
low specificity, whereas the multilevel model had high specificity and low sensitivity. 
The multilevel model was good at picking up deterioration, but not at identifying 
the no change group. The extended CART model had the best balance between 
sensitivity and specificity. Although sensitivity and specificity values were not as high 
as we are used to for instance in diagnostic tests (e.g. Gilbody, Richards, Brealey, & 
Hewitt, 2007), in predicting outcomes, those values are quite good, considering 
that there are many variables that influence the course and outcome of therapy and 
that most of the predictors in our study were measured pre-treatment. Our results 
match earlier multilevel prediction models (Lutz et al., 1999; 2001), in which the GAF 
score, expectancies and initial severity were found to be significant predictors, except 
we found some additional predictors to be significant and did not find an effect of 
expectancies in the multilevel analyses.
The factors that influence outcome and rate of change are in part overlapping, 
but not exactly the same. Expectancies and educational level were relatively strong 
predictors in the CART models, but not significant for predicting outcome. Having had 
prior treatment and having a personality disorder as main diagnosis was predictive for 
the rate of change, but not for outcome. Although they are highly related – people that 
progress fast, usually have a better chance of favorable outcomes – there are differences 
too. For instance, patients who have low initial severity (in the non-clinical range) in 
terms of symptom distress, usually have a low rate of change, but a better chance of 
positive outcome according to our definition. And patients who start with high initial 
severity and have an average progress may still have poor outcomes. We have defined 
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negative outcomes as being in the clinical range at the end of treatment and having 
experienced no (reliable) change or deterioration. This is a slightly different definition 
than that used by others (e.g. Lutz et al., 2006), that combined deterioration and no 
change as negative outcomes, including patients who functioned in the normal range 
at the end of treatment. We chose to define people who were functioning in the normal 
range as positive outcomes; since functioning for this group is comparable to people 
that do not have psychiatric complaints. As a result, our results differed as well. Lutz et 
al. (2006) found their model to be more sensitive than ours, but less specific, probably 
because they had a more homogeneous sample, resulting in smaller confidence 
intervals. The definition of negative outcome also influences the CART models, in the 
sense that patients who function in the normal range at the beginning of treatment 
usually still do so at the end of treatment. So it is no real surprise that patients with 
low initial severity are in the first branch of the regression tree. Patients who start just 
above the cut-off score for normal functioning (55) and end up just below it, and who 
have in fact not changed a lot, are also considered a treatment success according to 
our definition. However, every definition of negative outcomes has its drawbacks, 
including the Jacobson & Truax (1991) criteria, which are considered very conservative 
(Jacobson, Follette, & Revenstorf, 1984). Slight variations in the definition of negative 
outcomes could lead to different results in the prediction models. Sensitivity analysis 
could provide more insight in the extent to which these variations have impact on the 
results. It should be noted that the term negative outcomes has the connotation that 
patients could do better, but for some patients no change may be the best obtainable 
result. The no change group is a complicated group to start with, as it probably consists 
of several subgroups, including patients who have a more chronic course and are not 
expected to change, patients who have somewhat improved, but not enough to meet 
the criteria for reliable change of Jacobson & Truax (1991) and patients who come to 
therapy for other reasons than symptom reduction (e.g. insight or life phase problems) 
(Watson, 2011). This may be the reason that the multilevel model performed better in 
predicting deterioration than deterioration and no change combined.
In clinical practice, a combination of the CART models and multilevel model could be 
used to identify patients at risk for negative outcomes and to develop measures to 
prevent them. For instance, patients who are having high symptom distress and low or 
medium education may be monitored more closely during treatment, as they have an 
increased risk of having negative outcomes. The multilevel model can then be used to 
predict change. We can distinguish four groups: (1) patients who are at risk for negative 
outcomes and have an expected change treatment course that shows no change or 
deterioration; (2) patients who are at risk, but have an expected positive treatment 
course; (3) patients who are predicted to have positive outcomes, but have a negative 
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or no change expected treatment course and (4) patients who have predicted positive 
outcomes and also a positive expected treatment course. The first group probably has 
the highest risk of having actual negative outcomes. As these patients are expected to 
have a negative treatment course, the patient may not cross the failure boundary, but 
still have a negative treatment result. In these cases, the multilevel model might not 
be very effective in preventing the negative outcomes from happening, but intensive 
monitoring is still advisable. Other treatment options, such as seeing patients more 
frequently, or combining individual therapy and group therapy should be considered 
as well. The extended CART model could be used to identify subgroups of patients 
with better chances of favorable outcomes within this high risk group, and factors that 
also influence the rate of change, such as expectancies and the agreement on what 
needs to be done in therapy (Task) should be actively addressed by the therapist. For 
the second group, that is at risk for negative outcomes but with a favorable predicted 
treatment course, the multilevel model could be combined with intensive monitoring 
to assure that patients who go off track (and thus have a fair risk of deterioration) are 
identified early on in treatment. The third group, with positive predicted outcomes, 
but a non-positive expected treatment course probably includes patients who start 
with low symptom severity and are not expected to improve much. Another options 
is that they have favorable characteristics (e.g. low symptom severity, high education), 
combined with negative expectancies and a low (early) working alliance. Again, the 
extended CART model could provide more insight in which patients are more likely 
to have negative outcomes within this group. The fourth group probably has the 
best chances of favorable outcomes. In this group, the frequency of measurements 
could be decreased. We know from studies by Lambert that 30-50% of patients go 
off the expected track during treatment (e.g. Harmon et al., 2007; Hawkins, Lambert, 
Vermeersch, Slade, & Tuttle, 2004). His feedback system greatly improves outcomes 
for those off track patients (Lambert, 2007; Shimokawa, Lambert, & Smart, 2010), but 
has the consequence that patient progress has to be monitored for all patients on a 
session by session basis, which is a big investment of time and money. If we identify 
at risk patients prior to treatment, we could focus on monitoring those patients who 
are at risk more intensely and relax the measurement frequency for patients who have 
a low risk of negative outcomes and thereby improve the cost-effectiveness of the 
tracking system. 
Using state of the art statistical techniques in analyzing our data enabled us to use 
all available data, and provided us with enough power to detect relevant predictor 
variables. The complete case sample shows that had we not used multiple imputation, 
results would have been different, as we would have been forced to drop some of 
the predictor variables, including several of the ones we were interested in (e.g. 
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educational level, previous treatment and duration of complaints), and drop cases 
without complete values on the left-over predictor variables. Interesting as these 
methods are, like all other methods, they have their limitations as well. For instance, 
one of the criticisms on CART is that is not a hypothesis driven technique and therefore 
strongly depends on the data. Another issue is that the models usually are not very 
stable. That is why the models need to be cross-validated. The imputation mechanism 
of using surrogate splits in CART is more limited than multiple imputation, as it uses a 
binary value as a surrogate for the missing value (higher or lower than split value X on 
predictor Y), whereas multiple imputation provides a plausible value for the missing 
value. A major drawback is that CART cannot be performed on a multiply imputed 
dataset, as it would create a different tree for each imputed dataset and results could 
not be pooled. As a result, when outcome variables are missing, only single imputation 
or the last observation carried forward method can be used, both of which are not 
ideal. It should be noted that all methods that deal with missing data can only fix the 
problem to the extent that the data are Missing At Random (MAR), in other words: 
There should not be selective missingness that depends on unobserved variables. 
Although the methods applied here perform much better in Missing Not at Random 
(MNAR) situations than most other methods (e.g. Graham, 2009), results are still likely 
to be somewhat biased. Like in most naturalistic datasets, it is probable that at least 
part of our data was MNAR. 
The main objective of this study was to develop a good prediction model that 
is useful in clinical practice and could be used to help prevent negative treatment 
outcomes. In our aim to improve outcomes for this group, an important consideration 
is how much outcome is to be expected. Some of the patients may simply never achieve 
positive outcomes. However, comparing results from randomized trials and clinical 
practice (Barkham, et al., 2008; Hansen, et al., 2002) suggest that in clinical practice 
there is still room for improvement, even though patients who participate in clinical 
trials may not be entirely representative of patients who are seen in everyday practice. 
Using prediction models in clinical practice has mainly been successful in reducing 
deterioration rates, but less effective in improving the outcomes for the no change 
group. As a field, we need to continue looking for better prediction models to help 
improve outcomes for this group as well and combining models that aim to predict 
outcomes as well as rate of change. Searching for interactions between predictive 
factors might be helpful in building more complex predictive models. Fortunately, 
statistical developments are progressing fast to help us to develop more complex 
prediction models suitable for analysing data from naturalistic settings. 
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bstract
Providing outcome monitoring feedback to therapists seems to 
be a promising approach to improve outcomes in clinical practice. 
This study aims to examine the effect of feedback and investigate 
whether it is moderated by therapist characteristics. Patients (n = 
413) were randomly assigned to either a feedback or a no feedback 
control condition. There was no significant effect of feedback in 
the full sample, but feedback was effective for not on track cases 
for therapists that used the feedback. Internal feedback propensity, 
self-efficacy, and commitment to use the feedback moderated the 
effects of feedback. The results demonstrate that feedback is not 
effective under all circumstances and therapist factors are important 
when implementing feedback into clinical practice. 
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Introduction
A large body of research, performed over 40 years, has demonstrated that psychotherapy 
can effectively improve functioning in patients (Lambert & Ogles, 2004). In randomized 
controlled clinical trials (RCTs) an average of 67% of patients is statistically reliably 
improved at the end of treatment (Hansen, Lambert, & Forman, 2002). In clinical 
practice, the success rates are much lower: only 35% of the patients were improved and 
the effect sizes of improvement were less than half the effect sizes of RCTs (Barkham, 
et al., 2008; Hansen & Lambert, 2003; Weisz, Donenberg, Han, & Weiss, 1995). These 
differences in outcomes may in part be due to selection criteria used in RCTs. However, 
Blais et al. (2011) found that in clinical practice the improvement rate is 57% when 
patients are selected that would qualify for inclusion in RCTs, which is still lower than 
rates found in RCTs.
Bickman (2008) considers feedback interventions a promising approach to improve 
clinical practice. Kluger and DeNisi (1996) define feedback interventions as actions 
taken by external agents to provide information regarding some aspect of one’s 
task performance.” In psychotherapy research, a common example is the monitoring 
of patients’ progress during treatment and providing feedback to therapists on that 
progress. According to Bickman, clinicians need to have more systematic and reliable 
information about the status of their patients, in order to adjust their treatment if 
necessary, thus improving outcomes. In a recent review article, Carlier et al. (2010) 
concluded that feedback appears to have a positive impact on diagnosis and 
communication between patient and therapist, but effects on outcome were less clear. 
Meta-analyses show effects of feedback on outcome in the range of very small to very 
large (Knaup, Koesters, Schoefer, Becker, & Puschner, 2009; Sapyta, 2004 in Sapyta, 
Riemer, & Bickman, 2005; Shimokawa, Lambert, & Smart, 2010). Feedback appears to be 
most effective for patients that are not progressing well in therapy, the so-called not on 
track (NOT) cases (Lambert, et al., 2003; Sapyta, 2004 in Sapyta, et al., 2005). Carlier et al. 
found that feedback did not have a positive effect in 16 of the 45 (36%) mental health 
trials they included in their sample and Knaup et al. showed that feedback even had a 
negative effect in three of the twelve studies they included in their analyses. 
The largest effects of feedback in mental health care have been found by the 
research group of Michael Lambert. They have performed five controlled studies in 
which therapists received feedback about a patient’s improvement through the use of 
progress charts and warning signals about NOT cases. Results showed that NOT patients 
in the feedback condition had significantly more improvement than in the no-feedback 
control condition. The effect sizes of the various feedback conditions compared to the 
control conditions ranged from 0.16 to 0.70 in the full sample (Shimokawa, et al., 2010). 
Feedback did not have a significant effect in the on track (OT) cases (Lambert, 2007). 
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The feedback that the Lambert group provides to therapists is very specific. A 
patient’s change is compared to an expected treatment course based on a statistical 
model and the therapist gets a warning signal when the patient deviates too much 
from the expected course. Most outcome monitoring systems are not as advanced. 
Worldwide, there are many large initiatives (e.g. Burgess, Pirkis, & Coombs, 2006; 
Evans, et al., 2002; Howard, Moras, Brill, Martinovich, & Lutz, 1996; Kraus, Seligman, & 
Jordan, 2005; Miller, Duncan, Sorrell, & Brown, 2005; Wing, et al., 1998). Some systems 
have developed expected treatment recovery curves, but most do not include them 
in feedback on the individual patient. The existing systems vary greatly in frequency 
of assessment, content of the feedback and the way in which feedback is provided 
(Trauer, 2010). Often, feedback is not provided on a session-by-session basis, but at 
treatment evaluations, for instance every three months. Most feedback systems do not 
have signals for patients that are not progressing well in therapy. It is often assumed 
that all types of feedback will be effective in improving outcomes, but in fact, not much 
controlled research has been done on the subject (Marshall, Haywood, & Fitzpatrick, 
2006). 
Although it seems that feedback has potential to enhance outcomes in clinical practice, 
there are still many unanswered questions about how feedback works. In order to explain 
why outcome monitoring feedback leads to improvement in some cases and not in 
others, more insight is needed in the underlying processes of feedback. Characteristics 
of the therapists and the way in which they use feedback may play a central role in the 
effectiveness of feedback. After all, if therapists do not use feedback constructively, it is 
unlikely that it will improve outcomes. There is not much empirical knowledge on the 
effects that recipient characteristics have on the effectiveness of feedback (Kluger & DeNisi, 
1996). 
Riemer and Bickman (2011) propose the contextualized feedback intervention theory 
(CFIT) to explain how feedback is interpreted and used in clinical practice. CFIT focuses on 
the way that feedback gets attention and is accepted by therapists. When a person receives 
feedback a comparison is made between the content of the feedback and a goal. So if a 
therapist receives progress feedback, a comparison is made between the goal (recovery) 
and the feedback (current health status and progress so far). This comparison creates a 
positive or negative evaluation of the therapist’s performance relative to the goal. When a 
discrepancy is noted, people are motivated to reduce it (Kluger and DeNisi, 1996).
This implies that behaviour change as a result of feedback will only occur if therapists 
attend the feedback and accept the feedback as valid (Riemer & Bickman, 2011). Feedback 
is more likely to be accepted if it comes from a source that has credibility and has 
personal relevance to the receiver (Claiborn & Goodyear, 2005). This concept is referred 
to as perceived validity. Another factor that seems important in acceptance is feedback 
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orientation (Herold & Fedor, 2003; Herold, Parsons, & Rensvold, 1996). External feedback 
propensity reflects the preference for externally mediated feedback as well as greater 
faith in such information than in what one can self-generate, whereas internal feedback 
propensity reflects preference for internally generated feedback as well as the tendency to 
reconcile differences between internal and external feedback in the direction of internally 
generated information. An external feedback propensity is associated with more feedback 
seeking behavior and better performance on novel tasks (Herold & Fedor, 2003).
Self-efficacy is another recipient characteristic that influences the feedback process. It 
refers to a person’s beliefs concerning his or her ability to successfully perform a given task 
or behavior (Bandura, 1977). In case of negative feedback, people with high self-efficacy are 
motivated to increase their effort to reach the goal, whereas people with low self-efficacy 
tend to lower the goal (Kluger and DeNisi, 1996). People who have high self-efficacy also 
tend to consider negative feedback as more desirable than positive feedback (Claiborn 
and Goodyear, 2005).
Therapists’ commitment to use the feedback in therapy might also be an important 
factor. Australian research showed that 44% of therapists thought outcome monitoring 
was a waste of time (Aoun, Pennebaker, & Janca, 2002) and two-thirds of the therapists were 
not willing to use the monitoring feedback, even if it would lead to demonstrably better 
outcomes (Walter, Cleary, & Rey, 1998). Riemer and Bickman (2011) state that therapists 
will be more committed to use the feedback if they link it to higher-level personal goals, 
such as being a good therapist. An a priori commitment to use feedback is expected to be 
highly related to actual use of the feedback.
In summary, outcome monitoring has potential to improve outcomes, especially feedback 
with expected recovery curves and alarms for ‘not on track’ cases tending to result in 
positive effects. Most outcome monitoring systems used in clinical practice do not have 
these features and not much is known about the effectiveness of these systems. The 
effectiveness of feedback may also be related to therapist characteristics. If therapists 
do not accept the feedback and are not inclined to use it, feedback is not likely to be 
effective. In this study, we aim to research the efficacy of ‘simple’ (no warning signals or 
expected recovery curves) feedback in clinical practice compared to no feedback. Patients 
will be randomly assigned to a no-feedback control group or the feedback condition. We 
expect that patients in the feedback condition will have faster progress, compared to 
the no feedback control group. Although no alarms are used, therapists may be able to 
identify NOT cases themselves. Therefore, NOT patients will be identified post-hoc, based 
on reliable deterioration during the course of treatment, and it is expected that feedback 
will be most effective for this group. A secondary aim is to investigate whether therapist 
characteristics moderate the effect of feedback. 




During the inclusion period 1090 outpatients were screened for participation in the 
study in the three participating treatment departments. The treatment departments 
were part of two medium sized mental health care institutions in the Netherlands 
and typically treated a wide range of psychiatric disorders, including mood, anxiety, 
adjustment and personality disorders with an outpatient population. Exclusion criteria 
were: psychotic disorder, mental retardation, a current crisis at the time of referral, 
non-verbal treatment (e.g., internet therapy, pharmacological therapy, art therapy), 
group therapy as main treatment, re-referral within the same treatment centre within 
Figure 1  Flowchart of participants





Control group  
(n = 275)
Feedback group  
(n = 269)
Analyzed (n = 207)
< 3 session of therapy (n = 30)
< 33% completed OQ -45  
administrations (n = 17)
Stopped completing OQ-45 before 
session 3 (n = 17)
Baseline OQ-45 missing (n = 4)
Analyzed (n = 206)
< 3 session of therapy (n = 24)
< 33% completed OQ -45 
administrations (n = 21)
Stopped completing OQ-45 before 
session 3 (n = 13)
Baseline OQ-45 missing (n = 5)
Excluded (total n = 505)
Psychotic disorder, mental retardation 
or current crisis at intake (n = 79)
Non verbal therapy or group therapy (n = 234)
Insucient understanding of Dutch (n = 22)
Patient unable to participate for other 
reasons (n = 11)
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six months, and an insufficient level of understanding of Dutch. Of the remaining 703 
patients, 159 declined to participate in the study. 
In total, 544 patients were randomly assigned to the feedback group or control 
group. The first progress feedback was provided immediately before session 3; 
therefore, patients who had less than three sessions of therapy or stopped completing 
questionnaires before session 3 were excluded from analysis. Patients that had missing 
baseline measurements or completed less than a third of the measurements were 
also excluded from analysis. The flow of participants through the study is presented 
Table 1  Characteristics of the patients in the feedback and control group
Sample entered study (n = 544) Sample in analysis (n = 413)
Not in analysis In analysis Control Feedback
n % n % n % n %
Sex
- Female 131   75 (57%) 413 252 (61%) 207   124 (60%) 206 128 (62%)
Age 131 M = 37.0
SD = 12.3
413 M = 36.8
SD = 11.9
207 M = 36.9
SD = 11.8
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- Yes 127 75 (59%) 410 237 (58%) 206 124 (60%) 204 113 (55%)
Note
*  p < .05
*
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in Figure 1. The 413 patients that were included in the analysis included 252 females 
(62%), aged 18-64 years (M = 36.8; SD = 11.9). Patient characteristics are reported in 
Table 1.
Therapists
There were 57 therapists who participated in this study, 21 males (37%) and 36 females 
(63%), aged from 26 to 60 years with a mean age of 45.3 years (SD = 9.7). Therapists 
were psychologists (49%), psychiatric nurses (39%), social workers (7%) or other 
mental health care professionals (5%). The therapists had 0 to 35 years of experience 
after getting licensed, with a Mean of 13.8 years (SD = 11.3). Therapists had between 
1 and 23 clients in the study (M = 7.3; SD = 5.6). Therapies provided included cognitive 
behavioral therapy, interpersonal therapy, brief solution focused therapy and 
counseling. Most therapies were integrative and did not represent a single therapy 
orientation.
Instruments and manipulation
Outcome Questionnaire-45 item version (OQ-45)
The Outcome Questionnaire-45 (OQ-45) was used to measure patient progress during 
treatment. The OQ-45 (Lambert, et al., 2004) is a self-report instrument and has 45 
items, 9 of which are reversed, asking how the respondent has felt over the last week on 
a 5 point rating scale, ranging from 0 (never) to 4 (almost always). The OQ-45 consists 
of three subscales: Symptom Distress, Interpersonal Relations, and Social Role. The 
Symptom Distress domain consists of 25 items relating to psychological symptoms that 
are common in highly prevalent mental disorders. The Interpersonal Relations domain 
consists of 9 items that assess functioning in interpersonal relationships, and the Social 
Role domain consists of 11 items that assess functioning in social roles, such as work 
and school. The cutoff score for normal functioning is 55 for the Dutch OQ-45 and the 
reliable change index is 14. The internal consistency for the Dutch version of the OQ-
45 is between 0.92 and 0.96 for the Total Score in university, community, patients and 
community and patients combined samples. For the subscales, the internal consistency 
is 0.90-0.95 for the Symptom Distress scale, 0.74-0.84 for the Interpersonal Relations 
subscale and 0.53-0.72 for the Social Role subscale (De Jong, Nugter, Lambert, & 
Burlingame, 2009). 
Demographic questionnaire
The demographic questionnaire is a 19-item self-constructed questionnaire that 
assesses the demographic characteristics of the patient. It asks for the patient’s date 
 Jong de_PROEF (all).ps Back - 48     T1 -    Black
95
5
Therapist effects in outcome monitoring feedback
of birth, gender, postal area code, nationality, country of birth, country of birth of the 
patient’s parents, marital status, living and working situation, educational level, prior 
treatment, pretreatment use of medication, the main complaint, and the duration of 
the main complaint.
Feedback User Questionnaire
This questionnaire consisted of the Internal and External Feedback Propensity Scales 
and an adaptation of the CFIT User Survey. 
The Internal and External Feedback Propensity Scales (IEFPS; Herold, et al., 1996) 
are used to measure feedback propensity. The instrument consists of two subscales 
that measure internal and external feedback propensity. Each subscale consists of six 
items that are answered on a five-point rating scale that varies from strongly disagree 
to strongly agree. An item from the External Feedback Propensity Scale is ‘It is very 
important to me to know what people think of my work.’ A sample item from the Internal 
Feedback Propensity Scale is ‘How other people view my work is not as important as 
how I view my own work.’  The reliability of the IEFPS was 0.71 for the external feedback 
propensity scale and 0.73 for the internal feedback propensity scale (Herold, Parsons, & 
Fedor, 1997). In our sample, the internal feedback propensity scale had a Cronbach’s α 
of 0.71 and the external feedback propensity scale had an α of 0.62. 
An adaptation of the CFIT User Survey, designed by the Center for Evaluation and 
Program Improvement of Vanderbilt University, was used to measure commitment to 
use the feedback, self-efficacy and perceived validity of the feedback. The items are 
scored on various five-point rating scales. The commitment to use the feedback was 
measured with a scale based on the Goal Commitment Scale (Hollenbeck & Klein, 1987) 
that consists of seven items. A sample item is ‘It is hard to take the idea of using these 
measures in my clinical practice seriously.’  The self-efficacy scale consists of eight items. 
A sample item from that scale is ‘To what extent do you feel confident in your ability 
to know what to do if a client is not progressing in treatment.’  Perceived validity of 
the feedback was measured by a six-item scale. A sample item is: ‘I think that feedback 
based on the OQ-45 will be helpful for my counseling.’  The internal consistency in the 
current sample was 0.90 for the commitment scale, 0.88 for the perceived validity scale, 
and 0.82 for the self-efficacy scale.
Use of feedback
In the original study design the use of feedback was asked per patient, but due to 
problems in the software, this questionnaire was not administered. Therefore, the use 
of feedback by the therapist was assessed post hoc by asking by e-mail if the therapists 
had used the feedback with their patients (yes/no) and in what way (open question). 
Therapists that had used the feedback usually did so in multiple ways, including 
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discussing the feedback with patients, giving homework assignments, and using the 
feedback to end the therapy when sufficient progress was made.
Feedback intervention 
In the feedback condition, the therapist received e-mails that contain a progress report 
after sessions 1, 3, 5, and subsequently every fifth session. The patient’s progress on the 
OQ-45 Total Score was shown in a graph. A table showed the patient’s baseline score, 
the last available measurement, the change in scores on the OQ-45, and the clinical and 
reliable change status (see Appendix B). Patients were classified as deteriorated if their 
OQ-45 score increased 14 points or more compared to baseline on the OQ-45 Total Score 
and classified as reliably improved if their Total Score had decreased 14 points or more. If 
patients improved reliably and crossed the cut-off point for normal functioning (55), they 
were classified as clinically significantly changed. Patients that did not meet these criteria 
were considered unchanged. Positive changes were shown in green, negative changes 
in red. A second graph and table displayed the subscale scores. The critical items on the 
OQ-45 that alert the therapist to suicidal thoughts, aggression and drugs and alcohol 
use, were presented if patients answered them with a score of 1 (seldom) or higher. Prior 
to the study, all therapists were given training on how to interpret the feedback, but 
were given no specific guidelines to identify ‘not on track’ patients, consistent with the 
concept of simple feedback. They also received an instruction card that explained all 
elements of the feedback report.
Procedure
Patients were screened for eligibility after intake and contacted by phone if they did not 
meet the exclusion criteria. If patients agreed to participate in the study, they signed 
an informed consent form and received explanation using the on-site test computer. 
Patients completed the OQ-45 on the computer prior to each of the first five sessions of 
therapy, and subsequently every fifth session for a maximum period of one year. At the 
first session, patients also completed the demographic questionnaire. If patients were 
assigned to therapies that were excluded from the study, data collection was stopped 
and measurements up until that point were used in analysis. Therapists completed 
the Feedback Questionnaire prior to the study. The use of feedback questionnaire was 
e-mailed to the therapists after completion of the study.
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Analysis
Missing data
Missing data on the therapist level were imputed using the Multiple Imputation 
procedure in PASW Statistics 18.0 (SPSS, 2009). The multiple imputation procedure is 
based on the Multiple Imputation by Chained Equations (MICE; van Buuren, Brand, 
Groothuis-Oudshoorn, & Rubin, 2006) algorithm. Since multiple imputation is not 
supported for three-level models yet, single imputation of the missing values was 
selected by setting the imputation number as one. Only missing values on the therapist 
variables were imputed. Table 2 reports the percentage of missing data and the mean 
score and standard deviation in the original data.
Definition of not on track
Patients that were NOT were identified post hoc. Patients were considered NOT if they 
deteriorated, defined by an increase in the Total Score at least as large as the reliable 
change index (14 points) compared to the baseline measurement at any point in their 
treatment. This criterion was chosen since it was mentioned in the feedback report 
if the patient deteriorated. A total of 67 patients (16%) were NOT according to this 
definition.
Main hypotheses
Baseline differences in demographic and clinical characteristics between the 
treatment conditions were tested with chi-square tests and independent sample 
t-tests using PASW Statistics 18 (SPSS, 2009). The main hypotheses were tested by two 
three-level multilevel models, using the PROC MIXED procedure in SAS (SAS Institute 
Inc, SAS 9.2. Cary, NC, USA, 2008). As time variable the 10log of the session number 
was used to allow for a linear model (also see Lutz, Martinovich, & Howard, 1999). 
Maximum likelihood estimation was used to estimate the model parameters, using 
an unstructured variance structure. A random intercept, random slope model (on 
both patient and therapist level) was used to test the main hypothesis on the effect 
Table 2  Therapist variables (n = 57)
% missing Mean SD
Self-efficacy therapist role 21% 27.2 2.6
Internal feedback propensity 23% 19.6 3.4
External feedback propensity 23% 19.7 2.4
Perceived validity 18% 21.2 3.4
Commitment to use feedback 16% 23.9 3.9
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of feedback. First, an unconditional growth model was postulated, and then the main 
effect of feedback was added to the model, followed by the interaction with being 
NOT and use of feedback by the therapist. Redundant factors were eliminated from 
the model, in order to obtain a parsimonious model. To test for therapist effects, a 
model with a fixed slope on level two and a random slope at level 3 was used (with 
random intercepts). A backwards procedure was applied, starting with a full model 
including all relevant level 2 and 3 predictor variables and their interactions and 
eliminating non-significant factors (using the Wald test for fixed effects) one by one 
until a parsimonious model was reached, that was not significantly worse than the full 
model (compared with the deviance test).
To predict which therapist characteristics would predict use of feedback, a logistic 
regression analysis was performed in PASW statistics (SPSS, 2009), using a backwards 
procedure.
Results
Baseline differences between groups 
Baseline differences on gender, age, marital status, education, DSM-IV disorder, OQ-
45 intake score and prior treatment between the patients that were included and 
excluded in analysis were tested. The groups did not differ on most variables (see Table 
1), except for educational level.  Patients that were excluded from analysis were more 
likely to have a low education than patients that were included, χ2 (6) = 11.4, p = .039. 
For patients that were in analysis, baseline differences between the control group and 
feedback group were tested. The two groups only differed on marital status: patients 
in the control group were more likely to be widowed and less likely to be divorced than 
the feedback group, χ2 (2) = 7.2, p = .027.
Effect of feedback 
There was no significant effect of feedback on the rate of change (see Model A, Table 
3). The interaction between feedback and being NOT was also not significant. Adding 
the interaction with use of the feedback to the model revealed that for therapists that 
used the feedback (46%, representing 57% of the patients), there was a significant 
positive effect of feedback in NOT cases (see Model B, Table 3), although the effect was 
not large enough to counterbalance the negative change trajectory that NOT patients 
typically have.
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Table 3  3-level models on the effect of feedback and moderating therapists factors
Parameter
Model A Model B Model C
Estimate (SE) Estimate (SE) Estimate (SE)
Fixed effects
























Use * Feedback * NOT -10.77
(5.15)
Internal feedback propensity 0.58
(0.27)




Commitment * Feedback 1.33
(0.34)
Variance components
Level 1 Within-person 92.44 92.50 112.91
Level 2 Intercept 440.74 440.16 417.69
Slope 175.78 172.67
Covariance -56.27 -56.87
Level 3 Intercept 0.16 0.11 2.87
Slope 5.02 5.47 21.51
Covariance -6.46 -6.48 -16.19
Note: Time is modeled as the 10log of the session number. *p<0.05, **p<0.01, *** p<0.001
NOT = Not On Track
Negative values in the fixed part of the models correspond with a faster decrease of dysfunctioning over time. 
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Therapist characteristics 
The effects of therapist characteristics on the rate of change are presented in Model 
C, Table 3. The correlation between the therapist characteristics was below r = 0.45 
for all pairs, except for perceived validity and commitment to use feedback (r = 0.70). 
Having an internal feedback propensity had a negative effect on the rate of change, 
regardless of whether the therapist received feedback. A higher commitment to 
use the feedback had a general positive effect on the rate of change, but there was 
also a significant interaction between commitment and feedback in a negative 
direction, indicating that when therapists actually received feedback, having a higher 
commitment was predictive of a slower rate of change in their patients. Finally, there 
was a positive effect of self-efficacy in the feedback condition. Patients of therapists 
with higher self-efficacy expectations who received feedback had a higher rate of 
change than patients of therapists with lower self-efficacy expectations that did not 
receive feedback. Against our expectations, there was no significant effect of external 
feedback propensity and perceived validity.
Predicting use of feedback
Since use of feedback by the therapist significantly interacted with the effect of 
feedback in NOT cases, we were interested in which variables predicted use of the 
feedback by the therapists. Table 4 shows that a higher commitment to use the 
feedback increased the odds that therapists would use the feedback. Being a woman 
also increased the odds of using the feedback: female therapists were four times more 
likely to use the feedback than male therapists. No significant effects were found for 
the type of therapist, years of experience of the therapist, self-efficacy, internal and 
external feedback propensity, and perceived validity.
Table 4  Logistic regression analysis predicting use of feedback
95% confidence interval
B SE Odds ratio Lower bound Upper bound
Constant -5.23 2.21 0.01
Commitment to use feedback    0.25 0.10 1.28 1.06 1.54
Female  -6.61 2.48 4.01 1.10 14.45
Note: R2 = .18 (Cox & Snell), .23 (Nagelkerke). Model χ2 (2) = 10.78, p = .005. * p<.05, **p<.01
*
**
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Discussion
This study aimed to assess the effect of monitoring outcomes and providing feedback 
to therapists on the rate of change in patients. Contrary to our expectations, for the 
full sample no beneficial effect of feedback was found and there was no significant 
interaction between feedback and patients being NOT. However, in NOT cases a 
positive significant effect was found when therapists indicated that they used the 
feedback. Therapist variables moderated the effectiveness of feedback. Therapists with 
a high internal feedback propensity, who are more likely to trust their own opinion 
than feedback from external sources, had patients with a slower rate of change than 
therapist with a low internal feedback propensity, whereas therapists who were 
more committed to use the feedback at the beginning of the study had patients who 
progressed faster. These two results suggest that therapists with an open attitude 
towards getting feedback reach faster progress with their patients. Strangely though, 
when therapists with a high commitment to use the feedback actually received 
feedback, this slowed down the rate of change in their patients. There also was a 
positive effect of self-efficacy. Patients in the feedback condition whose therapist had 
higher self-efficacy progressed quicker in therapy than patients whose therapist had 
lower self-efficacy or patients whose therapist did not receive feedback. No effect was 
found for external feedback propensity and perceived validity. Therapists were more 
likely to use the feedback if they were more committed to use the feedback at the start 
of the study and if they were female.
Our results demonstrate that feedback may not be effective under all circumstances 
for all therapists. This is in line with a recent study by Lambert’s group, in which they 
used complex feedback in a hospital-based outpatient clinic and found much lower 
effects of feedback than in previous studies. Further analysis showed that feedback 
was only effective for half of the therapists (Simon, Harris, & Lambert, 2011). The 
therapists that were participating in that study had very heavy caseloads and seemed 
demoralized by organizational changes. Riemer and Bickman (2011) stress that 
organizational factors, such as a high administrative workload, can become barriers 
for therapists to use feedback. In a recent survey that included many of the therapists 
participating in the current study, therapists indicated lack of time and other tasks 
that were competing for their attention as important barriers to use the feedback (De 
Jong, in press). Londen, Smither and Adsit (1997, in Riemer & Bickman, 2011) state that 
if there is no accountability for using feedback, it will have little impact. Accountability 
should be handled with care though, as it can also provoke defensive reactions in 
therapists (Riemer & Bickman, 2011). Although the managers of the participating 
departments were actively involved in the study, it was still complicated to hold 
therapists accountable for using the feedback within the context of a research project. 
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Managers were not allowed to view therapists’ progress curves, in order to prevent 
defensive reactions.
Some of the choices we made in designing the study could have influenced 
results. The chosen frequency of measurements and feedback reports was not on a 
session-by-session basis, as Lambert does, which may reduce the chance to signal a 
patient being not on track and as a result might reduce the effect of the feedback. We 
encountered a relatively low rate of signal cases (16%) in this study. Another issue is 
that patients completed questionnaires up until one year or until they were referred 
to treatments that were excluded from this study. As a result, a portion of the patients 
in our dataset stopped with the study before the end of treatment, which may have 
reduced the feedback effect. However, one would still expect an effect of feedback for 
the sessions on which feedback was provided.  A third factor that may have influenced 
results in a negative way was several problems we occasionally encountered with the 
feedback software. One of the problems was that the questionnaires we had planned 
to administer on use of feedback did not work, which forced us to measure therapists’ 
use of feedback post hoc. This may have several disadvantages, as therapists may 
not always remember accurately if they used the feedback or not. Also, demand 
characteristic may play a role. Therapists are aware that they should have used the 
feedback and may be less likely to report that they did not. However, considering that 
half of the therapists indicated that they had not used the feedback, we believe that 
the effect of sociably desirable answers was limited in our study. A final issue is that the 
sample may be selective to a certain degree. It seemed that patients not included in 
analysis were more likely to have low education, which is consistent with results from 
dropout studies (Clarkin & Levy, 2004). Therefore, our results may be less representative 
for lower educated patients.
What implications do these results have for clinical practice? It seems important 
to realize that not all types of feedback may be equally effective. People often refer 
to Lambert to justify implementing feedback, but take out elements of his feedback 
system that may be particularly effective. Warning signals might be effective in getting 
therapists’ attention to look at the feedback and the statistical model underlying the 
expected recovery curves may cause the therapists to perceive the feedback as more 
valid. Another implication is that therapists’ commitment to use the feedback seems 
to influence the feedback’s effectiveness. It is especially important to pay attention to 
commitment to use the feedback, which predicts both rate of change and likelihood 
to use feedback, when implementing feedback into clinical practice. Unwillingness 
to use feedback may be due to uneasiness regarding receiving feedback on one’s 
performance. After professional training and licensing, therapists no longer receive 
structured feedback on their performance.  Not using the feedback might be a way to 
cope with the anxiety of not being a good therapist. That is consistent with our finding 
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that therapists with higher self-efficacy were able to use the feedback to their benefit, 
although self-efficacy was not a significant predictor of actually using the feedback. 
An alternative interpretation is that not all therapists might be interested in enhancing 
their therapeutic skills. In any case, it is important to pay attention to the role of the 
therapists and their use of outcome monitoring feedback when aiming to use outcome 
monitoring as a tool to improve clinical outcomes. Under pressure of third parties, 
such as health insurance companies, many organizations just start measuring and do 
not pay sufficient attention to how feedback works and how therapists can effectively 
use it (De Jong, 2012).
This is the first study that has measured therapist factors in the context of a 
feedback intervention.  Our results demonstrated that therapist characteristics 
are relevant and more research in this area is needed. Therapist characteristics that 
might be interesting to study include attribution style, locus of control, personality 
traits of the therapists and emotional stability. Therapist characteristics might be 
manipulated by training therapists in specific feedback-related skills. In addition, 
it would be important to get more insight in the dynamics of how feedback works 
and for whom. Perhaps some groups of therapists or patients perform worse when 
they are provided with feedback, but so far, we do not know if this is the case.  Finally, 
for the further development of feedback, it is crucial that the premises of feedback 
theory are tested in a clinical context, since most of these theories originate from social 
and organizational psychology. Feedback effects are considered context specific and 
currently the contextualized feedback intervention theory (CFIT; Riemer & Bickman, 
2011) is the only available theory that focuses on clinical practice. CFIT is complex 
and for the largest part untested, therefore alternative theoretical models could be 
explored as a basis to generate new hypotheses about how feedback works in clinical 
practice.
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A
bstract
Background. Outcome monitoring has become popular, but 
meta-analyses show mixed results. Feedback to so called ‘not on 
track’ (NOT) cases and to both patient and therapist seems most 
effective.
Aims. This study aimed to evaluate the effect of outcome 
monitoring feedback to therapists and patients on outcome.
Method. Patients (n = 474) were randomly assigned to three 
conditions: feedback to therapist (FbT), feedback to therapist and 
patient (FbTP) and no feedback (NFb).
Results. In the full sample, no significant effect of the FbT 
condition was found. FbT did result in less negative change pattern 
for NOT cases in short-term therapies (<35 weeks). FbTP was 
preventive of negative change for NOT cases in short-term therapies 
(d = 1.28 after 35 weeks) and had a small positive effect on the rate 
of change in long-term therapies (≥ 35 weeks).
Conclusions. FbTP results in faster progress, especially for NOT 
cases. FbT was only effective in short-term therapies. 
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Introduction 
Providing outcome monitoring feedback to clinicians and patients has become an 
increasingly popular method to improve outcomes and has been adopted by many 
mental health care providers all over the world (e.g. Evans et al., 2002; Howard, Moras, 
Brill, Martinovich, & Lutz, 1996; Kraus, Seligman, & Jordan, 2005; Miller, Duncan, 
Sorrell, & Brown, 2005). Research has shown that measuring outcomes and providing 
feedback as part of routine practice appears to have a positive impact on the accuracy 
of diagnosis (Carlier et al., 2010; Marshall, Haywood, & Fitzpatrick, 2006) and on 
communication between patient and clinician (Carlier et al., 2010), but the impact on 
patient outcome and treatment duration is less consistent. Meta-analyses on the effect 
of feedback on outcome show mixed effects.
A meta-analysis by Knaup et al. (Knaup, Koesters, Schoefer, Becker, & Puschner, 
2009) concluded that health status feedback has a small positive effect on outcome 
in short-term treatments (d = 0.10), but not in longer term treatments (d = -0.06). A 
problem in the meta-analysis by Knaup et al. is that compared short-term and long-
term effects of feedback, but the studies in these two groups differed substantially 
in patient population and frequency of the feedback. The long-term therapy group 
consisted mainly of studies conducted in severe mental disorders and infrequent 
feedback (once or twice), whereas the short-term group consisted of studies in mood 
and anxiety disorders and personal concerns, and most studies used weekly feedback. 
Lambert et al. (Lambert, Whipple, Hawkins, Vermeersch, Nielsen & Smart, 2003) 
and Shimokawa et al. and (Shimokawa, Lambert, & Smart, 2010) found much larger 
effects of feedback on outcome, ranging between 0.28 and 0.70, but their meta- and 
mega-analysis included only studies from their own research group and were mainly 
conducted in the university counselling center. Feedback seems mainly effective for 
patients who are not doing well in therapy, the so called ‘not on track’ (NOT) cases 
(Carlier et al., 2010; Lambert et al., 2003). Not on track cases are typically identified 
as being those individuals who fall below a cut-off indicating an expected treatment 
response. There are also some indications that feedback is more effective when both 
the therapist and the patient receive feedback (Hawkins, Lambert, Vermeersch, Slade, 
& Tuttle, 2004), but in other studies there was no significant additional effect (Harmon, 
Hawkins, Lambert, Slade, & Whipple, 2005; Slade, Lambert, Harmon, Smart, & Bailey, 
2008).
The current study investigates the effect of feedback in a sample of outpatients 
treated in mental health care institutions or private practices. Patients completed 
session-by-session questionnaires in a web-based application. The main research 
question was whether feedback improves outcomes and whether feedback to patients 
and therapists would be more effective than feedback to therapists alone. There were 
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three conditions: feedback to therapists, feedback to patients and therapists and a no 
feedback control group. The feedback was expected to be mainly effective for NOT 
cases. We were interested in the effects of feedback in both short-term and long-term 
therapies. Short-term and long-term therapies were defined post-hoc by splitting on 




Data were collected in a web-based monitoring application in the period of July 1, 2006 
to June 31, 2011. Participants were recruited in private psychotherapy practices and 
outpatient mental health institutes. Inclusion criteria were an age of 17 years or older 
and sufficient understanding of the Dutch language to answer questionnaires without 
assistance. Therapists asked their patients to participate in the study at intake. After 
agreeing to participate, subjects were randomly assigned to one of three conditions: 
Feedback to therapists (FbT), feedback to both therapists and patients (FbTP) or a 
control group without feedback (NFb). A randomized block design, with blocks within 
therapists, was applied. The study was approved of by the Medical Ethical Committee 
of the Erasmus University Medical Center Rotterdam, as well as by the cooperating 
institutes. All participants signed an informed consent form. 
Participants with less than three OQ-45 administrations were excluded from 
analyses, because two administrations are the absolute minimum to present feedback 
with a gain or decrease that can have an effect on treatment outcome at session three 
or later. Figure 1 shows the flow of participants through each stage of the trial.
Therapists
A total number of 110 therapists participated in the study on a voluntary basis. In the 
analysed sample, therapist had between 1 and 34 patients participating in the study, 
with a mean of 4.3 patients per therapist (SD = 6.4). Approximately half of the therapists 
worked in private practice and most therapists were originally trained as psychologists 
or psychiatrists. Years of experience after training varied from 0 to 36 years, with a 
mean of 16.9 (SD = 9.5) years. Therapists of all major therapy orientations participated 
in the study, although cognitive behavioural therapy, client-centred therapy and 
psychodynamic therapy were most frequent. Table 1 shows the characteristics of the 
participating therapists.
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Instruments
Outcome Questionnaire-45 item version (OQ-45) 
The Dutch version of the Outcome Questionnaire-45 item version (OQ-45) was used to 
measure patient progress during treatment. The OQ-45 (Lambert, et al., 2004) is a self-
report instrument and has 45 items, 9 of which are reversed, asking how the respondent 
has felt over the last week on a 5 point rating scale, ranging from 0 (never) to 4 (almost 
always). Higher scores reflect a higher level of dysfunctioning. The OQ-45 consists of three 
subscales that are aimed at assessing different domains of client functioning: Symptom 
Distress, Interpersonal Relations and Social Role. The internal consistency for the Total score 
of the Dutch OQ-45 ranges between 0.92 and 0.96 in university, community, patients and 
community and patients combined samples. For the subscales the consistency is 0.90-
0.95 for the Symptom Distress scale, 0.74-0.84 for the Interpersonal Relations subscale 
and 0.53-0.72 for the Social Role subscale (De Jong, Nugter, Lambert, & Burlingame, 2009).
Figure 1  Flowchart of participants






(total n = 186)
- Refused to participate (n = 41)

















< 3 administrations 
(n = 35)
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Patient characteristics
Patients completed a basic background questionnaire after entering the study. The 
questionnaire consisted of six items on gender, age and e-mail address of the patient, 
the name of the therapist and the frequency of visits to the therapist.
Clinical diagnosis
A psychiatric classification according to the Diagnostic and Statistic Manual of Mental 
Disorders IV on all five axes was provided by the therapist in the online system. 
Procedure
The background questionnaire was administered prior to the first therapy session. 
Before each therapy session, though not more than once a week, the patient filled 
out the OQ-45 online, through a secure internet connection. Patients were provided 
with an individual login and password and were able to log in from any location, 




Member of therapists association(s)
Private practice






Other university degree 
Other education
Most important professional orientation 
















M = 47.8, SD = 10.9
30 %
49 % 
M = 26.6, SD = 11.1
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although most completed their questionnaires in the waiting room of the therapist. 
Feedback was generated immediately for use in the therapy session. Therapists could 
access the feedback either through e-mail or by logging into the therapist portal of 
the online feedback system. Therapists and patients were free to discuss the feedback 
messages or not. Feedback consisted of a progress graph and a message tailored to 
the status of patients. The graph represented the total OQ-45 score and the subscale 
scores at the various therapy sessions. A horizontal red line indicated the cut-off score 
(i.e. 58) between the normal and clinical population. Messages to therapists included 
suggestions on the level of complaints and continuation of the therapy, for instance 
“Your patient shows a high level of complaints, but feels better than at the start of 
treatment. Your patient has a good chance to benefit from further treatment.” In the 
patient feedback, patients received the same feedback as the therapist, except the 
feedback messages used language that was directed towards the patient. 
Statistical analysis
Not On Track cases were defined by a deterioration of at least the reliable change 
index (14 points) compared to baseline at least twice in the course of the therapy, to 
ensure that a patient was really not on track and not just had one negative outlier once. 
Therapies were divided into short-term and long-term therapies post hoc using the 
median of the treatment duration (35 weeks), thus creating two groups of similar size. 
Data were analyzed with multilevel modelling, using the MIXED procedure in SAS 
(SAS Institute Inc, SAS 9.2. Cary, NC, USA. 2008). Initially, three levels were postulated: 
therapists as upper level, patients as second level, and time-points as lowest level. Bias 
caused by very long therapies was avoided by deletion of data after 2 years of therapy 
(104 weeks). The deviance statistic was used for testing the need for a three level model 
over a two level model. Saturated models were formulated with the natural logarithm 
of time, dummies for FbT, FbTP and NOT, second order interactions between feedback 
and NOT and third order interactions with time. Both intercept and slope were random. 
Non-significant predictors (p-out > 0.05) were removed until a parsimonious model 
was reached, that did not significantly differ from the saturated model. Effect sizes were 
computed using Equation 1, in which the difference between the estimate at time point 
t and the baseline OQ-45 score was divided by the baseline OQ-45 standard deviation. 
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Clinically significant and reliable change (Jacobson & Truax, 1991) were computed 
using the cut-off score for normal functioning of the Dutch OQ-45 that was available at 
the start of this study based on preliminary analyses (de Beurs, den Hollander-Gijsman, 
Buwalda, Trijsburg, & Zitman, 2005). The current cut-off score for the Dutch OQ-45 is 
55 (De Jong, et al., 2007), but since feedback was provided based on the cut-off score 
of 58, in the calculations for clinically significant change 58 rather than 55 was used. 
End status functioning of patients was determined by the last available OQ-45. Last 
observation carried forward was used if the OQ-45 from the session immediately 
preceding treatment termination was not available. Differences in clinical significant 
and reliable change between conditions were tested using a Chi Square test.
Results
Patients
A number of 475 outpatients met the requirements for inclusion in the study and had 
at least three administrations. Demographic characteristics and diagnoses in each 
condition are presented in Table 2. There were no significant baseline differences 
between conditions on the OQ-45 for all participants. However, after excluding patients 
with less than three OQ-45 administrations, small differences occurred:  within the 
FbT and FbTP groups, the OQ-45 baseline scores of included patients were somewhat 
higher than those of the excluded patients (t(203) = -2.48;  p = 0.014 and t(205) = -3.27; 
p = 0.001 respectively). This resulted in higher baseline scores for FbTP than the control 
group in the final sample (F(2, 472) = 4.41, p = 0.013, especially for long-term therapies.
The median therapy length was 35 weeks, and was used to distinguish between 
short (n = 231) and long-term (n = 243) therapies. Long-term therapies included more 
NOT patients (χ2(1) = 13.52, p < 0.001). Baseline differences for the short and long-term 
therapy group were not significant, except for age. Patients in the long term therapy 
group were somewhat older (M = 43.1, SD = 12.2) than patients in the short term 
therapy group (M = 40.1, SD = 11.7), t (472) = 2.71, p = 0.007).
Rate of change
The effect of feedback on outcome was examined in two ways: rate of change (speed 
of progress) and end state functioning (final outcome). The rate of change refers to 
the steepness of the slope in the change model and indicates how much faster or 
slower patients change over time due to the factors investigated.  Participants did 
not complete the OQ-45 on every therapy session, but compliance was reasonably 
good, given that on average more than half of the administered questionnaires were 
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Table 2  Patient characteristics
NFb FbT FbTP Total
n % or Mean 
(SD)
n % or Mean 
(SD)
n % or Mean 
(SD)






























 Mood disorder 
Adjustment disorder 
Anxiety disorder 





Co morbidity within axis 1 






































   Included >=3 administrations2


















Number of OQ-45 administrations

























Not On Track 
Short (< 35 weeks) term 

























Note. NFb = No Feedback; FbT= Feedback to Therapist; FbTP = Feedback to Therapist and Patient
1 Other disorders include: disorders usually first diagnosed in infancy, childhood or adolescence, impulse control disorders, eating disorders, dissociative 
disorders, sexual disorders, substance-related disorders and psychotic disorders (in order of frequency). 
completed by the patients (see Table 1). 
The analyses began by testing if all three levels were required in the multilevel 
model.  The intraclass correlation for the therapist level was computed on an empty 
model and had a value of 0.02, meaning that only 2% of the total variance in the data 
was situated at the therapist level. In the three-level model the slope for therapists 
level was not significant (χ²(2) = 1.47, p = 0.48). Therefore, the therapist level was 
dropped from subsequent analyses. Table 3 shows the results of the multilevel models 
on the effect of feedback on symptom reduction on the OQ-45. Table 4 and Figure 2a, 
2b and 2c shows the effect sizes of the feedback in the different models after 26, 35, 52 
and 78 weeks of treatment.
Then a model for all therapy lengths was analysed. There was an overall significant 
small positive effect (according to Cohen’s criteria (Cohen, 2002)) of feedback to 
therapists and patients over time, but contrary to expectations no significant effect 
of feedback to therapists alone was found. Also, no significant interaction was found 
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Table 4  Estimated effect sizes (Cohen’s d) of difference between groups









































Note: NFb = No Feedback;  FbT = Feedback to Therapist;  FbTP = Feedback to Therapist and Patient
Table 3  Fixed and random effects for change trajectories
All therapy lengths
Short term therapies 
(<35 weeks)
Long term therapies 
(≥35 weeks)







Time * FbTP 
Time * NOT 
Time * NOT * FbT 
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Note: NFb = No Feedback;  FbT = Feedback to Therapist;  FbTP = Feedback to Therapist and Patient; NOT = Not On Track; Time is the 
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Figure 2a  Effect sizes per group for all therapy lengths
Figure 2b  Effect sizes for short-term therapies
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NFb FbT FbTP NFb FbT FbTP NFb FbT FbTP
Recovered 37% 38% 43% 32% 30% 35% 41% 48% 50%
Improved 10% 8% 13% 11% 8% 12% 8% 8% 15%
No change 46% 42% 38% 47% 49% 47% 45% 35% 32%
Deteriorated 8% 11% 5% 10% 13% 7% 6% 9% 4%
Note: NFb = No Feedback;  FbT = Feedback to Therapist;  FbTP = Feedback to Therapist and Patient
between feedback (either FbT or FbTP) and the patient being not on track.
Next, two additional models were analyzed, for short and long-term therapies 
separately. In short-term therapies there was a significant three-way interaction 
between time, the status of the patient being not on track, and type of feedback. NOT 
cases have a negative change over time. In the FbT and FbTP conditions receiving 
feedback had respectively a large and a very large effect for the NOT cases and was 
preventive of negative outcomes. The negative effect of being NOT was compensated 
by receiving feedback, but did not result in positive change. There was no effect of 
feedback in the OT cases (see Table 3). Feedback to patient and therapists had a small 
advantage over feedback to therapists alone in the NOT cases, the additional effect 
sizes are 0.34 at 26 weeks and 0.37 at 35 weeks.
In the long-term therapy group there was a significant difference in OQ-45 scores at 
baseline for both feedback conditions compared to the NFb control group. Therefore, 
the baseline OQ-45 scores for the FbT and FbTP groups were included in the model as 
intercept predictors.  The FbTP condition had a favourable small effect on the rate of 
change, equally of OT and NOT cases (see Table 4). 
End state functioning
Table 5 shows the OQ-45 scores at the end of treatment. Although there were no 
overall significant differences between conditions (χ2 (6) = 8.01, p = 0.24), there was a 
trend for the FbTP condition to have the best results: the lowest rate of deteriorated 
patients (Z = -1.3; p = 0.097) were in this condition. Subgroup analysis of short and long 
term therapies showed similar results per subgroup, although recovery rates were 
somewhat better in the long term therapy group than the short term therapy group.
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Discussion
Summary of results
In this study we aimed to demonstrate the effect of feedback about patient progress to 
therapists and patients. As anticipated, feedback to both therapists and patients was 
most effective. The benefits were strongest for cases who were not progressing well 
in short-term therapies. Feedback provided to the therapist alone was effective of Not 
On Track (NOT) patients in short-term therapies. No significant effect of being NOT was 
found in the full sample. In long-term therapies only feedback to therapist and patient 
was effective. Feedback influenced that rate of change, but did not significantly 
improve end state functioning.
Short and long term effects
The effects in the short-term group resemble results found by Lambert’s group. His 
group was among the first to study the effect of feedback on patient outcomes and 
has performed the largest number of studies in the effect of feedback, compared to 
others. Their studies typically demonstrate that feedback is most effective for NOT 
cases (Lambert, 2007; Shimokawa, Lambert, & Smart, 2010b). Our overall effect of 
feedback was 0.15 after 26 weeks and 0.20 after 78 weeks, which is considered a small 
effect. However, if we look at the effect of feedback for NOT cases in the short-term 
therapy group – which most resembles Lambert’s samples – the effects are very similar 
to what they found. That is, feedback to therapists and patients had a very large effect 
in this subgroup of patients and feedback to therapists had a large (after 26 weeks) to 
very large (after 35 weeks) effect. For these cases the feedback reduced the number of 
negative outcomes.
For feedback in long-term therapies, Knaup et al. (Knaup, et al., 2009) found  no 
significant effect in their meta-analysis. In contrast, we did find a small but significant 
effect (d = 0.22 after 26 weeks and d =  0.29 after 78 weeks). Our sample of long-term 
therapies differed in several ways from the long-term therapies they included in their 
analysis. They defined long-term effects of feedback as measured between 3 and 12 
months after initial assessment, whereas in our long term group treatment duration is 
much longer. In addition, the majority of the studies they included focused on a more 
chronic population that includes patients with schizophrenia and chronic (bipolar) 
depression. Moreover, in three of the five studies the feedback was provided only once 
or twice. So their long-term group possibly did not include the most effective types of 
feedback and it may have included a group among whom not much progress might 
be expected.
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These findings raise the question of why feedback seems most effective in NOT 
cases in short-term therapies but not in long-term therapies. One explanation might 
be that in longer therapies therapists have more opportunities to identify and correct 
the negative track. The results show that more positive change trajectories are found 
in the NOT cases for the long-term therapies. Another issue is that patients who receive 
long-term therapy are possibly not the same type as patients who receive short-term 
therapies. Although we did not find relevant differences between patients in long and 
short-term therapy, patients may differ on unmeasured constructs that are related with 
the complexity of their complaints. For instance, patients that are not progressing well 
might have dropped out before 35 weeks in therapy and could be underrepresented 
in the long-term therapy group. An alternative  interpretation is that the OQ-45 might 
be better at measuring domains that are likely to change in short-term therapies, such 
as symptoms, than domains that are targeted in long-term therapies, such as character 
changes.
Therapist versus patient feedback
In the current study, the strongest effect of feedback was found when both therapist 
and patient received feedback. Our findings may shed light on possible reasons why 
previous studies on patient feedback have shown mixed results. In the Hawkins et al. 
(Hawkins, et al., 2004) study feedback to patients and therapists outperformed feedback 
to therapists alone, but the studies by Slade et al. (Slade, Lambert, Harmon, Smart, & 
Bailey, 2008b) and Harmon et al. (Harmon, et al., 2005) did not show significant effects 
of patient and therapist feedback over therapist feedback alone. The overall effect of 
these three studies resulted in no significant effect (Shimokawa et al., 2010). One of 
the explanations for the differential effects might be found in different populations. 
The study by Hawkins et al took place in an outpatient center, whereas the studies of 
both Harmon et al. and Slade et al. were done in a university counselling center that 
provided therapy to students with personal concerns. The outpatient group had more 
severe patients as well as a more mature group (Shimokawa et al., 2010) and thus, 
probably resembles our group more than the counselling center sample does.
One could wonder why feedback to therapist and patient shows a more pronounced 
effect than feedback to therapists alone. Since the therapist is the one providing the 
therapy, the added effect of providing feedback to patients could be low. There are 
a couple of explanations that could be viable. For instance, it could be a matter of 
implementation. The therapist knows that the patient sees the feedback too and this 
might encourage the therapist to look at the feedback as well. A recent study amongst 
therapists showed that two major barriers for therapists to look at the feedback 
were other tasks that demanded attention and not having enough time to look at 
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the feedback (De Jong, 2012). If the therapist knows that the feedback is not seen by 
the patient, looking at the feedback might be assigned a lower priority than other 
administrative tasks. Therapists may also experience resistance to being evaluated 
(Riemer & Bickman, 2011) and might avoid looking at the feedback as a result. When 
the patient receives feedback as well, they are not in a position to disregard the 
feedback, since they know the patient might ask about it.
Another explanation might be that patients are more empowered when they 
receive feedback about their own progress in therapy. Some of the therapists in our 
study indicated that providing feedback to patients may have resulted in an increased 
sense of ownership of their own change process. By receiving the feedback, patients 
might be more alarmed if there is a lack of progress and might actively discuss this 
with their therapist and manage their own lack of progress. In that way it may promote 
communication between patient and therapist. 
An alternative explanation is that if patients can track their own progress, they can 
also manipulate the results and the effect of feedback to therapists and patients might 
actually be due to a response shift. It is impossible to filter out such an effect, and in our 
experience some patients will use the feedback to communicate with their therapist 
through the questionnaires, but the effect of this usually disappears after a few weeks. 
Limitations
The current study has some limitations that might influence study results. One of 
the problems we encountered was that baseline scores were higher for the feedback 
to therapist and patients group than for the no feedback group. This difference was 
caused by excluding patients with less than three administrations of the OQ-45 and 
was most pronounced in the long term therapies. Possibly feedback causes patients 
with higher complaint levels to stay in the study. We tried to compensate for this 
problem by adding the baseline scores of the OQ-45 to the multilevel model as a 
covariate. 
A factor that might complicate the generalization of our results is that it is unclear 
to what extent our sample is selective. Therapists could have made self-selections of 
patients they approached to participate in the study and we had no way of checking 
this possibility. Similarly, not all therapists may have reported all patients that refused 
to participate in the study. The fact that we do not have sufficient insight in the 
selectiveness of the sample is mainly related to partnering with private practices 
rather than a single department in a mental health care institution. It was particularly 
complicated to get information from them on patients for whom the therapists 
provided treatment in the same time period, but who were not enrolled in the study.
Another issue that needs discussion is our definition of NOT cases. We decided to 
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use a definition in which a patient needed to have a deteriorated score at least two 
times. This resulted in relatively low percentages of NOT cases (14-20%), whereas 
other studies resulted in NOT cases in 20-30% of the cases (Slade, et al., 2008b), and 
sometimes even up to 50% of the cases (Hawkins, et al., 2004). We chose to have two 
deteriorations rather than one in order to rule out accidental high scores on the OQ-45 
and to ensure that a patient was actually on a negative track.  
Finally, our definition of short and long-term therapies has some drawbacks. We 
divided therapies in two groups post hoc, which resulted in equal group sizes and 
thus optimal power to detect an effect for both groups, but may have problems when 
drawing inferences. For instance, it is possible that receiving the feedback had its 
influence on treatment duration, although we did not find significant differences in 
treatment duration between the conditions.  In addition, it may be that patients not 
progressing well are over-represented in the long-term therapy group. We did indeed 
find that there were more NOT in the long-term therapy group, but this could also be 
due to higher chances for being NOT by having more sessions. Also, since we used 
treatment duration in weeks, this division does not tell us much about dosage. Short-
term treatments might have had a higher density (e.g. weekly sessions rather than 
bi-weekly).
 
Implications for practice and research
The current study shows that feedback can be effective in improving the rate of change 
in outpatient mental health care. Although outcomes were not necessarily better 
when feedback was provided, progress was achieved faster, which may result in more 
cost-effective interventions and earlier diminution of suffering. Feedback effects were 
small in long-term therapy and OT cases. Consistent with previous studies (Lambert 
et al., 2003), the strongest effects of feedback in our study were found in NOT cases in 
short-term therapies, so providing feedback is mainly recommended in those cases. 
It should be noted though that although feedback did seem to prevent a negative 
treatment course, the effect was not strong enough to result in a positive treatment 
course for these patients (see Figure 2b). However, previous studies have showed that 
NOT cases have an increased risk of achieving negative treatment outcomes (Lutz, et 
al., 2006) and if feedback can help prevent that, it should be considered. The use of 
an expected recovery curve in the feedback model and using clinical support tools to 
help the therapist may improve the effect of the feedback, since NOT cases could be 
identified sooner, based on the deviation of their expected progress (Shimokawa et 
al., 2010).  
Although more studies are emerging on the topic of feedback, there is still much 
we do not know about the subject yet. There is still little known on how feedback 
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works in clinical practice and why it improves outcomes in some situations, but does 
not in others. In addition, most feedback studies have been performed with outpatient 
adults, and we do not know what the results are in other treatment settings and other 
groups. Newnham et al. (Newnham, Hooke, & Page, 2010) showed for instance that 
in an acute clinic, feedback was only effective for depressed patients. A recent study 
by Bickman et al. (Bickman, Douglas Kelley, Breda, De Andrade, & Riemer, 2011) in 
youth mental health care demonstrated differential effects for outcomes measured 
by clinicians, parents or caregivers and the youth themselves, with the clinicians being 
most optimistic about these effects and the youth the least. Feedback theory (Riemer 
& Bickman, 2011) might be able to provide us with a better framework to understand 
how feedback works. More research is also needed on how therapist and patients use 
the feedback in therapy. Overall, this study provides us with more knowledge on the 
effectiveness of feedback to therapists and patients, for short and long-term therapies.
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Main objectives and conclusions
The principal aim of this thesis was to develop an outcome monitoring feedback 
model for Dutch outpatient mental health care in the Netherlands and to test whether 
providing feedback to therapists and patients can improve treatment outcomes. First, 
the psychometric properties of the Dutch translation of the Outcome Questionnaire 
(OQ-45; Lambert, et al., 2004) were tested and normative samples were collected 
(Chapter 2). The next step was designing a study in which feedback was provided to 
therapists. During the design phase of the study the power to detect an effect was 
attempted to be optimized, by looking for the right proportion of patients within 
therapists and by anticipating missing data (Chapter 3). Meanwhile, data were 
collected on patient progress in ten outpatient centers in three different mental 
health care institutions in both rural and residential areas in the Netherlands. These 
data were used to predict the functioning of patients at the end of treatment and 
the speed of recovery (rate of change). The data were analyzed using contemporary 
statistical techniques, that are flexible in handling missing data (Chapter 4). Finally, 
two feedback studies were conducted. The first study was a multicenter study in an 
outpatient mental health care setting and followed patients in their treatment for one 
year. Feedback was provided to the therapist only and in addition to patient outcomes, 
therapist characteristics on relevant traits related to feedback effectiveness were 
studied (see Chapter 5). The second study was conducted in both public outpatient 
centers and in private practices and contained both short and longer term therapies, 
up until two years. This study had three treatment conditions, a control group, a group 
with feedback to therapists alone and a group in which both therapists and patients 
received feedback about the patient’s progress (see Chapter 6).
Cross-cultural validation of the OQ-45
The cross-cultural validation of the OQ-45 results showed that the American and Dutch 
versions of the OQ-45 are similar when it comes to reliability and validity estimates, 
but differences in factor structure and normative scores were found. The three-domain 
structure of the instrument, for which there was no strong evidence in the original 
version, was slightly better in the Dutch population, but still not satisfactory. Further 
analyses on the residual correlation matrix, which consisted of the variance that was 
unexplained by the three factor solution, resulted in two additional factors. The first 
factor consisted of four items that were in the social role domain. The unexplained 
variance in this domain was most likely caused by the poor performance of item 14 (‘I 
work/study too much’), a problematic item in the American OQ-45 as well (see Mueller, 
Lambert, & Burlingame, 1998). The second factor, named Anxiety and Somatic Distress, 




was considered a useful addition to the existing scales. Reliability and validity estimates 
for the ASD factor were promising. This factor might be especially interesting for use 
by care providers that specialize in anxiety or psychosomatic disorders.
Comparison of normative scores between the American and Dutch populations 
showed that the Dutch community and clinical samples scored somewhat below 
their American equivalents. These differences resulted in a cutoff score for the Dutch 
population (55) of 8 points below the American cutoff point (63). Sensitivity and 
specificity values were very similar to those of the original version. The reliable change 
indices were equal (14 points). A marked difference between the American and Dutch 
normative scores is that in the Dutch population gender differences were found in 
both the clinical and the community sample. Men had more problems in the social role 
domain, whereas women showed higher levels of symptom distress as well as anxiety 
and somatic distress. 
The reliability of the subscales and the total scale was adequate in most of the 
samples. An exception was the internal consistency of the social role domain, which 
was too low in all three samples, but substantially better when the clinical and 
community sample were combined. Sensitivity to change was very good and the OQ-
45 could effectively discriminate between functional and dysfunctional populations. 
The concurrent validity showed proper values for the Symptom Distress and Anxiety 
and Somatic Distress subscales, but less support for the Interpersonal Relations and 
Social Role subscales. Overall, the Dutch version of the Outcome Questionnaire had 
sufficient to good psychometric properties.
Power in three-level multilevel models with therapist effects
Multilevel analysis has become increasingly popular for the analysis of longitudinal 
data in psychotherapy research. Thus far, limited attention had been paid to power 
analysis in these models. Chapter 3 demonstrates the effects of intraclass correlation, 
level of randomization, sample size, covariates and drop-out on the power to detect an 
effect, using data from a routine outcome monitoring study as the basis for simulation 
studies. A three-level multilevel model was postulated, with therapists at the highest 
level (level 3), patients within therapists at the middle level (level 2) and measurements 
within patients at the lowest level (level 1). Results demonstrated that randomization 
at the patient level was more effective, in terms of power, than randomization at the 
therapist level. Increasing the number of patients within therapists was shown to be 
the best way to improve power when randomization took place at the patient level. In 
the case of randomization at the therapist level, including more therapists was more 
effective. Increasing the number of measurements per patient did not have a strong 
effect on power in both randomization designs. In our example, adding gender as a 
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covariate did not influence the power much. However, our covariate did not have a 
strong effect and other, more significant covariates may have different effects on power. 
Drop-out from the study or treatment also did not affect power substantially, although 
it did reduce power to some extent, especially when drop-out was concentrated at the 
beginning of the study. Besides power, it is necessary to have appropriate sample sizes 
at each level to ensure accurate estimation of parameters and standard errors. In some 
cases this may require larger sample sizes than are necessary for sufficient power. In 
addition, in order to effectively distinguish between the slope variances at the patient 
and therapist level, there needs to be a sufficient number of patients per therapist. 
Results indicate that in three-level multilevel models larger sample sizes are required 
than are common in general linear model approaches. This is especially the case in 
naturalistic data, in which the proportion of variance explained by therapist variance 
in outcomes is usually larger than in randomized controlled trials (Crits-Christoph, et 
al., 1991). The larger the portion of variance that is explained by the therapist level 
(referred to as the intraclass-correlation), the larger the sample size needed. Providing 
feedback to therapists on their patients’ progress may reduce variance in outcomes 
between therapists, since therapists that have more negative outcomes are provided 
with the opportunity to adapt their treatments based on the feedback.
Risk factors for negative outcomes
Since one of the main objectives of feedback is to prevent negative outcomes, it 
would be useful to know which factors are associated with negative outcomes. In 
Chapter 4 we aimed to predict the risk for negative treatment outcomes at the end 
of treatment using Classification And Regression Trees (CART) and for rate of change 
using multilevel modeling. A common problem in finding predictors of outcomes is 
that naturalistic databases are used and those usually have missing data. Both CART 
and multilevel analysis are flexible in handling missing data: CART for missing values 
on the predictor variables and multilevel models for missing values on the dependent 
variable. Multiple imputation was used to impute missing data in predictor variables 
in the multilevel analysis.
Fifty-one per cent of the patients in our sample (n = 1540) improved and had 
scores on the OQ-45 outside the clinical range at the end of treatment. In the CART 
analyses we found that patients with relatively low pre-treatment scores for symptom 
distress, and patients with high education have a better chance of favorable outcomes. 
An extended model, with more nodes (branches) to the regression tree, showed the 
complexity of the relation between predictors and outcome and showed how pre-
treatment expectancies, social role problems and GAF scores and the working alliance 
at the beginning of treatment (Task subscale) interacted in different ways to predict 




negative outcomes at the end of treatment. The multilevel analyses showed that initial 
severity, the working alliance (Task or Goal subscale) and GAF score were significant 
predictors for the rate of change in patients. In the complete case sample, having a 
mood or adjustment disorder as main diagnosis had a positive relationship with the 
rate of change, whereas in the imputed sample previous treatment, having comorbid 
Axis I disorders and having a personality disorder as main diagnosis had a negative 
relationship with the rate of change. The model based on the multiply imputed data 
was considered the most reliable model, and further analyses were computed only 
for this model. The CART models and multilevel models differed in their sensitivity 
to detect negative outcomes. The first CART model had high sensitivity, but low 
specificity, whereas the multilevel model had high specificity and low sensitivity. The 
multilevel model was good at picking up deterioration, but not at identifying the no 
change group. The extended CART model had the best balance between sensitivity 
and specificity. 
Effect of feedback
The effect of feedback on outcome was investigated in two randomized clinical trials. 
In the first study (Chapter 5), we aimed to research the efficacy of ‘simple’ (no warning 
signals or expected recovery curves) feedback compared to no feedback. The largest 
effects of feedback have been found in models that have expected treatment recovery 
curves and warning systems for patients that are deviating too much from the 
expected course. However, most outcome monitoring feedback systems do not have 
these features and the effectiveness of those systems has been studied insufficiently 
(Marshall, Haywood, & Fitzpatrick, 2006). Patients (n = 413) were randomly assigned 
to a no-feedback control group or the feedback condition. Patients that were not 
progressing well in therapy, so called ‘not on track’ cases (NOT), were identified post-hoc 
based on experiencing reliable deterioration in the course of treatment and feedback 
was expected to be especially effective for them. Contrary to our expectations, for the 
full sample of therapists no additional beneficial effect of feedback was found and 
there was no significant interaction between feedback and patients being not on track 
(NOT). However, in NOT cases a positive significant effect was found when therapists 
indicated that they used the feedback. 
In the second study (Chapter 6) we aimed to demonstrate the additional effect 
of feedback to therapists and patients. Patients were randomly assigned to three 
conditions: no feedback, feedback to the therapist alone and feedback to both 
patient and therapist. Feedback was provided without expected recovery curves, but 
therapists did get feedback messages that suggested that a patient had deteriorated 
or not changed. As anticipated, feedback to both therapists and patients was most 
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effective. Subgroup analyses were performed for short-term (less than 35 weeks of 
therapy) and long-term (35 weeks of therapy or longer) treatment. The benefits were 
strongest for NOT cases in short-term therapies. Feedback provided to the therapist 
alone was also effective for NOT patients in short-term therapies. In long-term 
therapies only feedback to therapist and patient was effective. In general, feedback 
influenced the rate of change, but did not significantly improve end state functioning.
Therapist effects
Characteristics of the therapists and the way in which they use feedback may play a 
central role in the effectiveness of feedback. After all, if therapists do not use feedback 
constructively, it is unlikely that outcomes will improve. Several characteristics of the 
therapists that might influence the effectiveness of feedback were studied (Chapter 
5). Feedback is more likely to be accepted if it comes from a source that has credibility 
and has personal relevance to the receiver (Claiborn & Goodyear, 2005). This concept 
is referred to as perceived validity. Another factor that seems important in acceptance 
is feedback orientation (Herold & Fedor, 2003; Herold, Parsons, & Rensvold, 1996). 
External feedback propensity reflects the preference for externally mediated feedback 
as well as greater faith in such information than in what one can self-generate, whereas 
internal feedback propensity reflects preference for internally generated feedback as 
well as the tendency to reconcile differences between internal and external feedback 
in the direction of internally generated information (Herold & Fedor, 2003). Self-efficacy 
is another characteristic that influences the feedback process. It refers to a person’s 
beliefs concerning his or her ability to successfully perform a given task or behavior 
(Bandura, 1977). The commitment to use the feedback in therapy might also be an 
important factor. Australian research showed that 44% of therapists thought outcome 
monitoring was a waste of time (Aoun, Pennebaker, & Janca, 2002) and two-third of 
the therapists was not willing to use the monitoring feedback, not even if it would lead 
to demonstrably better outcomes (Walter, Cleary, & Rey, 1998). 
The results of the study showed that therapists variables moderated the 
effectiveness of feedback. Therapists with a high internal feedback propensity, who 
are more likely to trust their own opinion than feedback from external sources, had 
patients with a slower rate of change than therapists with a low internal feedback 
propensity, whereas therapists who were more committed to use the feedback at the 
beginning of the study had patients who progressed faster. Both findings occurred 
regardless of whether therapists actually received feedback, which suggests that 
therapists with an open attitude towards getting feedback reach faster progress 
with their patients. Strangely though, when therapists with a high commitment to 
use the feedback actually received feedback, this slowed down the rate of change in 




their patients. There also was a positive effect of self-efficacy. Patients in the feedback 
condition who had therapists with higher self-efficacy progressed quicker in therapy 
than patients of therapist with lower self-efficacy or patients of therapists that did not 
receive feedback. No effect was found for external feedback propensity and perceived 
validity. Therapists were more likely to use the feedback if they were more committed 
to use the feedback at the start of the study and if they were female.
Theoretical and methodological considerations
Symptoms versus functioning
There has been discussion on whether symptom reduction is the best outcome 
measure to study the effect of psychosocial interventions. Gladis, Gosch, Dishuk and 
Crits-Christoph (1999) state that a fundamental problem with a symptom-focused 
approach is that it is based on a narrow, outdated notion of health and disease. 
Although symptom relief is a major goal of treatment efforts, there are many reasons 
to expand outcome assessment to include other aspects of clinical progress. The OQ-
45, which was used as the outcome measure in the studies in this thesis, measures 
symptoms as well as social functioning in work and interpersonal relationships and is 
broader than symptoms alone. However, analyses were on the level of the total score 
and outcomes were not assessed separately on the different domains of the OQ-45. 
Using an outcome instrument that assesses multiple domains has its implication on 
the effect sizes found. Outcome measures that are tailored to specific complaints 
(for instance the BDI for depression) usually have the highest effect sizes (Lee, Jones, 
Goodman, & Heyman, 2005). Moreover, since therapy length is under pressure by 
insurers and is often limited to a certain number of sessions, and studies show that 
change on symptoms usually occurs before social functioning improves (Howard, 
Lueger, Maling, & Martinovich, 1993; Stulz & Lutz, 2007) it is likely that a clinically 
significant improvement in social functioning may not have taken place yet by the 
end of therapy. A recent (internal) analysis of data collected as part of routine outcome 
monitoring in our outpatient psychotherapy centers supported this hypothesis and 
showed that of the patients entering treatment with problems on interpersonal and 
work functioning, around 70% leaves treatment unchanged on these domains (De 
Jong & Mooij, unpublished).
Self-report versus other perspectives
Gold and Stricker (2011) state that: “exclusive reliance on self-observation and self-
report by the patient may be an ineffective and unreliable method for assessing 
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psychotherapy. ” (p. 1098). Patients may exaggerate or diminish their complaints on a 
questionnaire in a need to please or rebel against the therapist or by cause of another 
motivational conflict (Gold & Stricker, 2011). This effect might be more pronounced 
if patients receive feedback themselves. We saw this phenomenon in a study we 
recently performed in a inpatient long-term psychotherapy setting for patients with 
personality disorder. Preliminary data-analysis showed that in the first few weeks, the 
feedback to patients and therapists group had on average higher dysfunctioning than 
the feedback to therapists only and no feedback control group. This effect faded after 
a few weeks (De Jong, Segaar, Busschbach, & Timman, in preparation). An alternative 
example is that patients sometimes may score higher close to discharge, if they are 
anxious to end therapy, or lower if they want to end it. Another issue is that patients 
may not always have insight in their own thoughts and feelings. People often attempt 
to block out unwanted thoughts and feelings and mental processes in the mind are for 
a large part implicit and inaccessible (Wilson & Dunn, 2004). Although patient reports 
have their limitations, the patient perspective in assessing level of symptoms and 
functioning remains valuable, but should be evaluated in the light of its limitations. 
Other perspectives may provide valuable information on the patients’ functioning 
as well. A common perspective in outcome monitoring is that of the therapists, 
especially in patients that are not capable of completing self-report instruments or in 
patient populations that are prone to biased reports, such as addiction and forensic 
populations. Where patients may experience response bias, therapists may be subject 
to observer bias. For instance, therapists were found to have inaccurate ideas about 
how symptoms interrelated and this affected their judgments (e.g. Lewis, 1991). The 
study by Hannan et al. (2005) that was discussed in Chapter 1, demonstrated that 
therapists tend to overestimate treatment success and underestimate treatment 
failure. However, making a prediction over time may require different mental processes 
than assessing functioning of the patients at a certain moment in time. Recent studies 
on fast and frugal heuristics in decision making demonstrate that with the help of 
simple decision rules, clinical judgment can outperform statistical predictions (e.g. 
Katsikopoulos, Pachur, Machery, & Wallin, 2008). Comparisons of measurements from 
the therapist and patient perspective attest that correlations are usually low and that 
measurements from the therapist perspective shows more positive effects (Trauer, 
2010). It seems that both perspectives have their advantages and disadvantage and 
provide a different type of information. 
Alternative perspectives might be the patients’ family and friends, employer or 
society. Kazdin suggests to include measures in the outcome evaluation that are 
generally accepted to be of critical importance in everyday life (e.g. days missed from 
work or amount of arrests) for the population under examination (Kazdin, 2003). 
Ideally, multiple perspectives are chosen, but collecting information from multiple 




sources, especially family members or friends, can be time consuming and costly. 
Therefore, most outcome measurement systems tend to focus on either the therapist 
or the patient. 
Definition of treatment success and failure
In Chapter 1 we stated that the definition of treatment success and failure is complicated 
and each definition has its drawbacks. Or, as one reviewer put it: “Defining negative 
outcomes is a tricky business, that might affect the results.”. Although we tried to stay 
close to existing literature on the topic in our definition of negative outcomes, we 
did deviate from it to some extent as well. For instance, we did not consider people 
functioning in the normal range as negative outcomes, even if they had not changed in 
functioning through the course of therapy. Others have considered the full ‘no change’ 
group as negative outcomes (e.g. Lutz, et al., 2006). Whether functioning in the normal 
range is a good criterion for treatment success remains the question. Some people in the 
normal population may experience marked symptomatology, but do not seek treatment 
for it.
An alternative criterion for treatment success is that a patient is mentally healthy 
when finishing treatment. The World Health Organization (WHO) defines mental health 
as “A state of well-being in which the individual realises his or her own abilities, can cope 
with the normal stresses of life, can work productively and fruitfully, and is able to make 
a contribution to his or her community”(WHO, 2001). In outcome research mental health 
is seldom used as a criterion for treatment success. Traditionally, researchers tended to 
focus on patients being no longer being mentally ill. One reason that mental health is 
so seldom used as criterion for successful treatment may be that the concept of mental 
health is complicated to measure and there is no generally accepted theory of what 
mental health should encompass. Some models of mental health are available (e.g. 
Jacobson & Greenley, 2001; e.g.Taylor & Brown, 1988), but these have not been adopted 
on a larger scale.
Cultural equivalence
The cultural equivalence between the Dutch and American versions of the OQ-45 were 
discussed in Chapter 2. There seemed to be both differences and similarities between 
the instruments. The most striking difference was found in the normative samples: Dutch 
respondents tended to report lower scores in dysfunctioning than American respondents. 
The measurements reported in Chapter 2 were all prior to the start of treatment for the 
patient group, but the discussion of cultural equivalence can be extended to the topic of 
change patterns and the use of feedback. Almost all data on expected treatment recovery 
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curves and feedback has been collected in the United States. Little is known about the 
cultural equivalence of change patterns and even less about cultural differences in how 
therapists respond to feedback. Do patients from different countries change in the same 
way, or are there differences to be expected? Although Dutch respondents score lower 
than American respondents, outcomes seem similar in the US and the Netherlands. The 
care system is quite different as well, which makes it hard to disentangle the language 
and cultural factor on the one hand and the characteristics of the care system and the 
patients within it on the other hand. The same holds for therapists: the training for 
therapists is different in the US than in the Netherlands, which may result in different 
attitudes towards feedback. More research in this area might provide better insight in 
this issue. In addition, our own sample of patients has its limitations as well. The vast 
majority of our patient and therapist groups were Caucasian and not much is known on 
how other cultural subgroups in the Netherlands are responding to therapy.
Implications for clinical practice
Providing outcome monitoring feedback to whom?
Feedback is a complicated process and many factors may influence its effectiveness. Our 
results show that providing feedback on outcomes in clinical practice can be effective, 
but is not equally effective in all cases. Results from Chapter 6 suggest that feedback 
to therapists and patients both might be more effective than feedback to therapists 
alone. Outcome monitoring feedback may also not be equally effective in all treatment 
settings: the largest effects were found in short-term therapies (up to 35 weeks). A 
recent (yet unpublished) study in crisis care patients showed that patients that got 
feedback were worse off than the no feedback control group (J.J.M. Dekker, personal 
communication). Getting feedback that you have severe problems and that these are 
not improving can be demoralizing for patients. The same may be true for patients that 
are not expected to improve in symptoms, like patients with severe mental disorders or 
patients that are seeking therapy for personal growth and life issues rather than reducing 
symptoms. Feedback is probably most effective in improving outcomes if progress is 
possible but not achieved at that moment. In other patient groups it may be helpful in 
promoting patient-therapist communication (Carlier, et al., 2010), but may not be helpful 
in improving outcomes.
Besides feedback to patients and therapists, feedback on outcomes can also be 
provided at higher levels of the care organization, in which case it contains information 
on outcomes at the group level. No research has yet been performed on the effect of this 
type of feedback on outcomes or implementation, but in our experience it can be very 
stimulating for teams and organizations.




Characteristics of the feedback
Important characteristics of the feedback are the timing and frequency of measuring 
outcomes and providing feedback and the valence and content of the feedback. 
Research shows that providing feedback immediately is more effective than delayed 
feedback (Slade, Lambert, Harmon, Smart, & Bailey, 2008). Deciding on the frequency 
of measuring outcomes and providing feedback is more complicated. No research 
has been done on the subject, but common sense tells us that the more frequently 
outcome is measured, the more likely it is that we are able to detect negative progress 
early on and the more effective the feedback may be. However, studies (including 
ours) also show that feedback is most effective for patients that are not progressing 
well in treatment and that is only a small portion of the patients that are in therapy. 
Measuring all patients frequently can be time consuming and expensive. Finding a 
tradeoff between time invested in measuring and preventing negative outcomes 
must be found. Using the prediction models from Chapter 4 might be instrumental in 
that. Patients that are at risk for negative functioning at the end of treatment or have 
negative expected treatment recovery curves could be measured more intensively, 
whereas patients that are expected to progress well might get a lighter measurement 
schedule. It should be noted that we have found models with many predictor 
variables, which may not always be practical to use in clinical practice, since it requires 
that values on all predictor variables are known. This is often not the case; especially 
the early treatment predictors (expectancies and early working alliance) are often 
not available for all patients, which was one of the reasons we encountered so many 
missing variables in our study.
An alternative option, if one does not have access to prediction models for patients 
at risk, is to measure all patients frequently (every session) for the first 3-5 sessions of 
therapy to get an idea of the direction the progress is taking. Research shows that early 
change is highly predictive of outcome at the end of therapy (e.g. Haas, Hill, Lambert, 
& Morrell, 2002; Lambert, 2005; Lutz, Stulz, & Kock, 2009), so if patients do not improve 
in the beginning of therapy, that could be an indication to monitor their progress more 
closely. In the Netherlands, many outcome monitoring systems in outpatient settings 
measure outcomes not more than once every three months. Depending on how much 
therapy is provided in that period, that may not be frequent enough to detect negative 
outcomes early on.
Feedback to the therapist does not necessarily have to be provided every time 
outcome is measured in patients. In the study in Chapter 5 we measured outcome every 
session for the first five sessions of therapy, but provided feedback to the therapists at 
sessions 1, 3 and 5. Especially when outcome is measured on a session by session basis, 
providing feedback to therapists every session could be too much, especially in longer 
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treatments, where providing feedback to therapists may have a reduced effectiveness 
(see Chapter 6). One model could be to provide feedback only when patients are not 
progressing well and do not report actively to the therapist if the patient is on track. 
However, this may demotivate therapists, as they will only get negative feedback in 
that case. Another option is to provide feedback regularly (e.g. every five sessions) if 
patients are on track and more often if the patient is not progressing well. Riemer and 
Bickman (2011) propose a hierarchical system in which one brief feedback signal is 
provided to therapist (e.g. red or green), and more information is provided only if the 
patient is not progressing well. 
Studies show that feedback is more effective if is more specific (Kluger & DeNisi, 
1996). This is not surprising, after all just getting the message that the patient is not 
progressing well might not be very helpful. It may trigger further inquiry and promote 
a discussion with the patient on the lack of progress, but it would be better if more 
specific information were available. Lambert has implemented an instrument that 
assesses the patients’ motivation, social support and alliance with the therapist, as 
well as events that happened in the patients’ life that might help explain why the 
patient is not doing well. In addition to the assessment, suggestions are given on what 
interventions might be helpful to improve problems in these areas. A recent meta-
analysis showed that using the clinical support tools – as this system is called– has 
superior outcomes compared to feedback on outcome alone (Shimokawa, Lambert, 
& Smart, 2010).
In this thesis we have focused on measuring outcomes, but other factors might 
be useful to monitor as well. Therapists often prefer adding process measures to the 
outcome monitoring (Riemer & Bickman, 2011). Process measures that have been used 
include the working alliance, expectancies and motivation. Results on how monitoring 
these concepts influence outcomes has been scarce and inconsistent. For instance, 
one study that monitored the working alliance besides outcome showed a positive 
overall effect on outcome (Reese, Norsworthy, & Rowlands, 2009), but no effect of 
monitoring the alliance was found in other studies (Crits-Christoph, et al., 2010).
What applies to feedback at the individual level, probably also applies to feedback 
at the organizational level. Other than individual patient feedback, team level feedback 
is usually on the outcome of completed cases and has the objective to learn from 
outcomes on an aggregated level and inform treatment policy. It is usually provided 
periodically (e.g. once a year). Teams are most likely more willing to accept feedback 
from a source they perceive as valid and if the information is presented in a clear and 
easy way. It can be complicated to compare different teams, especially if they differ in 
patient populations and in the level of implementation of outcome monitoring. It is 
expected that in organizations feedback on outcome will be most effective for ‘not on 
track’ teams - teams that perform below the standard - since they will be motivated 




to make changes to improve outcomes. An important question is what should be 
considered the standard? In the Netherlands, a national benchmark for mental health 
care aims to provide such a standard, although the discussion on whether we are 
trying to compare apples and oranges will probably continue, as any comparison has 
its limitations. By applying statistical case mix correction or providing case mix based 
comparison groups, the quality of such a comparison can be improved. An interesting 
alternative approach has been developed by Lambert, who uses prediction models to 
compute the expected outcomes for a mental health care organization. In that way, 
the institution can be benchmarked against their own expected outcomes (Hansen, 
Lambert & Forman, 2002; Hansen & Lambert, 2003).
Therapist and organizational factors
The study in Chapter 5 shows that traits of the therapist may moderate the effect of 
feedback. Gold and Stricker (2011) indicate that therapists have their ‘own needs to 
avoid the perception of failure’ and getting feedback about cases that do not progress 
well in therapy might cause resistance in the therapists. This may especially be the 
case for therapists with low self-efficacy (see chapter 5). A recent exploratory study 
showed that therapists with a high external feedback propensity and who perceived 
the outcome monitoring feedback as more valid, had a more positive attitude towards 
outcome monitoring feedback (De Jong, 2012). In Chapter 5 it was demonstrated that 
having a positive attitude towards the feedback before implementation of outcome 
monitoring, was predictive of actual use of the feedback.
Getting negative feedback about one’s patients can be unpleasant. This unpleasant 
feeling is referred to in the professional literature as cognitive dissonance and is 
theorized to be the driving mechanism in feedback. By experiencing cognitive 
dissonance people get motivated to change their behavior (for instance change 
their treatment strategy). However, changing behavior is not the only option. As the 
original experiments by Festinger demonstrated, changing one’s cognitions is another 
possibility to reduce cognitive dissonance (Festinger, 1957). Through the process of 
causal attribution, therapists may attribute the reasons for lack of progress in the 
patient outside themselves (e.g. ‘it is part of the complaints of this patient’), which 
may reduce the effectiveness of feedback. On the other hand, therapists that hold 
themselves accountable and get negative feedback on a regular basis may be at risk for 
burnout (Riemer & Bickman, 2011). Although traits in the therapists are not within the 
influence of someone who wants to implement outcome monitoring, it is important to 
understand the dynamics within the therapists and discuss these with them.
Beside personality traits and external causal attribution, other barriers may be 
present, that may cause therapists to disregard the feedback. A survey amongst 
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therapists showed that ‘other tasks that asked for attention’ (40%), not having enough 
time (21%) and having trouble interpreting the feedback (21%) were frequent barriers 
for therapists to use the feedback (De Jong, 2012). Organizational factors that may 
be barriers to look at the feedback are high administrative pressure or full caseloads. 
Another factor is accountability. Riemer and Bickman (2011) state that if therapists are 
not hold accountable for using the feedback, implementation may have little impact. 
Creating external pressure will increase the likelihood that the therapist will have 
attention for the feedback.
Future research
Methodological innovations
Although many prediction models that aim to predict outcome in psychosocial 
interventions are available, it remains complicated to predict negative outcomes. 
More specifically, the patients that show no (reliable) change seem most complicated 
to predict. Patients that deteriorate can be predicted reasonably well, but model 
performance for the no change group is much worse (Finch, Lambert, & Schaalje, 2001; 
Lutz, et al., 2006). Better prediction models are needed and increasingly, statistical 
techniques from other disciplines are applied in our field in order to increase prediction 
precision. One technique that is gaining popularity in psychotherapy research is the 
use of latent variable models, such as growth mixture modeling. In these models, 
homogeneous change patterns are identified and based on the characteristics of 
the change patterns group membership is predicted (e.g. Stulz, Lutz, Leach, Lucock, 
& Barkham, 2007). This approach uses a reverse method compared to traditional 
regression models and may provide new insights in which patients are likely to 
improve and deteriorate. 
Many of the techniques used in predicting outcomes have been regression 
based techniques in which the relation between predictor variables and outcome 
is assumed to be linear. The CART analysis in Chapter 4 showed that linearity may 
not always be correct. Kendler (2008) states that we need to start looking at more 
complex interactions in explanatory models for psychiatric illness and apply models 
that consider predictors at different levels – inside and macro, within and outside the 
individual – to better understand what risk factors are relevant in psychiatry. Over the 
last decade, new applications of statistical techniques have been introduced in clinical 
psychology that allow for more complex interactions, including state-space models 
that allow for dynamic individual change patterns (e.g. Fisher, Newman, & Molenaar, 
2011) and case-based time-series analysis, that uses bootstrapping as a benchmark for 
individual change (e.g. Borckardt, et al., 2008).




Most of the methods mentioned above use outcome measures at the scale level, 
but repeatedly completing questionnaires can place a considerable burden on 
patients. A promising approach is the application of computerized adaptive testing. 
Adaptive testing involves the administration of a questionnaire in such a way that an 
optimal amount of information if obtained in a minimal amount of time. Based on 
the responses of the patients, only relevant questions that are necessary to determine 
the severity of the patients complaints are administered, which typically leads to a 
reduction of items of 50% (Weiss & Kingsbury, 1984). An important initiative in this area 
is a joint initiative working on building a Patient-Reported Outcomes Measurement 
Information System (PROMIS; http://www.nihpromis.org). The aim of this network is 
to develop a large bank of items that measure patient-reported outcomes and allow 
efficient assessment in clinical research of a wide range of diseases, using state of the 
art scientific techniques. The outcome measures in PROMIS are constructed according 
to item-response theory, which has several advantages over classical test-theory 
(Embretson & Reise, 2000).
Feedback studies
Most of the studies on the effectiveness of feedback have been performed in the 
United States, using outpatients in university based clinics and counseling centers. 
Often, patients were students and staff at the university were the study was performed 
(e.g. Harmon, et al., 2007; Lambert, et al., 2001; Reese, et al., 2009; Slade, et al., 2008; 
Whipple, et al., 2003). Therapists often were faculty at the university and in that sense 
used to exposure to research in their clinical work. Our studies were performed in the 
real world and have demonstrated that implementing feedback may be more complex 
in those settings. More research should be done in settings outside universities and 
with other patient groups than outpatients. Some work has been done in inpatient 
settings (Berking, Orth, & Lutz, 2006; Newnham, Hooke, & Page, 2010) and with 
substance abuse counseling (Crits-Christoph, et al.).
Another line of research that is necessary is optimizing the feedback. In our studies, 
we did not use expected treatment recovery curves. So far, Lambert’s group is the only 
one that we know of that has incorporated prediction models in the feedback. More 
research should be done evaluating the use of prediction models as a benchmark 
for patients’ progress. Especially the combination of the CART and multilevel model 
(see Chapter 4), which is a new approach, would be interesting to use as a base for 
feedback. In addition, the clinical support tools should be validated – there is no 
research supporting the premise that feedback on the alliance, social support and 
motivation has a specific effect in these domains. An expansion of the clinical support 
tools could include information based on multidisciplinary treatment guidelines. 
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Our study (Chapter 5) was among the first studies to research the effect of 
recipient characteristics in feedback on mental health care. The results demonstrated 
that therapist characteristics are relevant and more research in this area is needed. 
Therapist characteristics that might be interesting to study include attribution style, 
locus of control, personality traits of the therapists and emotional stability. In addition, 
it would be important to get more insight in the dynamics of how feedback works for 
whom. Are there therapists that perform worse if they are provided with feedback? Is 
feedback helpful for all patients?
Another line of research that would be interesting is to combine feedback studies 
with basic research. For instance, one problem with feedback is that it does not seem 
to have a learning effect in therapists. This issue could be studied in an experimental 
design, and is currently being studied by the research group of Andrew Page (personal 
communication). Another experiment would be to try and manipulate the therapists 
characteristics by training specific feedback related characteristics. Finding an optimal 
way to present the feedback to therapists could also be tested in small experimental 
studies.
Finally, for the further development of feedback, it is crucial that the premises of 
feedback theory are tested in a clinical context, since most theories originate from 
social and organizational psychology. Feedback effects are considered context 
specific and currently the contextualized feedback intervention theory (CFIT; Riemer 
& Bickman, 2011) is the only available theory that focuses on clinical practice. CFIT is 
complex and for the largest part untested, therefore alternative theoretical models 
could be explored as a basis to generate new hypotheses about how feedback works 
in clinical practice.
Concluding thoughts
Feedback is a complicated process and there are many things we still do not know 
about it, especially on how it works in clinical practice. This thesis demonstrated that 
providing outcome monitoring feedback to therapists and patients certainly does 
not improve outcomes under all circumstances. The metaphor of learning archery 
blindfolded by Sapyta et al (2005) was used earlier to illustrate why therapists may 
need outcome monitoring feedback about their patients’ progress. They stated 
that “without direct feedback on how their clients are progressing, clinicians are 
essentially wearing a blindfold while shooting at a target” (p. 152). This – somewhat 
bold – statement may be true, but the question remains whether outcome monitoring 
feedback provides the kind of feedback that is necessary for mastering “hitting the 
target” and whether it is the only source of feedback. In addition, targets may change 
during the course of therapy.




People have sometimes asked me if we should consider stopping with outcome 
monitoring, considering that effects on outcome are smaller than anticipated and the 
effort to implement it can be large. I do not think that we should. Although effects are 
small now, with new developments in research and better implementation into clinical 
practice effects may very well increase. Even with relatively small effects on outcome, 
and feedback mainly being effective for a portion of patients that are not progressing 
well, providing feedback on patients’ progress can still be useful. As long as patients 
leave therapy deteriorated or unchanged and there is a chance for change, we owe it 
to our patients to give it our best shot.
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Appendix A: Equations used to compute power plots
Notation
Level 1 repeated measures subscript i n1 measurements per person
Level 2 patients subscript j n2 persons per therapist
Level 3 therapists subscript k n3 therapists
cond treatment condition (-1 = control, +1 = experimental)
Optimality criterion
As optimality criterion we use the variance of the estimator of the interaction effect 
between treatment and time. If such an interaction exists, then the growth rate 
differs across treatment conditions. Only for very simple designs an explicit formula 
for this variance can be derived:
•	 all subjects measured on the same occasions
•	 no drop-out; no intermittently missed observations
•	 number of patients per therapist is fixed
•	 within each therapist: equal number of patients per treatment condition 
(randomization at patient level)
•	 equal number of therapists per treatment condition (randomization at 
therapist level)
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Appendix A: Equations used to compute power plots
Multilevel model with three levels, randomization at therapist level 
We assume that there are n3/2 therapists per treatment condition.
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Multilevel model with three levels, randomization at patient level
Assuming that the treatment effect and interaction effect treatment*time does not 
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Appendix A: Equations used to compute power plots
Multilevel model with three levels, randomization at patient level
Again, we assume that for each therapist there are n2/2 patients per treatment 
condition. Now assume that there are differences between therapists in rate of 
change (time, treatment, treatment*time interaction have random effects). This 
changes the level-three model: 
Level-3 model
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Appendix B: Example of the feedback used in chapter 5
Gemiddelde schaalscore per item (grafiek)
Schaalscores (tabel)
Max. score Begin score Huidige score
Symptomatische Distress (SD) 100 66 35
Angst en Somatische Distress (ASD) 52 35 18
Interpersoonlijke Relaties (IR) 27 19 16
Sociale Rol (SR) 36 17 12
Risicovragen
8.  Suïcide - Ik denk erover om een einde aan mijn leven te maken Soms
26. Alcohol/drugs - Ik erger mij aan mensen die kritiek hebben op 
mijn drinken of drugsgebruik
Zelden
44. Agressie - Ik ben zo kwaad op het werk / op school dat ik iets 
kan doen waarvan ik spijt zou kunnen krijgen
Zelden
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Appendix B: Example of the feedback used in chapter 6
Feedbackbericht naar aanleiding van uw laatste sessie
Laatste sessie: 5
De evaluatie laat zien dat uw cliënt ten tijde van de vorige sessie veel last had 
van klachten en problemen. Uw cliënt voelt zich slechter dan in het begin van 
behandeling. Uw cliënt heeft een goede kans om nog verder van de behandeling 
te profiteren. 
Totaalscore De totaalscore toont u het verloop van u klachten gebaseerd op de ‘Outcome 
Questionnaire’- vragenlijsten die u voorafgaand aan elke therapiesessie 
invult.
De ernst van de 
klachten (Symptom 
distress)
Bij het onderdeel klachten gaat het vooral om klachten van depressie en 
angst, maar ook over drank- of drugsmisbruik en -afhankelijkheid.
Functioneren in 
relaties
(Interpersonal relations): Bij het onderdeel relaties gaat het om de omgang 
met uw partner, andere gezinsleden, familieleden en/of vrienden.
Maatschappelijk 
functioneren
(Social role): Het onderdeel maatschappelijk functioneren geeft aan hoe 
het gaat op uw werk, met uw opleiding, of met uw huishoudelijk werk. 
Problemen op het werk, een hoge werkdruk verslechterd werk of slechte 
opleidingsresultaten, leiden tot een hoge score op deze schaal.
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Appendix B: Example of the feedback used in chapter 6
Uw cliënt heeft bij de laatste invulling van de OQ-45 een verhoogde score 
aangegeven op één of meer ‘kritische items’.
Deze duiden op problemen waarvoor bijzondere aandacht gewenst kan zijn. Als u 
overweegt het probleem met uw cliënt of bijvoorbeeld met een collega te bespreken, 
kunnen de volgende punten van belang zijn: 





4 = bijna altijd
2. Uw cliënt kan zich hebben vergist bij het invoeren.
3. Uw cliënt zou kunnen veronderstellen dat de informatie geen deel uitmaakt van de feedback.
Onderwerp Item Score
 Suïcidaliteit Ik denk erover om een einde aan mijn leven te maken. 3
 Middelen-
misbruik
Na zwaar gedronken te hebben, moet ik de volgende 









Ik heb moeilijkheden op het werk/op school door mijn 
drinken of drugsgebruik.
1
 Agressie op 
het werk
Ik ben zo kwaad op het werk/op school dat ik iets kan 
doen, waarvan ik spijt zou kunnen krijgen.
3
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Doelstelling 
Het hoofddoel van dit proefschrift was om een feedbackmodel voor routine outcome 
monitoring (ROM) te ontwikkelen voor ambulante kortdurende psychiatrische en 
psychotherapeutische behandelingen in Nederland. Om dit doel te bereiken moest een 
aantal stappen worden gezet. De eerste stap was om de kwaliteit van de Nederlandse 
vertaling van de Outcome Questionnaire (OQ-45; Lambert et al., 2004) te onderzoeken 
(Hoofdstuk 2). Deze vragenlijst wordt gebruikt als uitkomstmaat in de onderzoeken 
in de rest van het proefschrift. De tweede stap was om te bepalen wat gemiddeld 
gezien het behandelverloop is van patiënten en welke factoren geassocieerd zijn 
met een verhoogd risico op negatieve behandeluitkomsten (Hoofdstuk 4). Hiervoor 
werden gegevens verzameld bij drie GGZ-instellingen. Er werd gebruik gemaakt 
van geavanceerde statistische technieken om negatieve behandeluitkomsten te 
voorspellen. De derde stap was het onderzoeken van de effectiviteit van het geven 
van feedback over het behandelverloop. Hiervoor werden twee onderzoeken gedaan. 
In elk onderzoek was de feedback anders vormgegeven. Eerst werd bekeken hoe groot 
de steekproeven in de onderzoeken moesten zijn om een effect te kunnen vinden 
(power) (Hoofdstuk 3). In het eerste feedbackonderzoek werd alleen aan behandelaars 
feedback gegeven. Dit werd vergeleken met geen feedback (Hoofdstuk 5). In het 
tweede onderzoek werd feedback aan behandelaars vergeleken met feedback aan 
zowel behandelaars als patiënten en geen feedback (Hoofdstuk 6). Verder werd 
onderzocht of eigenschappen van behandelaars invloed hebben op de mate waarin 
behandelaars gebruik maken van de feedback en op de effectiviteit van de feedback 
(Hoofdstuk 5).
Cross-culturele validatie van de OQ-45
De cross-culturele validatie van de OQ-45 liet zien dat de Amerikaanse en Nederlandse 
versies van de OQ-45 vergelijkbaar waren in betrouwbaarheid en validiteit, maar 
er werden verschillen gevonden in de factorstructuur en de normen. Voor de 
drie-factor structuur van de OQ-45 met de subschalen Symptomatische Distress 
(SD), Interpersoonlijke Relaties (IR) en Sociale Rol (SR) was geen sterk bewijs in de 
Amerikaanse versie. In de Nederlandse versie paste deze structuur beter, maar was 
nog steeds niet voldoende goed. Verdere analyses leidden tot het toevoegen van een 
extra factor, die aanvullend op de drie oorspronkelijke factoren gebruikt kan worden. 
Deze factor, Angst en Somatische Distress (ASD) genoemd, is vooral interessant 
voor het meten van uitkomsten bij patiënten met angst- of psychosomatische 
stoornissen. Een vergelijking van de Amerikaanse en Nederlandse normen liet zien 
dat de Nederlandse normale populatie en poliklinische populatie wat lager scoren 
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dan Amerikaanse populaties. Deze verschillen leidden ertoe dat de grenswaarde voor 
normaal functioneren bij de Nederlandse populatie (55) acht punten lager ligt dan 
de Amerikaanse grenswaarde. De sensitiviteit en specificiteit waren vergelijkbaar met 
die van de originele Amerikaanse versie. De reliable change index (een maat voor 
statistisch betrouwbare verandering) was gelijk voor de twee versies (14 punten). Een 
verschil tussen de Amerikaanse en Nederlandse normen was dat er in de Nederlandse 
populatie sekseverschillen gevonden werden. Mannen hadden meer problemen op 
de sociale rol schaal, terwijl vrouwen een hoger klachtenniveau hadden op de schaal 
symptomatische distress en de schaal angst- en somatische distress.
De betrouwbaarheid van de subschalen en totaalscore was voldoende tot goed, 
met uitzondering van de sociale rol schaal. De gevoeligheid voor verandering was 
uitstekend en de OQ-45 kon goed onderscheiden tussen de normale en disfunctionele 
populaties. De concurrente validiteit van de schalen voor symptomatische distress 
en angst- en somatische distress was goed, maar was minder sterk voor de schalen 
interpersoonlijke relaties en sociale rol. Samenvattend kan gezegd worden dat de 
Nederlandse versie van de OQ-45 voldoende tot goede psychometrische kenmerken 
heeft.
Power in drie-level multilevel modellen met behandelaareffecten
Multilevel analyse, een vorm van regressieanalyse met geneste data waarbij patiënten 
bijvoorbeeld genest zijn binnen behandelaars, is de laatste jaren steeds populairder 
geworden als methode om longitudinale data te analyseren. Dit komt mede doordat 
multilevel analyse zo flexibel om kan gaan met ontbrekende metingen. Tot op heden is er 
maar beperkt aandacht besteed aan poweranalyse in deze modellen. Hoofdstuk 3 laat de 
effecten zien van de intraclass correlatie coëfficiënt (ICC), het niveau van randomiseren, 
de steekproefgrootte, covariaten en drop-out op de power om een effect te vinden. Data 
uit routine outcome monitoring werden gebruikt als basis voor simulatieonderzoek. Er 
werd uitgegaan van een drie-level model, met behandelaars op het hoogste niveau (level 
3), patiënten binnen behandelaars op het middelste niveau (level 2) en metingen binnen 
patiënten op het laagste niveau (level 1). De resultaten lieten zien dat het effectiever 
voor de power was om patiënten willekeurig aan condities toe te wijzen (randomisatie) 
dan behandelaars. Het aantal patiënten vergroten was de beste manier om de power 
te verhogen wanneer de randomisatie op patiëntniveau plaatsvond. Bij randomisatie 
op behandelaarniveau was het toevoegen van meer behandelaars effectiever. Het 
vergroten van het aantal metingen per patiënt had weinig effect op de power in beide 
onderzoeksdesigns, net als het toevoegen van een covariaat. Drop-out had eveneens 
geen groot effect op de power, hoewel het de power wel enigszins verlaagde, vooral 
wanneer de drop-out in het begin van het onderzoek geconcentreerd was.
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Risicofactoren voor negatieve behandeluitkomsten
Omdat het voorkomen van negatieve uitkomsten een van de belangrijkste doelen van 
feedback aan behandelaars is, is het nuttig om te weten welke factoren geassocieerd 
worden met negatieve behandeluitkomsten. In hoofdstuk 4 was het doel om het risico 
op negatieve uitkomsten aan het einde van de behandeling te voorspellen. Uitkomsten 
werden op twee manieren bekeken: de snelheid van veranderen met multilevel 
analyse en het functioneren van de patiënt aan het einde van de behandeling met 
Classification And Regression Trees (CART). CART is een vorm van regressieanalyse 
waarbij automatisch gezocht wordt naar interacties tussen de voorspellers en 
resulteert in een voorspellingsmodel met een boomstructuur.
Er werden gegevens over het behandelverloop verzameld bij drie GGZ-
instellingen. Daarbij werd geen feedback gegeven aan behandelaars of patiënten. In 
totaal scoorde 51% van de patiënten in de steekproef (n = 1540) aan het einde van de 
behandeling vergelijkbaar met de normale populatie en kan derhalve als verbeterd 
worden beschouwd. In de CART analyse vonden we dat patiënten met relatief lage 
scores op de OQ-45 voor de start van de behandeling en patiënten met een hoger 
opleidingsniveau betere kansen hadden op positieve behandeluitkomsten. Een 
uitgebreider CART model liet zien hoe verwachtingen van patiënten over de uitkomst 
van de behandeling, scores op de sociale rol schaal, scores op de Global Assessment 
of Functioning (GAF) en de werkalliantie in de beginfase van de behandeling (Taak 
schaal) op verschillende manieren met elkaar interacteerden. In de multilevel analyse 
waren de werkalliantie in de beginfase van de behandeling (Taak of Doel subschaal), 
comorbiditeit op As I, het hebben van een persoonlijkheidsstoornis als hoofddiagnose 
en de GAF score voorspellend voor de snelheid van verandering bij patiënten. 
Er waren verschillen tussen de CART modellen en de multilevel modellen in hun 
gevoeligheid om negatieve uitkomsten te detecteren. Het eerste CART model (3 
takken) had een hoge sensitiviteit, maar een lage specificiteit, terwijl het multilevel 
model een hoge specificiteit had maar een lage sensitiviteit. Het uitgebreidere CART 
model (10 takken) had de beste balans tussen sensitiviteit en specificiteit.
Effect van feedback
Het effect van feedback op de uitkomst van de behandeling werd onderzocht in 
twee gecontroleerde gerandomiseerde onderzoeken. In het eerste onderzoek 
(Hoofdstuk 5) was het doel om de effectiviteit van ‘eenvoudige’ feedback (zonder 
waarschuwingssignalen of verwachte respons curves) te onderzoeken ten opzichte 
van geen feedback. In de literatuur zijn de grootste effecten van feedback gevonden bij 
het gebruik van meer complexe feedback modellen waarbij op basis van een statistisch 
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model een behandelverloop werd voorspeld voor de patiënt, waar het werkelijke 
behandelverloop tegen afgezet werd en waarbij de behandelaar een signaal kreeg als 
de patiënt teveel afweek van het verwachte beloop. De meeste outcome monitoring 
feedback systemen hebben deze functionaliteit echter niet en de effectiviteit van 
deze meer ‘eenvoudige’ systemen is onvoldoende onderzocht, terwijl deze wel op 
grote schaal gebruikt worden. Patiënten (n = 413) werden willekeurig toegewezen aan 
een controlegroep zonder feedback of de feedback conditie. Er werd verwacht dat de 
feedback vooral effectief zou zijn voor patiënten die niet goed vooruit gingen in de 
behandeling, de zogenaamde ‘not on track’ (NOT) patiënten. Tegen de verwachtingen 
in was de feedback echter niet effectiever dan geen feedback en er was geen interactie 
tussen feedback en NOT zijn voor patiënten. Echter, wanneer behandelaars aangaven 
dat ze de feedback actief gebruikt hadden in de behandeling, had het geven van 
feedback aan de behandelaar een significant positief effect voor NOT patiënten.
In het tweede onderzoek (Hoofdstuk 6) was het doel om het effect te laten zien van 
feedback aan zowel patiënt als behandelaar. Patiënten werden willekeurig toegewezen 
aan drie condities: geen feedback, feedback aan alleen de behandelaar en feedback 
aan behandelaar en patiënt. Feedback werd gegeven zonder voorspellingsmodel 
met verwacht behandelverloop, maar behandelaars kregen wel feedback berichten 
die aangaven of de patiënt verslechterd was of onvoldoende verandering had 
doorgemaakt. Er werden aparte analyses gedaan voor korte behandelingen (korter 
dan 35 weken) en langere behandelingen (35 weken of langer). Het effect van 
feedback was het sterkste bij NOT patiënten in korte behandelingen, wanneer 
feedback werd gegeven aan zowel de behandelaar als de patiënt. Feedback aan alleen 
de behandelaar was ook effectief bij NOT patiënten in korte behandelingen, maar in 
langere behandelingen was alleen feedback aan behandelaar en patiënt effectief. De 
feedback had vooral effect op de snelheid waarmee patiënten vooruitgingen in de 
behandeling, maar had geen significant effect op het niveau van functioneren van 
patiënten aan het einde van de behandeling.
Behandelaar effecten
Kenmerken van de behandelaars en de manier waarop zij feedback gebruiken spelen 
mogelijk een belangrijke rol in de effectiviteit van feedback. Immers, als behandelaars 
de feedback niet constructief gebruiken, is het onwaarschijnlijk dat de feedback 
de uitkomsten verbetert. Er werden diverse kenmerken van de behandelaar die 
potentieel van invloed zijn op de effectiviteit van de feedback onderzocht (Hoofdstuk 
5). Feedback wordt door behandelaars eerder geaccepteerd wanneer het van een 
betrouwbare bron komt, die persoonlijke relevantie heeft voor de ontvanger van de 
feedback. Dit concept wordt perceived validity genoemd. Een andere factor die van 
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belang is bij de acceptatie van feedback is de feedback voorkeur. Mensen met een 
interne feedback voorkeur vertrouwen meer op hun eigen oordeel dan op feedback 
uit een externe bron, terwijl mensen met een externe feedback voorkeur zelf actief 
feedback zoeken, ook bijvoorbeeld bij collega’s. Vertrouwen in de eigen competenties 
(self-efficacy) is een andere factor die van invloed is op het feedbackproces. Het verwijst 
naar het vertrouwen dat iemand heeft om een bepaalde taak succesvol uit te voeren. 
De motivatie om de feedback te gebruiken in de behandeling is ook een belangrijke 
factor, omdat bekend is dat behandelaars niet altijd gemotiveerd zijn om feedback te 
gebruiken en deze dan waarschijnlijk niet effectief is.
De resultaten van ons onderzoek lieten zien dat kenmerken van de behandelaar de 
effectiviteit van feedback modereren. Behandelaars met een hoge interne feedback 
voorkeur hadden patiënten die minder snel vooruit gingen in de behandeling dan 
patiënten van behandelaars met een lage interne feedback voorkeur. Behandelaars 
die voor aanvang van het onderzoek gemotiveerder waren om de feedback in 
de behandeling te gaan gebruiken, hadden patiënten die sneller vooruit gingen. 
Beide effecten traden op ongeacht of de behandelaar feedback ontving of niet en 
lijken te suggereren dat behandelaars met een open houding ten aanzien van 
feedback snellere vooruitgang boeken bij hun patiënten. Opvallend genoeg ging de 
verandering langzamer bij patiënten waarvan de behandelaar een hoge motivatie 
had om de feedback te gebruiken wanneer deze de feedback ook daadwerkelijk 
ontving. Verder gingen patiënten in de feedback conditie waarvan de behandelaar 
meer vertrouwen had in de eigen competenties sneller vooruit in de behandeling dan 
patiënten van behandelaars die minder vertrouwen hadden of dan patiënten in de 
controle conditie. Er werd geen effect gevonden van een externe feedback voorkeur 
en perceived validity. Behandelaars waren meer geneigd om de feedback daadwerkelijk 
te gebruiken in de behandeling als ze voorafgaand aan het onderzoek hoger scoorden 
op de motivatievragenlijst en vrouw waren.
Consequenties voor de praktijk
Routine outcome monitoring en het geven van feedback aan behandelaars is 
momenteel sterk in opkomst in Nederland, mede onder druk van de zorgverzekeraars. 
Dit proefschrift laat zien dat feedback een ingewikkeld proces is en dat vele factoren 
van invloed zijn op de effectiviteit ervan. De resultaten laten zien dat feedback geven 
over het behandelverloop effectief kan zijn, maar niet onder alle omstandigheden. 
De resultaten in hoofdstuk 6 suggereren dat feedback aan zowel patiënten als 
behandelaars het meest effectief is.
Feedback is bij voorkeur direct beschikbaar en vaker meten biedt meer 
mogelijkheden om negatieve uitkomsten te voorkomen. Het kan echter kostbaar 
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zijn om bij alle patiënten frequent te meten. De voorspellingsmodellen in Hoofdstuk 
4 kunnen een leidraad zijn om te bepalen welke patiënten een verhoogd risico 
hebben op negatieve uitkomsten en deze kunnen dan intensiever gevolgd worden 
in de behandeling. Bij andere patiënten kan dan minder vaak gemeten worden. Een 
alternatief is om bij alle patiënten gedurende de eerste sessies elke sessie te meten en 
daarna te bepalen hoe vaak verder meten noodzakelijk is. 
Onderzoek laat zien dat feedback effectiever is wanneer het specifieker is. In het 
kader daarvan is het nuttig om de uitkomsten uit te breiden met clinical support tools 
(zie Shimokawa, Lambert & Smart, 2010), die aangeven welke problemen er zijn en 
welke interventies mogelijk behulpzaam zijn, wanneer patiënten not on track zijn. 
Clinical support tools bevatten procesmaten, zoals de werkrelatie met de behandelaar 
en de motivatie van de patiënt en veel behandelaars geven de voorkeur aan dit 
type informatie boven uitkomstmetingen. Een ander aandachtspunt is dat niet alle 
behandelaars de feedback gebruiken en dat deze derhalve dan ook niet effectief kan 
zijn. Het krijgen van negatieve feedback kan onaangenaam zijn en erin resulteren 
dat de behandelaar de oorzaak voor de negatieve feedback, of het gebrek aan 
vooruitgang van de patiënt, buiten zichzelf legt, wat de effectiviteit van de feedback 
zou kunnen verminderen. Er zijn ook andere factoren die ervoor kunnen zorgen dat 
een behandelaar de feedback niet gebruikt, zoals geen tijd hebben om de feedback te 
bekijken of moeite hebben om de feedback te interpreteren.
Wat op individueel niveau geldt, is ook te vertalen naar een geaggregeerd niveau, 
bijvoorbeeld een organisatie of team. Anders dan bij feedback aan behandelaars gaat 
feedback op teamniveau vaak over afgesloten behandelingen en heeft het meer tot 
doel om te leren van de totale uitkomsten in een bepaalde periode of om beleid op te 
baseren. Het is te verwachten dat ook bij teams feedback het meest effectief is bij ‘not 
on track’ teams, oftewel teams die minder goede resultaten halen dan de standaard, 
maar het is ingewikkeld te bepalen wat de standaard zou moeten zijn. Benchmarken 
zou daar een oplossing voor kunnen bieden. 
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